
<html lang="en"     class="pb-page"  data-request-id="3d5978b1-18e0-45e2-9859-e8c4f4181687"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-2;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01921;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos" /></meta><meta name="dc.Creator" content="Mary E.  Matyskiela" /></meta><meta name="dc.Creator" content="Weihong  Zhang" /></meta><meta name="dc.Creator" content="Hon-Wah  Man" /></meta><meta name="dc.Creator" content="George  Muller" /></meta><meta name="dc.Creator" content="Godrej  Khambatta" /></meta><meta name="dc.Creator" content="Frans  Baculi" /></meta><meta name="dc.Creator" content="Matthew  Hickman" /></meta><meta name="dc.Creator" content="Laurie  LeBrun" /></meta><meta name="dc.Creator" content="Barbra  Pagarigan" /></meta><meta name="dc.Creator" content="Gilles  Carmel" /></meta><meta name="dc.Creator" content="Chin-Chun  Lu" /></meta><meta name="dc.Creator" content="Gang  Lu" /></meta><meta name="dc.Creator" content="Mariko  Riley" /></meta><meta name="dc.Creator" content="Yoshitaka  Satoh" /></meta><meta name="dc.Creator" content="Peter  Schafer" /></meta><meta name="dc.Creator" content="Thomas O.  Daniel" /></meta><meta name="dc.Creator" content="James  Carmichael" /></meta><meta name="dc.Creator" content="Brian E.  Cathers" /></meta><meta name="dc.Creator" content="Philip P.  Chamberlain" /></meta><meta name="dc.Description" content="The drugs lenalidomide and pomalidomide bind to the protein cereblon, directing the CRL4–CRBN E3 ligase toward the transcription factors Ikaros and Aiolos to cause their ubiquitination and degradat..." /></meta><meta name="Description" content="The drugs lenalidomide and pomalidomide bind to the protein cereblon, directing the CRL4–CRBN E3 ligase toward the transcription factors Ikaros and Aiolos to cause their ubiquitination and degradat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 20, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01921" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01921" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01921" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01921" /></link>
        
    
    

<title>A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01921" /></meta><meta property="og:title" content="A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0005.jpeg" /></meta><meta property="og:description" content="The drugs lenalidomide and pomalidomide bind to the protein cereblon, directing the CRL4–CRBN E3 ligase toward the transcription factors Ikaros and Aiolos to cause their ubiquitination and degradation. Here we describe CC-220 (compound 6), a cereblon modulator in clinical development for systemic lupus erythematosis and relapsed/refractory multiple myeloma. Compound 6 binds cereblon with a higher affinity than lenalidomide or pomalidomide. Consistent with this, the cellular degradation of Ikaros and Aiolos is more potent and the extent of substrate depletion is greater. The crystal structure of cereblon in complex with DDB1 and compound 6 reveals that the increase in potency correlates with increased contacts between compound 6 and cereblon away from the modeled binding site for Ikaros/Aiolos. These results describe a new cereblon modulator which achieves greater substrate degradation via tighter binding to the cereblon E3 ligase and provides an example of the effect of E3 ligase binding affinity with relevance to other drug discovery efforts in targeted protein degradation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01921"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01921">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01921&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01921&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01921&amp;href=/doi/10.1021/acs.jmedchem.6b01921" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 535-542</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01917" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00168" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+E.++Matyskiela">Mary E. Matyskiela</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weihong++Zhang">Weihong Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hon-Wah++Man">Hon-Wah Man</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Muller">George Muller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Godrej++Khambatta">Godrej Khambatta</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frans++Baculi">Frans Baculi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Hickman">Matthew Hickman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurie++LeBrun">Laurie LeBrun</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbra++Pagarigan">Barbra Pagarigan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gilles++Carmel">Gilles Carmel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chin-Chun++Lu">Chin-Chun Lu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Lu">Gang Lu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mariko++Riley">Mariko Riley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoshitaka++Satoh">Yoshitaka Satoh</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Schafer">Peter Schafer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+O.++Daniel">Thomas O. Daniel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Carmichael">James Carmichael</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+E.++Cathers">Brian E. Cathers</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+P.++Chamberlain">Philip P. Chamberlain</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6407-7344" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>1</sup>Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 858-795-4728. E-mail: <a href="/cdn-cgi/l/email-protection#4b3b28232a26292e39272a22250b282e272c2e252e65282426"><span class="__cf_email__" data-cfemail="8afae9e2ebe7e8eff8e6ebe3e4cae9efe6edefe4efa4e9e5e7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01921&amp;href=/doi/10.1021%2Facs.jmedchem.6b01921" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 535–542</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 20, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 January 2017</li><li><span class="item_label"><b>Published</b> online</span>20 April 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 January 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01921" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01921</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D535%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMary%2BE.%2BMatyskiela%252C%2BWeihong%2BZhang%252C%2BHon-Wah%2BMan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D2%26contentID%3Dacs.jmedchem.6b01921%26title%3DA%2BCereblon%2BModulator%2B%2528CC-220%2529%2Bwith%2BImproved%2BDegradation%2Bof%2BIkaros%2Band%2BAiolos%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D542%26publicationDate%3DJanuary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01921"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8038</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">77</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01921" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;E. Matyskiela&quot;},{&quot;first_name&quot;:&quot;Weihong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Hon-Wah&quot;,&quot;last_name&quot;:&quot;Man&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Muller&quot;},{&quot;first_name&quot;:&quot;Godrej&quot;,&quot;last_name&quot;:&quot;Khambatta&quot;},{&quot;first_name&quot;:&quot;Frans&quot;,&quot;last_name&quot;:&quot;Baculi&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Hickman&quot;},{&quot;first_name&quot;:&quot;Laurie&quot;,&quot;last_name&quot;:&quot;LeBrun&quot;},{&quot;first_name&quot;:&quot;Barbra&quot;,&quot;last_name&quot;:&quot;Pagarigan&quot;},{&quot;first_name&quot;:&quot;Gilles&quot;,&quot;last_name&quot;:&quot;Carmel&quot;},{&quot;first_name&quot;:&quot;Chin-Chun&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Mariko&quot;,&quot;last_name&quot;:&quot;Riley&quot;},{&quot;first_name&quot;:&quot;Yoshitaka&quot;,&quot;last_name&quot;:&quot;Satoh&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Schafer&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;O. Daniel&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Carmichael&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;E. Cathers&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;P. Chamberlain&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;535-542&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01921&quot;},&quot;abstract&quot;:&quot;The drugs lenalidomide and pomalidomide bind to the protein cereblon, directing the CRL4–CRBN E3 ligase toward the transcription factors Ikaros and Aiolos to cause their ubiquitination and degradation. Here we describe CC-220 (compound 6), a cereblon modulator in clinical development for systemic lupus erythematosis and relapsed/refractory multiple myeloma. Compound 6 binds cereblon with a higher affinity than lenalidomide or pomalidomide. Consistent with this, the cellular degradation of Ikaros and Aiolos is more potent and the extent of substrate depletion is greater. The crystal structure of cereblon in complex with DDB1 and compound 6 reveals that the increase in potency correlates with increased contacts between compound 6 and cereblon away from the modeled binding site for Ikaros/Aiolos. These results describe a new cereblon modulator which achieves greater substrate degradation via tighter binding to the cereblon E3 ligase and provides an example of the effect of E3 ligase binding affinity with relevan&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01921&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01921" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01921&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01921" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01921&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01921" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01921&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01921&amp;href=/doi/10.1021/acs.jmedchem.6b01921" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01921" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01921" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01921%26sid%3Dliteratum%253Aachs%26pmid%3D28425720%26genre%3Darticle%26aulast%3DMatyskiela%26date%3D2018%26atitle%3DA%2BCereblon%2BModulator%2B%2528CC-220%2529%2Bwith%2BImproved%2BDegradation%2Bof%2BIkaros%2Band%2BAiolos%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D2%26spage%3D535%26epage%3D542%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291781" title="Degradation">Degradation</a>,</li><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a>,</li><li><a href="/action/doSearch?ConceptID=292239" title="Surface interactions">Surface interactions</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/jmcmar.2018.61.issue-2/20180125/jmcmar.2018.61.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The drugs lenalidomide and pomalidomide bind to the protein cereblon, directing the CRL4–CRBN E3 ligase toward the transcription factors Ikaros and Aiolos to cause their ubiquitination and degradation. Here we describe CC-220 (compound <b>6</b>), a cereblon modulator in clinical development for systemic lupus erythematosis and relapsed/refractory multiple myeloma. Compound <b>6</b> binds cereblon with a higher affinity than lenalidomide or pomalidomide. Consistent with this, the cellular degradation of Ikaros and Aiolos is more potent and the extent of substrate depletion is greater. The crystal structure of cereblon in complex with DDB1 and compound <b>6</b> reveals that the increase in potency correlates with increased contacts between compound <b>6</b> and cereblon away from the modeled binding site for Ikaros/Aiolos. These results describe a new cereblon modulator which achieves greater substrate degradation via tighter binding to the cereblon E3 ligase and provides an example of the effect of E3 ligase binding affinity with relevance to other drug discovery efforts in targeted protein degradation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/61/2"><issue-title>Inducing Protein Degradation as a Therapeutic Strategy</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11473" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11473" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lenalidomide and pomalidomide are immunomodulatory drugs that are clinically effective in the treatment of cancer, including newly diagnosed and relapsed multiple myeloma.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These drugs target cereblon (CRBN), a substrate receptor for the CRL4 (CUL4–RBX1–DDB1) ubiquitin ligase complex.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Rather than inhibiting cereblon, ligand binding confers neomorphic activity, altering the substrate specificity of the ubiquitin ligase by promoting the recruitment of substrate proteins. Bound substrates are ubiquitinated by the cereblon–CRL4 complex, leading to their degradation by the 26S proteasome, thereby driving the clinical activity in myeloma.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Ikaros and Aiolos (encoded by the genes IKZF1 and IKZF3, respectively) were the first cereblon substrates to be identified, and it was demonstrated that the addition of cereblon modulating ligands triggers their recruitment and degradation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Ikaros and Aiolos are zinc finger transcription factors with critical roles in hematological development and differentiation,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and the downstream effects of degrading these proteins mediate the antiproliferative and immunomodulatory activities of lenalidomide and pomalidomide.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Polymorphisms in both IKZF1 and IKZF3 are associated with a risk of developing systemic lupus erythematosus (SLE).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Lenalidomide is further approved for use in 5q-deletion-associated myelodysplastic syndrome, where clinical activity has been associated with degradation of an additional substrate, the protein kinase Ck1a.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In addition, the translation termination factor GSPT1 has now been described as a ligand-directed substrate of the cereblon,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> highlighting the potential breadth of activity of cereblon modulators, as now three unrelated classes of substrate proteins, zinc finger transcription factors, protein kinases, and protein translation factors, have been targeted. The work on CK1a and GSPT1 further demonstrates the potential for ligand-substrate specificity, as CK1a is targeted to cereblon by lenalidomide but not by pomalidomide, and GSPT1 is targeted by a recently reported cereblon modulator<a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> but not by either lenalidomide or pomalidomide. Cereblon modulators therefore provide an important proof-of-principle for the further development of compounds targeting specific proteins for destruction that may have previously been considered undruggable.</div><div class="NLM_p">Structural studies have shown that cereblon modulators bind to cereblon through the glutarimide moiety, which docks into a hydrophobic tritryptophan pocket formed by Trp380, Trp386, and Trp400.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This binding mode leaves the insoindolinone/phthalimide ring of the compounds exposed on the cereblon surface, and it was predicted that this would form a hotspot of unsatisfied hydrogen bonds that would mediate substrate binding via direct protein–protein interactions.<a onclick="showRef(event, 'cit8a cit9a'); return false;" href="javascript:void(0);" class="ref cit8a cit9a">(8a, 9a)</a> Subsequent structural and mutagenesis studies on cereblon–substrate complexes have confirmed this hypothesis and surprisingly revealed that unrelated proteins CK1a and GSPT1 bind to cereblon through a common structural feature, thereby defining a degron.<a onclick="showRef(event, 'cit8b ref10'); return false;" href="javascript:void(0);" class="ref cit8b ref10">(8b, 10)</a> The enhancement of protein–protein interactions by a small molecule is highly reminiscent of the “molecular glue” mechanism described for the plant hormones auxin and jasmonate.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This mechanism contrasts with the linker-based approaches, where heterobifunctional ligands recruit substrates to a ligase via distinct small molecule binding events on each side of a linker.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p last">Here we describe the cereblon modulator CC-220 (compound <b>6</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> which is currently in phase 2 clinical trials for the treatment of systematic lupus erythematosus (SLE) and phase 1b/2a clinical trials for relapsed and refractory multiple myeloma (MM). We demonstrate that compound <b>6</b> has a higher affinity for cereblon than lenalidomide or pomalidomide. Consistent with these findings, compound <b>6</b> has a higher potency for the cellular degradation of Ikaros and Aiolos. The crystal structure of compound <b>6</b> bound to CRBN–DDB1 reveals that there are additional contacts with the surface of cereblon compared to lenalidomide or pomalidomide. These results provide a demonstration that increased target degradation can be achieved by alterations of the ligand binding affinity for the ligase and supports the further evaluation of compound <b>6</b> in the clinic.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Compound <b>6</b> Is a Cereblon Modulator with Improved Biochemical and Cellular Potencies</h3><div class="NLM_p">Like lenalidomide and pomalidomide, compound <b>6</b> contains a glutarimide ring that binds in the try-tryptophan pocket of cereblon and an isoindolinone ring that can interact with both cereblon and substrates (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a). In addition, the chemical structure of compound <b>6</b> is extended compared to lenalidomide and pomalidomide, containing additional phenyl and morpholino moieties enabling further interactions with cereblon or substrates. To determine the relative binding affinities between lenalidomide, pomalidomide, and compound <b>6</b>, we used a TR-FRET cereblon binding assay to determine the IC<sub>50</sub> values for these compounds. This assay monitors the displacement of a Cy5-conjugated cereblon modulating compound (compound <b>7</b>) from the tri-trp pocket of CRBN. Under these assay conditions, the IC<sub>50</sub> values for lenalidomide and pomalidomide were similar at 1.5 and 1.2 μM, respectively, while compound <b>6</b> exhibited significantly higher affinity with an IC<sub>50</sub> of approximately 60 nM (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b). IC<sub>50</sub>s for lenalidomide and pomalidomide have been previously reported in multiple assay formats. The potencies reported here are comparable to the values determined from thermal shift studies, where lenalidomide and pomalidomide showed similar potencies toward cereblon (both ∼3 μM).<a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">(3a)</a> A fluorescence polarization-based assay reported ∼10-fold more potent binding (∼150 nM),<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> however this is likely due to the different assay formats, and lenalidomide and pomalidomide were approximately equipotent which is consistent with this study. A cereblon FRET assay has also been previously reported,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> however the concentrations of protein used would preclude assessment of potent compounds such as compound <b>6</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Chemical structures of selected clinical stage cereblon modulators including compound <b>6</b>. (b) Determination of the relative cereblon binding affinities for compound <b>6</b>, lenalidomide, and pomalidomide by TR-FRET. IC<sub>50</sub>s under these conditions were 1.5 μM for lenalidomide (circles), 1.2 μM for pomalidomide (diamonds), and 60 nM for compound <b>6</b> (squares).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistent with increased biochemical binding affinity, we also observe greater potency of compound <b>6</b> in cellular degradation assays measuring the ligand-dependent depletion of Ikaros or Aiolos. However, compound <b>6</b> does not significantly degrade GSPT1 or CK1α (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf" class="ext-link">Figure S1</a>, and data not shown). To measure the effects of compound treatment on Ikaros and Aiolos degradation in cells, we used a cell-based assay that follows the chemiluminescent signal of proteins incorporating an ePL tag. We find that treatment with compound <b>6</b> results in the loss of Ikaros protein levels with an EC<sub>50</sub> of 1 nM compared to 67 nM for lenalidomide and 24 nM for pomalidomide. Compound <b>6</b> is similarly potent toward Aiolos, with an EC<sub>50</sub> of 0.5 nM compared to 87 nM for lenalidomide and 22 nM for pomalidomide. In addition, the extent of substrate depletion is more dramatic with compound <b>6</b>, indicating more efficient substrate degradation relative to the rate of protein resynthesis. The increase in the cellular degradation potency of compound <b>6</b> corresponds with the increase in binding affinity observed in the biochemical assay, suggesting that the increase in cereblon affinity likely contributes to the increase in cellular potency. In contrast, the 3–4-fold increase in cellular potency observed for pomalidomide compared to lenalidomide is more likely driven by other factors, such as the alteration of substrate recruitment affinity or physicochemical properties of the compound.</div><div class="NLM_p">To confirm these effects are relevant with respect to the endogenous proteins, we treated DF15 and OPM2 myeloma cell lines<a onclick="showRef(event, 'cit3a ref15'); return false;" href="javascript:void(0);" class="ref cit3a ref15">(3a, 15)</a> with lenalidomide, pomalidomide, and compound <b>6</b> for 5 h (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). Compound <b>6</b> treatment led to greater degradation of Ikaros and Aiolos compared to lenalidomide and pomalidomide, consistent with the results from the chemiluminescence-based cellular degradation assay.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Quantitation of Ikaros degradation with chemiluminescent cell-based assay. EC<sub>50</sub>s determined were 67 nM for lenalidomide (circles), 24 nM for pomalidomide (diamonds), and 1 nM for compound <b>6</b> (squares). (b) Quantitation of Aiolos degradation with chemiluminescent cell-based assay. EC<sub>50</sub>s determined were 87 nM for lenalidomide (circles), 22 nM for pomalidomide (diamonds), and 0.5 nM for compound <b>6</b> (squares). (c) Immunoblot analysis of whole-cell extracts of DF15 and OPM2 cells incubated for 5 h with DMSO, lenalidomide, pomalidomide, or compound <b>6</b> at the indicated concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Crystal Structure of Cereblon in Complex with DDB1 and Compound <b>6</b></h3><div class="NLM_p">To examine the mechanism of higher affinity binding by compound <b>6</b>, we determined the crystal structure of the ternary complex of compound <b>6</b> bound to human cereblon (aa 40–442) and human DDB1 (full length) at 3.2 Å resolution. Data collection statistics are in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf" class="ext-link">Supporting Information</a>, along with sample electron density (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf" class="ext-link">Table S1 and Figure S3</a>). The overall structure was highly similar to the previously reported cereblon–DDB1 structures, with the binding site for cereblon modulators on the opposite face of cereblon compared to the DDB1 interaction site.</div><div class="NLM_p">The glutarimide ring of compound <b>6</b> binds in the tri-trp pocket in a similar binding mode to the previously reported structures, and the isoindolinone ring is presented on the surface in a similar binding mode to lenalidomide and other reported analogues<a onclick="showRef(event, 'cit8b ref9 ref10'); return false;" href="javascript:void(0);" class="ref cit8b ref9 ref10">(8b, 9, 10)</a> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, for a detailed structural comparison of compound <b>6</b> and lenalidomide binding modes, see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf" class="ext-link">Figure S2</a>). Compound <b>6</b> has an extended structure compared to lenalidomide and pomalidomide (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a), and the crystal structure shows that the phenyl ring of compound <b>6</b> is positioned inside a groove on the cereblon surface formed by E377, H378, P352, and H353 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). The morpholine ring is oriented toward a hydrophobic pocket formed of residues I154 and F102, however this moiety is poorly defined in the electron density, possibly due to motion (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf" class="ext-link">Figure S3</a>). F150 is positioned adjacent to the morpholino group of compound <b>6</b>, in contrast to some other structures, where this is found in an extended conformation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b<a onclick="showRef(event, 'cit8b cit9a'); return false;" href="javascript:void(0);" class="ref cit8b cit9a">(8b, 9a)</a>). However, this conformation should be interpreted with caution as F150 occurs at the apex of a loop that has exhibited mobility in other structures, and often participates in crystal lattice contacts.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) The crystal structure of cereblon (blue) in complex with DDB1 (green) and compound <b>6</b> (yellow sticks). Inset: detail of bound compound <b>6</b>, with the glutarimide ring docked in the tri-trp pocket and the phenyl ring extending from the isoindolinone positioned in a groove formed by E377, H378, P352, and H353 of cereblon. (b) Comparison of the binding surface interactions of lenalidomide (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZ4">4TZ4</a>, left panel) and compound <b>6</b> (yellow, this study, right panel) with cereblon (blue, surface representation). Cereblon surface residues that were previously shown to mediate binding to Ikaros by mutational studies are shown in orange.<a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> The amino acid side chain F150 is labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The structures of cereblon in complex with CK1a and GSPT1 revealed that the primary site of cereblon substrate interactions is shared between the characterized substrates, and docking and mutagenesis studies predicted the same site of interaction for Ikaros and Aiolos.<a onclick="showRef(event, 'cit8b ref10'); return false;" href="javascript:void(0);" class="ref cit8b ref10">(8b, 10)</a> This site of interaction is formed by three hydrogen bond donors on cereblon, N351, H357, and W400, which are positioned proximal to the isoindolinone or phthalimide rings of bound cereblon modulators (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). These residues (shown in orange surface representation in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b) are positioned away from the phenyl and morpholine rings of compound <b>6</b>, such that differences in compound activity are unlikely to be the result of direct substrate interactions of these moieties with Ikaros or Aiolos. Instead, a comparison of the crystal structures of lenalidomide and compound <b>6</b> bound to cereblon–DDB1 reveals that the observed increase in affinity correlates well with the increased surface interactions between compound <b>6</b> and cereblon (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">These results describe a new cereblon modulator which achieves potent cellular degradation of the transcription factors Ikaros and Aiolos. We find that the cellular potency increase correlates with a higher affinity between compound <b>6</b> and cereblon, which is likely driving higher occupancy of cereblon in the cell and effectively increasing the active fraction of cereblon–CRL4 enzyme capable of binding to substrate. The extended chemical moieties relative to lenalidomide and pomalidomide appear to enhance the surface area of compound <b>6</b> that contacts cereblon, which correlates with the observed binding affinity increase in biochemical assays. Furthermore, the 20-fold increase in binding affinity in vitro observed compared to lenalidomide correlates well with the increased potency of compound <b>6</b> in cellular degradation of Ikaros and Aiolos. However, potency increases are not always driven by enhanced cereblon binding affinity. For example, lenalidomide and pomalidomide have similar IC<sub>50</sub> values in the TR-FRET assay (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and yet pomalidomide is 3–4-fold more potent than lenalidomide in the cell-based chemiluminescent degradation assays. In this case, additional factors including increased affinity for substrates, physcicochemical properties, or other pharmacological differences may be contributing to the differences in compound potency.</div><div class="NLM_p">The crystal structures of cereblon–DDB1 in complex with the bound substrates CK1a or GSPT1 revealed a common site of interaction on the cereblon surface, which docking and mutagenesis studies indicated are shared by Ikaros. It is interesting, therefore, to consider whether the modified structure of compound <b>6</b> would in some way contribute to the cereblon–Ikaros interaction. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b, the phenyl and morpholino groups of compound <b>6</b> are positioned in an orientation away from the site where the zinc finger domain of Ikaros is predicted to interact on the surface of cereblon, indicating that the observed differences in potency are more likely to be driven by the improved compound <b>6</b>–cereblon interactions than by additional substrate interactions. This system will benefit from a kinetic analysis of substrate and compound binding in order to fully characterize the contributions of cereblon versus substrate binding and ubiquitination to the increased potency of the compound.</div><div class="NLM_p last">Robust ligand-directed substrate degradation requires many sequential steps (ligand binding, substrate recruitment, ubiquitination, release, proteosomal degradation), representing a potentially complex system for medicinal chemistry optimization compared to classical small molecule inhibitors. As such, there are many factors that could lead to alteration of cellular efficacy of a ligase modulator. This study describes one strategy for improving substrate degradation rates by enhancing ligand interactions and affinity with the ligase while describing a next-generation clinical stage cereblon modulator with improved activity against Ikaros and Aiolos. The resulting increase in potency is expected to contribute to clinical outcomes in the treatment of both SLE and relapsed/refractory MM.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Chemistry</h3><div class="NLM_p">Proton and carbon magnetic resonance (<sup>1</sup>H NMR and <sup>13</sup>C NMR) spectra were recorded on a Bruker UltraShield 300 spectrometer and are reported in ppm relative to the reference solvent of the sample in which they were run. HPLC and LC-MS analyses were conducted using a Waters Aquity HPLC system and Water Aquity PDA detector at 240 nm with the MS detection using Waters Aquity SQ spectrometer. All flash column chromatography was performed on EM Science silica gel 60 (particle size of 40–60 μm). All reagents were purchased from commercial sources and used without further purification unless otherwise noted. All reactions were performed under an inert atmosphere. HPLC analyses were performed using the following conditions.</div><div class="NLM_p last">All final compounds had an HPLC purity of ≥95% unless specifically mentioned.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> HPLC Method</h3><div class="NLM_p last">A linear gradient (<i>t</i> = 0 min, 5% B; <i>t</i> = 15 min, 95% B) using 5% acetonitrile, 95% water with 0.1% phorsphoric acid (solvent A) and 95% acetonitrile, 5% water with 0.1% phorsphoric acid (solvent B) was employed on a Waters Symmetry C18, 5 μm, 3.9 mm × 150 mm column. Flow rate was 1 mL/min, and UV detection was set to 240 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chiral HPLC Method</h3><div class="NLM_p last">An isocratic gradient using 50% 10 mM NH<sub>4</sub>OAc in H<sub>2</sub>O (sovlent A) and 50% acetonitrile (solvent B) was employed on a CHIRALPAK AGP, 5 μm, 4.0 mm × 150 mm column. Flow rate was 1 mL/min, and UV detection was set to 240 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Synthesis of Compound <b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h3><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the synthesis started with optically pure (<i>S</i>)-3-(4-hydroxy-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione (<b>1</b>), which was alkylated with 1,4-bis(bromomethyl)benzene (<b>2</b>) in the presence of potassium carbonate to furnish bromide (<b>3</b>). Reaction of the bromide (<b>3</b>) with morpholine (<b>4</b>) afforded <b>5</b>. Subsequent cyclization of <b>5</b> with potassium <i>tert</i>-butoxide at −78 °C proceeded to give imide (compound <b>6</b>) in a yield of 82% with a HPLC purity of 98.5%. The configuration of compound <b>1</b> was assigned based on the commercially available startling material, (<i>S</i>)-methyl 4,5-diamino-5-oxopentanoate hydrochloride. The configuration and chiral purity of <b>3</b> and <b>5</b> were not measured. However, the chiral purity of compound <b>6</b> was determined to be greater than 99% by chiral HPLC. Thus, the configuration of compound <b>6</b> was assigned as the <i>S</i>-isomer. Compound <b>6</b> is chirally stable in vivo. During DMPK study dosing with compound <b>6</b> (ee >99%), <i>R</i>-enantiomer was observed at low levels (<3% in monkey and <6% in rat).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> (<i>S</i>)-3-(4-Hydroxy-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione (<b>1</b>)</h4><div class="NLM_p last">(<i>S</i>)-methyl 4,5-diamino-5-oxopentanoate hydrochloride (58.7 g, 299 mmol) was added to a solution of methyl 2-(bromomethyl)-3-(<i>tert</i>-butyldimethylsilyloxy)benzoate (113 g, 299 mmol) in acetonitrile (1 L) to form a suspension. <i>N</i>-Ethyl-<i>N</i>-isopropylpropan-2-amine (104 mL, 597 mmol) was then added, and the resulting mixture was stirred at 40 °C overnight. The reaction mixture was concentrated under vacuum to give yellow solid. The solid was dissolved in ether (900 mL) and washed by aq HCl (1N, 750 mL), satd aq NaHCO<sub>3</sub> (2 × 350 mL), and brine (600 mL). The organic layer was concentrated to give (<i>S</i>)-methyl 5-amino-4-(4-(<i>tert</i>-butyldimethylsilyloxy)-1-oxoisoindolin-2-yl)-5-oxopentanoate as yellow oil. Without further purification, to the oil was added DMF (500 mL) and water (55 mL). The solution was added to K<sub>2</sub>CO<sub>3</sub> (16.18 g, 117 mmol). The resulting suspension was stirred at room temperature for 1 h. HCl (12N, 19.5 mL) and acetonitrile (290 mL) were then added to the suspension. The resulting suspension was filtered, and the filtrate was concentrated in vacuo. Then 70 mL of acetonitrile was added to the resulting oil and heated to 50 °C until a solution formed. The solution was cooled gradually to room temperature, and the resulting suspension was filtered. Solid was dried to give compound <b>1</b> (25 g, 30%); HPLC purity 97.6%; mp 163–165 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.33 (s, 9 H), 1.88–2.08 (m, 1 H), 2.08–2.27 (m, 3 H), 4.32 (d, <i>J</i> = 17.42 Hz, 1 H), 4.49 (d, <i>J</i> = 17.42 Hz, 1 H), 4.72 (dd, <i>J</i> = 10.22, 4.26 Hz, 1 H), 6.92–7.08 (m, 1 H), 7.09–7.26 (m, 2 H), 7.26–7.47 (m, 1 H), 7.57 (s, 1 H), 10.04 (s, 1 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.86, 30.32, 44.76, 51.24, 53.30, 113.63, 117.78, 128.15, 128.20, 133.51, 152.44, 168.13, 171.76, 172.48. LCMS: M + 1 279. Anal. Calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>: C, 57.53; H, 5.52; N, 9.58. Found: C, 57.35; H, 5.27; N, 9.45.</div></div><div id="sec4_3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> 4-[4-(4-Bromomethylbenzyloxy)-l-oxo-1,3-dihydro-isoindol-2-yl]-4-carbamoylbutyric Acid Methyl Ester (<b>3</b>)</h4><div class="NLM_p last">In a 2 L round-bottom flask were charged (<i>S</i>)-methyl 5-amino-4-(4-hydroxy-l-oxoisoindolin-2-yl)-5-oxopentanoate (<b>1</b>) (30 g, 103 mmol), 1,4-bis(bromomethyl)benzene (<b>2</b>) (81 g, 308 mmol), potassium carbonate (14.19 g, 103 mmol), and acetonitrile (1.2 L). The mixture was stirred at 50 °C for 12 h then cooled to room temperature. The mixture was filtered, and the filtrate was concentrated on rota-vap. The resulting solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and purified on silica gel columns eluted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH to give 4-[4-(4-bromomethylbenzyloxy)-l-oxo-1,3-dihydro-isoindol-2-yl]-4-carbamoylbutyric acid methyl ester (<b>3</b>) as white solid (40 g, 82% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.98–2.13 (m, 1H, CHH), 2.14–2.23 (m, 1H, CHH), 2.23–2.32 (m, 2H, CHH, CHH), 3.50 (s, 3H, CH<sub>3</sub>), 4.34–4.63 (m, 2H, CH<sub>2</sub>), 4.67–4.80 (m, 3H, CH<sub>2</sub>, NCH), 5.25 (s, 4H, CH<sub>2</sub>), 7.19 (s, 1H, NHH), 7.24–7.34 (m, 2H, Ar), 7.41–7.54 (m, 5H, Ar), 7.58 (br s, 1H, NHH). LCMS: M + 1 475.</div></div><div id="sec4_3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 4-Carbamoyl-4-[4-(4-morpholin-4-ylmethyl-benzyloxy)-l -oxo-1,3-dihydro-isoindol-2-yl]-butyric Acid Methyl Ester (<b>5</b>)</h4><div class="NLM_p last">Morpholine (<b>4</b>) (14.72 mL, 169 mmol) was added to the CH<sub>2</sub>Cl<sub>2</sub> solution of methyl 5-amino- 4-(4-(4-(bromomethyl)benzyloxy)-l-oxoisoindolin-2-yl)-5-oxopentanoate (<b>3</b>) (36.5 g, 77 mmol) at room temperature. The mixture was stirred at room temperature for 1 h. The resulting suspension was filtered, and the filtrate was concentrated on rota-vap. The resulting oil was dissolved in EtOAc and washed with water (50 mL × 3). The organic layer was concentrated on rota-vap to give 4-carbamoyl-4-[4-(4-morpholin-4-ylmethyl-benzyloxy)-l-oxo-1,3-dihydro-isoindol-2-yl]-butyric acid methyl ester (<b>5</b>) as a foamy solid (39 g, 95% yield); mp 66–68 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 2.00–2.12 (m, 1H, CHH), 2.14–2.22 (m, 1H, CHH), 2.22–2.29 (m, 2H, CHH, CHH), 2.30–2.39 (m, 4H, CH<sub>2</sub>, CH<sub>2</sub>), 3.46 (s, 2H, CH<sub>2</sub>), 3.50 (s, 3H, CH<sub>3</sub>), 3.53–3.63 (m, 4H, CH<sub>2</sub>, CH<sub>2</sub>), 4.28–4.59 (m, 2H, CH<sub>2</sub>), 4.73 (dd, <i>J</i> = 4.7, 10.2 Hz, 1H, NCH), 5.22 (s, 2H, CH<sub>2</sub>), 7.14–7.23 (m, 1H, NHH), 7.26–7.39 (m, 4H, Ar), 7.41–7.51 (m, 3H, Ar), 7.58 (s, 1H, NHH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.82, 30.34, 44.78, 51.24, 53.12, 53.39, 62.09, 66.15, 69.35, 114.67, 115.13, 127.60, 129.00, 129.56, 130.18, 133.43, 135.32, 137.66, 153.43, 167.85, 171.74, 172.47. LCMS: M + 1 482.2. Anal. Calcd for C<sub>23</sub>H<sub>31</sub>N<sub>3</sub>O<sub>6</sub> + 0.3H<sub>2</sub>O: C, 64.13; H, 6.54; N, 8.63. Found: C, 63.89; H, 6.39; N, 8.56.</div></div><div id="sec4_3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 3-[4-(4-Morpholin-4-ylmethyl-benzyloxy)-oxo-1,3-dihydro-isoindol-2-yl]-piperidine-2,6-dione (<b>6</b>)</h4><div class="NLM_p last">To the THF solution of methyl 5-amino-4-(4-(4-(morpholinomethyl)benzyloxy)-yl-oxoisoindolin-2-yl)-5-oxopentanoate (<b>5</b>) (40 g, 83 mmol) was added potassium <i>tert</i>-butoxide (9.80 g, 87 mmol) at −78 °C. The mixture was stirred at this temperature for 30 min, then 45 mL of 1 N HCl solution was added to the reaction mixture, followed by 200 mL of saturated NaHCO<sub>3</sub> solution. The mixture was diluted with 500 mL of EtOAc at 0 °C, stirred for 5 min, and separated. The organic layer was washed with water (50 mL × 3), brine (100 mL) and concentrated on rota-vap to give a white solid, which was stirred in diethyl ether (300 mL) to give a suspension. The suspension was filtered to give 3-[4-(4-morpholin-4-ylmethyl-benzyloxy)-oxo-1,3-dihydro-isoindol-2-yl]-piperidine-2,6-dione (<b>6</b>) as white solid (28.5 g, 72% yield). HPLC: Waters Symmetry C18, 5 μm, 3.9 mm × 150 mm, 1 mL/min, 240 nm, gradient to 95/5 acetonitrile/0.1% H<sub>3</sub>PO<sub>4</sub> in 5 min, RT = 4.78 min (98.5%); Chiral HPLC (Chiralpak AGP column, 4.0 mm × 150 mm, 5 μm particle size, isocratic 50% 10 mM NH<sub>4</sub>OAc in H<sub>2</sub>O and 50% acetonitrile) RT = 8.15 min (0.5%, <i>R</i>-isomer), RT = 10.33 min (99.5%, <i>S</i>-isomer); mp 209–211 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.86–2.09 (m, 1H, CHH), 2.29–2.38 (m, 4H, CH<sub>2</sub>, CH<sub>2</sub>), 2.44 (dd, <i>J</i> = 4.3, 13.0 Hz, 1H, CHH), 2.53–2.64 (m, 1H, CHH), 2.82–2.99 (m, 1H, CHH), 3.46 (s, 2H, CH<sub>2</sub>), 3.52–3.61 (m, 4H, CH<sub>2</sub>, CH<sub>2</sub>), 4.18–4.51 (m, 2H, CH<sub>2</sub>), 5.11 (dd, <i>J</i> = 5.0,13.3 Hz, 1H, NCH), 5.22 (s, 2H, CH<sub>2</sub>), 7.27–7.38 (m, 5H, Ar), 7.40–7.53 (m, 3H, Ar), 10.98 (s, 1H, NH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 22.36, 31.21, 45.09, 51.58, 53.14, 62.10, 66.17, 69.41,114.97, 115.23, 127.64, 128.99, 129.81, 129.95, 133.31, 135.29, 137.68, 153.50, 168.01, 170.98, 172.83. LCMS: M + 1 465. Anal. Calcd for C<sub>25</sub>H<sub>27</sub>N<sub>3</sub>O<sub>5</sub> + 0.86H<sub>2</sub>O: C, 64.63; H, 6.22; N, 9.04. Found: C, 64.39; H, 6.11; N, 8.89; H2O, 3.24.</div></div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Crystallography</h3><div class="NLM_p last">The purification of CRBN–DDB1 for crystallization was performed as previously described.<a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> Crystallization of CRBN–DDB1 with compound <b>6</b> was performed using sitting-drop vapor diffusion. Thirty mg/mL CRBN–DDB1 in the presence of 1 mM compound <b>6</b> was mixed 1:1 with, and subsequently equilibrated against, a mother liquor containing 200 mM sodium fluoride and 20% PEG 3350 at 20 C. Crystals were cryoprotected in the reservoir solution supplemented with 20% ethylene glycol and cooled under liquid nitrogen. Data was collected at the Advance Photon Source beamline LS-CAT 21ID-F. The complex crystal structure was solved by molecular replacement using Phaser with search model of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZ4">4TZ4</a>.<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> Subsequent manual model building using Coot and refinement were performed using Refmac5.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Data collection statistics and sample electron density can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf" class="ext-link">Supporting Information</a>. Coordinates have been deposited in the Protein Data Bank with the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V3O">5V3O</a>.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> TR-FRET Assay</h3><div class="NLM_p">The 6XHis-tagged full length human CRBN bound to full length human DDB1 used in the assay was purified as described elsewhere with the exception that the thrombin cleavage/ortho nickle step was removed.<a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> In the assay, 60 nM 6Xhis-tagged CRBN-DDB1 was combined with 30 nM cy5-conjugated cereblon modulator (compound <b>7</b>) and 3 nM LanthaScreen Eu-anti-His Tag antibody (ThermoFisher catalogue no. PV5596) in 20 mM HEPES pH 7, 150 mM NaCl, 0.005% Tween-20 assay buffer. FRET was observed by exciting at 340 nm and monitoring emission at 615 nm (non-FRET emission) and 665 nm (FRET emission), and FRET efficiency was determined by the ratio of FRET to non-FRET emission (665 nm/615 nm). Competing cereblon modulating compound or DMSO carrier was titrated and incubated for 10 min before scanning on the Envision plate reader with a 60 μs delay to quantitate loss of FRET efficiency. All FRET competition curves were processed and evaluated using ActivityBase (IDBS), a data analysis software package.</div><div class="NLM_p">The compound used in the FRET assay (compound <b>7</b>) is:</div><div id="sec4_3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-((1<i>E</i>,3<i>E</i>,5<i>Z</i>)-5-(1-(6-((4-(2-((2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)acetamido)butyl)amino)-6-oxohexyl)-3,3-dimethylindolin-2-ylidene)penta-1,3-dien-1-yl)-1,3,3-trimethyl-3<i>H</i>-indol-1-ium (Compound <b>7</b>)</h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0006.gif" alt="" id="fx1" /></img></div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cell-Based Chemiluminescent Substrate Degradation Assays</h3><div class="NLM_p last">DF15 multiple myeloma cells expressing cereblon substrates Ikaros, Aiolos, and GSPT1 fused to an ePL tag (DiscoverX) were dispensed into a 384-well plate (Corning no. 3712) prespotted with compound. Compounds were dispensed by an acoustic despenser (ATS acoustic transfer system from EDC Biosystems) into a 384-well plate in a 10-point dose response curve using 3-fold dilutions starting at 10 μM and going down to 0.0005 μM. Then 25 μL of media (RPMI-1640 + 10% heat inactivated FBS + 25 mM Hepes + 1 mM Na pyruvate + 1× NEAA + 0.1% Pluronic F-68 + 1× Pen Strep Glutamine) containing 5000 cells was dispensed per well. Assay plates were incubated at 37 °C with 5% CO<sub>2</sub> for 4 h. After incubation, 25 μL of the InCELL Hunter detection reagent working solution (DiscoverX, catalogue no. 96-0002, Fremont, CA) was added to each well and incubated at room temperature for 30 min protected from light. After 30 min, luminescence was read on a PHERAstar luminometer (Cary, NC). To determine the EC<sub>50</sub> value of a compound for the degradation of a given substrate (the half-maximum effective concentration), a four-parameter logistic model (sigmoidal dose–response model) (FIT = (<i>A</i> + {(<i>B</i> – <i>A</i>)/1 + [(<i>C</i>/<i>x</i>)<sup><i>D</i></sup>]})) where <i>C</i> is the inflection point (EC<sub>50</sub>), <i>D</i> is the correlation coefficient, and <i>A</i> and <i>B</i> are the low and high limits of the fit, respectively) was used. All substrate degradation curves were processed and evaluated using ActivityBase (IDBS), a data analysis software package.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Immunoblot Analysis of Endogenous Substrate Protein Levels</h3><div class="NLM_p last">First, 1 ×10<sup>6</sup> cells (either DF15 and OPM2) were treated with lenalidomide, pomalidomie, or compound <b>6</b> for 5 h before harvest. Then after quick 1× cold PBS rinse, cells were lysed by cell lysis buffer (Cell Signaling’s Technologies). Then 10 μg of total lysate was loaded in each lane. Proteins were transferred to nitrocellulose membrane using Bio-Rad’s Turbo System. Antibodies used in the Western included: Ikaros (14859S, Cell Signaling Technologies), Aiolos (15103S, Cell Signaling Technologies), actin (A5316, Sigma), and CRBN (in house antibody from Celgene).<a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">(3a)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01921">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85823" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85823" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01921" class="ext-link">10.1021/acs.jmedchem.6b01921</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Quantitation of GSPT1 degradation with chemiluminescent cell-based assay; comparison of lenalidomide and compound <b>6</b> binding modes; sample electron density from the CRBN-DDB1-compound <b>6</b> crystal structure; X-ray data and refinement statistics (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf">jm6b01921_si_001.pdf (580.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_002.csv">jm6b01921_si_002.csv (0.22 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates for the structure of CRBN-DDB1- <b>6</b> have been deposited in the Protein Data Bank with the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V3O">5V3O</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01921" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip P. Chamberlain</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6407-7344" title="Orcid link">http://orcid.org/0000-0002-6407-7344</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e8988b8089858a8d9a84898186a88b8d848f8d868dc68b8785"><span class="__cf_email__" data-cfemail="95e5f6fdf4f8f7f0e7f9f4fcfbd5f6f0f9f2f0fbf0bbf6faf8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary E. Matyskiela</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weihong Zhang</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hon-Wah Man</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Muller</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Godrej Khambatta</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frans Baculi</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Hickman</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurie LeBrun</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbra Pagarigan</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilles Carmel</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chin-Chun Lu</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Lu</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mariko Riley</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshitaka Satoh</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Schafer</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas O. Daniel</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Carmichael</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian E. Cathers</span> - <span class="hlFld-Affiliation affiliation">Celgene Corporation, 10300 Campus Point Drive, Suite
100, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Authors are or have been employees, consultants, or collaborators of Celgene.<br /></br></div></li></ul></div><div class="ack" id="ACK-d82e1240-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Shamrock Biostructures for data collection services. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> Abbreviations Used</h2><tr><td class="NLM_term">CRBN</td><td class="NLM_def"><p class="first last">cereblon</p></td></tr><tr><td class="NLM_term">IKZF1</td><td class="NLM_def"><p class="first last">Ikaros</p></td></tr><tr><td class="NLM_term">IKZF3</td><td class="NLM_def"><p class="first last">Aiolos</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systematic lupus erythematosus</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">multiple myeloma</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 16 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Dimopoulos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Current treatment landscape for relapsed and/or refractory multiple myeloma</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nrclinonc.2014.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnrclinonc.2014.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=25421279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2nu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=42-54&issue=1&author=M.+A.+Dimopoulosauthor=P.+G.+Richardsonauthor=P.+Moreauauthor=K.+C.+Anderson&title=Current+treatment+landscape+for+relapsed+and%2For+refractory+multiple+myeloma&doi=10.1038%2Fnrclinonc.2014.200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current treatment landscape for relapsed and/or refractory multiple myeloma</span></div><div class="casAuthors">Dimopoulos, Meletios A.; Richardson, Paul G.; Moreau, Philippe; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-54</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent developments in the treatment of multiple myeloma have led to improvements in response rates and to increased survival; however, relapse is inevitable in almost all patients.  Recurrence of myeloma is typically more aggressive with each relapse, leading to the development of treatment-refractory disease, which is assocd. with a shorter survival.  Several phase II and III trials have demonstrated the efficacy of recently approved agents in the setting of relapsed and/or refractory multiple myeloma, including immunomodulatory agents, such as lenalidomide and pomalidomide, and proteasome inhibitors, such as bortezomib and carfilzomib.  Currently, however, there is no std. treatment for patients with relapsed and/or refractory disease.  This Review discusses the current treatment landscape for patients with relapsed and/or refractory multiple myeloma and highlights disease-related and patient-related factors-such as pre-existing comorbidities or toxicities-that are important considerations for clinicians when selecting an appropriate treatment regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM2K0P45qZfbVg90H21EOLACvtfcHk0lik5Sw6CPKQXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2nu7fM&md5=cf51cf7abe3a77cc2cf4697280ee9ac7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2014.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2014.200%26sid%3Dliteratum%253Aachs%26aulast%3DDimopoulos%26aufirst%3DM.%2BA.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DMoreau%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DCurrent%2520treatment%2520landscape%2520for%2520relapsed%2520and%252For%2520refractory%2520multiple%2520myeloma%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D12%26issue%3D1%26spage%3D42%26epage%3D54%26doi%3D10.1038%2Fnrclinonc.2014.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span> </span><span class="NLM_article-title">Identification of a primary target of thalidomide teratogenicity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x"> (</span><span class="NLM_issue">5971</span><span class="NLM_x">) </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span><span class="refDoi"> DOI: 10.1126/science.1177319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1126%2Fscience.1177319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=20223979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=1345-1350&issue=5971&author=T.+Itoauthor=H.+Andoauthor=T.+Suzukiauthor=T.+Oguraauthor=K.+Hottaauthor=Y.+Imamuraauthor=Y.+Yamaguchiauthor=H.+Handa&title=Identification+of+a+primary+target+of+thalidomide+teratogenicity&doi=10.1126%2Fscience.1177319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Primary Target of Thalidomide Teratogenicity</span></div><div class="casAuthors">Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5971</span>),
    <span class="NLM_cas:pages">1345-1350</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects.  Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown.  Here, we identified cereblon (CRBN) as a thalidomide-binding protein.  CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.  Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the assocd. ubiquitin ligase activity.  This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivs. without teratogenic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPC_7RXLkfabVg90H21EOLACvtfcHk0liPyEAwQGresQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D&md5=4565a67837e0ec34ede2c93c1036f312</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1177319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1177319%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520primary%2520target%2520of%2520thalidomide%2520teratogenicity%26jtitle%3DScience%26date%3D2010%26volume%3D327%26issue%3D5971%26spage%3D1345%26epage%3D1350%26doi%3D10.1126%2Fscience.1177319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span> </span><span class="NLM_article-title">Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2326</span><span class="NLM_x">–</span> <span class="NLM_lpage">2335</span><span class="refDoi"> DOI: 10.1038/leu.2012.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fleu.2012.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=22552008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2326-2335&issue=11&author=A.+Lopez-Gironaauthor=D.+Mendyauthor=T.+Itoauthor=K.+Millerauthor=A.+K.+Gandhiauthor=J.+Kangauthor=S.+Karasawaauthor=G.+Carmelauthor=P.+Jacksonauthor=M.+Abbasianauthor=A.+Mahmoudiauthor=B.+Cathersauthor=E.+Rychakauthor=S.+Gaidarovaauthor=R.+Chenauthor=P.+H.+Schaferauthor=H.+Handaauthor=T.+O.+Danielauthor=J.+F.+Evansauthor=R.+Chopra&title=Cereblon+is+a+direct+protein+target+for+immunomodulatory+and+antiproliferative+activities+of+lenalidomide+and+pomalidomide&doi=10.1038%2Fleu.2012.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide</span></div><div class="casAuthors">Lopez-Girona, A.; Mendy, D.; Ito, T.; Miller, K.; Gandhi, A. K.; Kang, J.; Karasawa, S.; Carmel, G.; Jackson, P.; Abbasian, M.; Mahmoudi, A.; Cathers, B.; Rychak, E.; Gaidarova, S.; Chen, R.; Schafer, P. H.; Handa, H.; Daniel, T. O.; Evans, J. F.; Chopra, R.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2326-2335</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thalidomide and the immunomodulatory drug, lenalidomide, are therapeutically active in hematol. malignancies.  The ubiquitously expressed E3 ligase protein cereblon (CRBN) has been identified as the primary teratogenic target of thalidomide.  Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.  CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells, as well as lenalidomide- and pomalidomide-induced cytokine prodn. in T cells.  Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBNYW/AA.  Overexpression of CRBN wild-type protein, but not CRBNYW/AA mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated redns. in c-myc and IRF4 expression and increases in p21WAF-1 expression.  Long-term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a redn. in CRBN, while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide, CRBN protein was undetectable.  Our biophys., biochem. and gene silencing studies show that CRBN is a proximate, therapeutically important mol. target of lenalidomide and pomalidomide.  Leukemia (2012) 26, 2326-2335; doi:10.1038/leu.2012.119; published online 15 June 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp85RvB33HGjbVg90H21EOLACvtfcHk0liPyEAwQGresQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI&md5=81f83b5f6c4c043a35a049df3b4d63ae</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fleu.2012.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2012.119%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMendy%26aufirst%3DD.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKarasawa%26aufirst%3DS.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DP.%26aulast%3DAbbasian%26aufirst%3DM.%26aulast%3DMahmoudi%26aufirst%3DA.%26aulast%3DCathers%26aufirst%3DB.%26aulast%3DRychak%26aufirst%3DE.%26aulast%3DGaidarova%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DChopra%26aufirst%3DR.%26atitle%3DCereblon%2520is%2520a%2520direct%2520protein%2520target%2520for%2520immunomodulatory%2520and%2520antiproliferative%2520activities%2520of%2520lenalidomide%2520and%2520pomalidomide%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26issue%3D11%26spage%3D2326%26epage%3D2335%26doi%3D10.1038%2Fleu.2012.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4771</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span><span class="refDoi"> DOI: 10.1182/blood-2011-05-356063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1182%2Fblood-2011-05-356063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=4771-4779&issue=18&author=Y.+X.+Zhuauthor=E.+Braggioauthor=C.+X.+Shiauthor=L.+A.+Bruinsauthor=J.+E.+Schmidtauthor=S.+Van+Wierauthor=X.+B.+Changauthor=C.+C.+Bjorklundauthor=R.+Fonsecaauthor=P.+L.+Bergsagelauthor=R.+Z.+Orlowskiauthor=A.+K.+Stewart&title=Cereblon+expression+is+required+for+the+antimyeloma+activity+of+lenalidomide+and+pomalidomide&doi=10.1182%2Fblood-2011-05-356063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-05-356063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-05-356063%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DBraggio%26aufirst%3DE.%26aulast%3DShi%26aufirst%3DC.%2BX.%26aulast%3DBruins%26aufirst%3DL.%2BA.%26aulast%3DSchmidt%26aufirst%3DJ.%2BE.%26aulast%3DVan%2BWier%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DX.%2BB.%26aulast%3DBjorklund%26aufirst%3DC.%2BC.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DCereblon%2520expression%2520is%2520required%2520for%2520the%2520antimyeloma%2520activity%2520of%2520lenalidomide%2520and%2520pomalidomide%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26issue%3D18%26spage%3D4771%26epage%3D4779%26doi%3D10.1182%2Fblood-2011-05-356063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kronke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udeshi, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConkey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svinkina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciarlo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span> </span><span class="NLM_article-title">Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x"> (</span><span class="NLM_issue">6168</span><span class="NLM_x">) </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1126/science.1244851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1126%2Fscience.1244851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=24292625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A280%3ADC%252BC2c3itFajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=301-305&issue=6168&author=J.+Kronkeauthor=N.+D.+Udeshiauthor=A.+Narlaauthor=P.+Graumanauthor=S.+N.+Hurstauthor=M.+McConkeyauthor=T.+Svinkinaauthor=D.+Hecklauthor=E.+Comerauthor=X.+Liauthor=C.+Ciarloauthor=E.+Hartmanauthor=N.+Munshiauthor=M.+Schenoneauthor=S.+L.+Schreiberauthor=S.+A.+Carrauthor=B.+L.+Ebert&title=Lenalidomide+causes+selective+degradation+of+IKZF1+and+IKZF3+in+multiple+myeloma+cells&doi=10.1126%2Fscience.1244851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells</span></div><div class="casAuthors">Kronke Jan; Udeshi Namrata D; Narla Anupama; Grauman Peter; Hurst Slater N; McConkey Marie; Svinkina Tanya; Heckl Dirk; Comer Eamon; Li Xiaoyu; Ciarlo Christie; Hartman Emily; Munshi Nikhil; Schenone Monica; Schreiber Stuart L; Carr Steven A; Ebert Benjamin L</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6168</span>),
    <span class="NLM_cas:pages">301-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lenalidomide is a drug with clinical efficacy in multiple myeloma and other B cell neoplasms, but its mechanism of action is unknown.  Using quantitative proteomics, we found that lenalidomide causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase.  IKZF1 and IKZF3 are essential transcription factors in multiple myeloma.  A single amino acid substitution of IKZF3 conferred resistance to lenalidomide-induced degradation and rescued lenalidomide-induced inhibition of cell growth.  Similarly, we found that lenalidomide-induced interleukin-2 production in T cells is due to depletion of IKZF1 and IKZF3.  These findings reveal a previously unknown mechanism of action for a therapeutic agent: alteration of the activity of an E3 ubiquitin ligase, leading to selective degradation of specific targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQiiGR0Yx7nuYFEOhA_Im3cfW6udTcc2eYN7GqzpR-7gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3itFajsQ%253D%253D&md5=8cae3e554399308493aa38f0d05ed610</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1244851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1244851%26sid%3Dliteratum%253Aachs%26aulast%3DKronke%26aufirst%3DJ.%26aulast%3DUdeshi%26aufirst%3DN.%2BD.%26aulast%3DNarla%26aufirst%3DA.%26aulast%3DGrauman%26aufirst%3DP.%26aulast%3DHurst%26aufirst%3DS.%2BN.%26aulast%3DMcConkey%26aufirst%3DM.%26aulast%3DSvinkina%26aufirst%3DT.%26aulast%3DHeckl%26aufirst%3DD.%26aulast%3DComer%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCiarlo%26aufirst%3DC.%26aulast%3DHartman%26aufirst%3DE.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DSchenone%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26atitle%3DLenalidomide%2520causes%2520selective%2520degradation%2520of%2520IKZF1%2520and%2520IKZF3%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DScience%26date%3D2014%26volume%3D343%26issue%3D6168%26spage%3D301%26epage%3D305%26doi%3D10.1126%2Fscience.1244851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naniong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaelin, W. G.,  Jr.</span><span> </span><span class="NLM_article-title">The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x"> (</span><span class="NLM_issue">6168</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1126/science.1244917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1126%2Fscience.1244917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=24292623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtV2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=305-309&issue=6168&author=G.+Luauthor=R.+E.+Middletonauthor=H.+Sunauthor=M.+Naniongauthor=C.+J.+Ottauthor=C.+S.+Mitsiadesauthor=K.+K.+Wongauthor=J.+E.+Bradnerauthor=W.+G.+Kaelin&title=The+myeloma+drug+lenalidomide+promotes+the+cereblon-dependent+destruction+of+Ikaros+proteins&doi=10.1126%2Fscience.1244917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins</span></div><div class="casAuthors">Lu, Gang; Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Ott, Christopher J.; Mitsiades, Constantine S.; Wong, Kwok-Kin; Bradner, James E.; Kaelin, William G., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6168</span>),
    <span class="NLM_cas:pages">305-309</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Thalidomide-like drugs such as lenalidomide are clin. important treatments for multiple myeloma and show promise for other B cell malignancies.  The biochem. mechanisms underlying their antitumor activity are unknown.  Thalidomide was recently shown to bind to, and inhibit, the cereblon ubiquitin ligase.  Cereblon loss in zebrafish causes fin defects reminiscent of the limb defects seen in children exposed to thalidomide in utero.  Here we show that lenalidomide-bound cereblon acquires the ability to target for proteasomal degrdn. two specific B cell transcription factors, Ikaros family zinc finger proteins 1 and 3 (IKZF1 and IKZF3).  Anal. of myeloma cell lines revealed that loss of IKZF1 and IKZF3 is both necessary and sufficient for lenalidomide's therapeutic effect, suggesting that the antitumor and teratogenic activities of thalidomide-like drugs are dissociable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0froz4Kipu7Vg90H21EOLACvtfcHk0lgOMit1wEcmcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtV2ktg%253D%253D&md5=a9df5bbde0f676b92b1bec48fdbbb502</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1244917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1244917%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DG.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNaniong%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DC.%2BJ.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DThe%2520myeloma%2520drug%2520lenalidomide%2520promotes%2520the%2520cereblon-dependent%2520destruction%2520of%2520Ikaros%2520proteins%26jtitle%3DScience%26date%3D2014%26volume%3D343%26issue%3D6168%26spage%3D305%26epage%3D309%26doi%3D10.1126%2Fscience.1244917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havens, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakurta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klippel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span> </span><span class="NLM_article-title">Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.)</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1111/bjh.12708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1111%2Fbjh.12708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=24328678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslWmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2014&pages=811-821&issue=6&author=A.+K.+Gandhiauthor=J.+Kangauthor=C.+G.+Havensauthor=T.+Conklinauthor=Y.+Ningauthor=L.+Wuauthor=T.+Itoauthor=H.+Andoauthor=M.+F.+Waldmanauthor=A.+Thakurtaauthor=A.+Klippelauthor=H.+Handaauthor=T.+O.+Danielauthor=P.+H.+Schaferauthor=R.+Chopra&title=Immunomodulatory+agents+lenalidomide+and+pomalidomide+co-stimulate+T+cells+by+inducing+degradation+of+T+cell+repressors+Ikaros+and+Aiolos+via+modulation+of+the+E3+ubiquitin+ligase+complex+CRL4%28CRBN.%29&doi=10.1111%2Fbjh.12708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN</span></div><div class="casAuthors">Gandhi, Anita K.; Kang, Jian; Havens, Courtney G.; Conklin, Thomas; Ning, Yuhong; Wu, Lei; Ito, Takumi; Ando, Hideki; Waldman, Michelle F.; Thakurta, Anjan; Klippel, Anke; Handa, Hiroshi; Daniel, Thomas O.; Schafer, Peter H.; Chopra, Rajesh</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-821</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cereblon (CRBN), the mol. target of lenalidomide and pomalidomide, is a substrate receptor of the cullin ring E3 ubiquitin ligase complex, CRL4CRBN.  T cell co-stimulation by lenalidomide or pomalidomide is cereblon dependent: however, the CRL4CRBN substrates responsible for T cell co-stimulation have yet to be identified.  Here we demonstrate that interaction of the transcription factors Ikaros (IKZF1, encoded by the IKZF1 gene) and Aiolos (IKZF3, encoded by the IKZF3 gene) with CRL4CRBN is induced by lenalidomide or pomalidomide.  Each agent promotes Aiolos and Ikaros binding to CRL4CRBN with enhanced ubiquitination leading to cereblon-dependent proteosomal degrdn. in T lymphocytes.  We confirm that Aiolos and Ikaros are transcriptional repressors of interleukin-2 expression.  The findings link lenalidomide- or pomalidomide-induced degrdn. of these transcriptional suppressors to well documented T cell activation.  Importantly, Aiolos could serve as a proximal pharmacodynamic marker for lenalidomide and pomalidomide, as healthy human subjects administered lenalidomide demonstrated Aiolos degrdn. in their peripheral T cells.  In conclusion, we present a mol. model in which drug binding to cereblon results in the interaction of Ikaros and Aiolos to CRL4CRBN, leading to their ubiquitination, subsequent proteasomal degrdn. and T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNm80s9sQNeLVg90H21EOLACvtfcHk0liB6hVgypXN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslWmu74%253D&md5=8ddf00ec1e3c1b1176603f22e8832f58</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1111%2Fbjh.12708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjh.12708%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DHavens%26aufirst%3DC.%2BG.%26aulast%3DConklin%26aufirst%3DT.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%2BF.%26aulast%3DThakurta%26aufirst%3DA.%26aulast%3DKlippel%26aufirst%3DA.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DChopra%26aufirst%3DR.%26atitle%3DImmunomodulatory%2520agents%2520lenalidomide%2520and%2520pomalidomide%2520co-stimulate%2520T%2520cells%2520by%2520inducing%2520degradation%2520of%2520T%2520cell%2520repressors%2520Ikaros%2520and%2520Aiolos%2520via%2520modulation%2520of%2520the%2520E3%2520ubiquitin%2520ligase%2520complex%2520CRL4%2528CRBN.%2529%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2014%26volume%3D164%26issue%3D6%26spage%3D811%26epage%3D821%26doi%3D10.1111%2Fbjh.12708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dijon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabannon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnelle, C.</span><span> </span><span class="NLM_article-title">The role of Ikaros in human erythroid differentiation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span><span class="refDoi"> DOI: 10.1182/blood-2007-07-098202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1182%2Fblood-2007-07-098202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=1138-1146&issue=3&author=M.+Dijonauthor=F.+Bardinauthor=A.+Muratiauthor=M.+Batozauthor=C.+Chabannonauthor=C.+Tonnelle&title=The+role+of+Ikaros+in+human+erythroid+differentiation&doi=10.1182%2Fblood-2007-07-098202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-07-098202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-07-098202%26sid%3Dliteratum%253Aachs%26aulast%3DDijon%26aufirst%3DM.%26aulast%3DBardin%26aufirst%3DF.%26aulast%3DMurati%26aufirst%3DA.%26aulast%3DBatoz%26aufirst%3DM.%26aulast%3DChabannon%26aufirst%3DC.%26aulast%3DTonnelle%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520Ikaros%2520in%2520human%2520erythroid%2520differentiation%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26issue%3D3%26spage%3D1138%26epage%3D1146%26doi%3D10.1182%2Fblood-2007-07-098202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">John, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. C.</span><span> </span><span class="NLM_article-title">The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">9–10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span><span class="refDoi"> DOI: 10.1016/j.molimm.2011.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1016%2Fj.molimm.2011.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=21477865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksleks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=1272-1278&issue=9%E2%80%9310&author=L.+B.+Johnauthor=A.+C.+Ward&title=The+Ikaros+gene+family%3A+transcriptional+regulators+of+hematopoiesis+and+immunity&doi=10.1016%2Fj.molimm.2011.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity</span></div><div class="casAuthors">John, Liza B.; Ward, Alister C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">1272-1278</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The Ikaros family of proteins - comprising Ikaros, Aiolos, Helios, Eos and Pegasus - are zinc finger transcription factors.  These proteins participate in a complex network of interactions with gene regulatory elements, other family members and a raft of other transcriptional regulators to control gene expression including via chromatin remodelling.  In this way, Ikaros family members regulate important cell-fate decisions during hematopoiesis, particularly in the development of the adaptive immune system.  Mutation of several family members results in hematol. malignancies,esp. those of a lymphoid nature.  This review describes the key roles of Ikaros proteins in development and disease, their mechanisms of action and gene targets, as well as explaining their evolutionary origins and role in the emergence of adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3sGG4yL_iZ7Vg90H21EOLACvtfcHk0liB6hVgypXN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksleks7Y%253D&md5=9fd077ecc5088d9a451ed8d13652acc9</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2011.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2011.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DL.%2BB.%26aulast%3DWard%26aufirst%3DA.%2BC.%26atitle%3DThe%2520Ikaros%2520gene%2520family%253A%2520transcriptional%2520regulators%2520of%2520hematopoiesis%2520and%2520immunity%26jtitle%3DMol.%2520Immunol.%26date%3D2011%26volume%3D48%26issue%3D9%25E2%2580%259310%26spage%3D1272%26epage%3D1278%26doi%3D10.1016%2Fj.molimm.2011.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bjorklund, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havens, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amatangelo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klippel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakurta, A. G.</span><span> </span><span class="NLM_article-title">Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4</span> <span class="citation_source-journal">Blood Cancer Journal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e354</span><span class="refDoi"> DOI: 10.1038/bcj.2015.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fbcj.2015.66" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=e354&author=C.+C.+Bjorklundauthor=L.+Luauthor=J.+Kangauthor=P.+R.+Hagnerauthor=C.+G.+Havensauthor=M.+Amatangeloauthor=M.+Wangauthor=Y.+Renauthor=S.+Coutoauthor=M.+Breiderauthor=Y.+Ningauthor=A.+K.+Gandhiauthor=T.+O.+Danielauthor=R.+Chopraauthor=A.+Klippelauthor=A.+G.+Thakurta&title=Rate+of+CRL4%28CRBN%29+substrate+Ikaros+and+Aiolos+degradation+underlies+differential+activity+of+lenalidomide+and+pomalidomide+in+multiple+myeloma+cells+by+regulation+of+c-Myc+and+IRF4&doi=10.1038%2Fbcj.2015.66"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2015.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2015.66%26sid%3Dliteratum%253Aachs%26aulast%3DBjorklund%26aufirst%3DC.%2BC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DHagner%26aufirst%3DP.%2BR.%26aulast%3DHavens%26aufirst%3DC.%2BG.%26aulast%3DAmatangelo%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DCouto%26aufirst%3DS.%26aulast%3DBreider%26aufirst%3DM.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DKlippel%26aufirst%3DA.%26aulast%3DThakurta%26aufirst%3DA.%2BG.%26atitle%3DRate%2520of%2520CRL4%2528CRBN%2529%2520substrate%2520Ikaros%2520and%2520Aiolos%2520degradation%2520underlies%2520differential%2520activity%2520of%2520lenalidomide%2520and%2520pomalidomide%2520in%2520multiple%2520myeloma%2520cells%2520by%2520regulation%2520of%2520c-Myc%2520and%2520IRF4%26jtitle%3DBlood%2520Cancer%2520Journal%26date%3D2015%26volume%3D5%26spage%3De354%26doi%3D10.1038%2Fbcj.2015.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span> </span><span class="NLM_article-title">Association between polymorphisms of the IKZF3 gene and systemic lupus erythematosus in a Chinese Han population</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e108661</span><span class="refDoi"> DOI: 10.1371/journal.pone.0108661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1371%2Fjournal.pone.0108661" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e108661&issue=10&author=X.+Caiauthor=Y.+Qiaoauthor=C.+Diaoauthor=X.+Xuauthor=Y.+Chenauthor=S.+Duauthor=X.+Liuauthor=N.+Liuauthor=S.+Yuauthor=D.+Chenauthor=Y.+Jiang&title=Association+between+polymorphisms+of+the+IKZF3+gene+and+systemic+lupus+erythematosus+in+a+Chinese+Han+population&doi=10.1371%2Fjournal.pone.0108661"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108661%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DDiao%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DAssociation%2520between%2520polymorphisms%2520of%2520the%2520IKZF3%2520gene%2520and%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520Chinese%2520Han%2520population%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26issue%3D10%26spage%3De108661%26doi%3D10.1371%2Fjournal.pone.0108661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cunninghame Graham, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syvanen, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronnblom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyse, T. J.</span><span> </span><span class="NLM_article-title">Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus</span> <span class="citation_source-journal">PLoS Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1002341</span><span class="refDoi"> DOI: 10.1371/journal.pgen.1002341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1371%2Fjournal.pgen.1002341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002341&issue=10&author=D.+S.+Cunninghame+Grahamauthor=D.+L.+Morrisauthor=T.+R.+Bhangaleauthor=L.+A.+Criswellauthor=A.+C.+Syvanenauthor=L.+Ronnblomauthor=T.+W.+Behrensauthor=R.+R.+Grahamauthor=T.+J.+Vyse&title=Association+of+NCF2%2C+IKZF1%2C+IRF8%2C+IFIH1%2C+and+TYK2+with+systemic+lupus+erythematosus&doi=10.1371%2Fjournal.pgen.1002341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1002341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1002341%26sid%3Dliteratum%253Aachs%26aulast%3DCunninghame%2BGraham%26aufirst%3DD.%2BS.%26aulast%3DMorris%26aufirst%3DD.%2BL.%26aulast%3DBhangale%26aufirst%3DT.%2BR.%26aulast%3DCriswell%26aufirst%3DL.%2BA.%26aulast%3DSyvanen%26aufirst%3DA.%2BC.%26aulast%3DRonnblom%26aufirst%3DL.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DVyse%26aufirst%3DT.%2BJ.%26atitle%3DAssociation%2520of%2520NCF2%252C%2520IKZF1%252C%2520IRF8%252C%2520IFIH1%252C%2520and%2520TYK2%2520with%2520systemic%2520lupus%2520erythematosus%26jtitle%3DPLoS%2520Genet.%26date%3D2011%26volume%3D7%26issue%3D10%26spage%3De1002341%26doi%3D10.1371%2Fjournal.pgen.1002341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, F. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Z. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. J.</span><span> </span><span class="NLM_article-title">Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1234</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span><span class="refDoi"> DOI: 10.1038/ng.472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fng.472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=19838193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ogsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1234-1237&issue=11&author=J.+W.+Hanauthor=H.+F.+Zhengauthor=Y.+Cuiauthor=L.+D.+Sunauthor=D.+Q.+Yeauthor=Z.+Huauthor=J.+H.+Xuauthor=Z.+M.+Caiauthor=W.+Huangauthor=G.+P.+Zhaoauthor=H.+F.+Xieauthor=H.+Fangauthor=Q.+J.+Luauthor=J.+H.+Xuauthor=X.+P.+Liauthor=Y.+F.+Panauthor=D.+Q.+Dengauthor=F.+Q.+Zengauthor=Z.+Z.+Yeauthor=X.+Y.+Zhangauthor=Q.+W.+Wangauthor=F.+Haoauthor=L.+Maauthor=X.+B.+Zuoauthor=F.+S.+Zhouauthor=W.+H.+Duauthor=Y.+L.+Chengauthor=J.+Q.+Yangauthor=S.+K.+Shenauthor=J.+Liauthor=Y.+J.+Shengauthor=X.+X.+Zuoauthor=W.+F.+Zhuauthor=F.+Gaoauthor=P.+L.+Zhangauthor=Q.+Guoauthor=B.+Liauthor=M.+Gaoauthor=F.+L.+Xiaoauthor=C.+Quanauthor=C.+Zhangauthor=Z.+Zhangauthor=K.+J.+Zhuauthor=Y.+Liauthor=D.+Y.+Huauthor=W.+S.+Luauthor=J.+L.+Huangauthor=S.+X.+Liuauthor=H.+Liauthor=Y.+Q.+Renauthor=Z.+X.+Wangauthor=C.+J.+Yangauthor=P.+G.+Wangauthor=W.+M.+Zhouauthor=Y.+M.+Lvauthor=A.+P.+Zhangauthor=S.+Q.+Zhangauthor=D.+Linauthor=Y.+Liauthor=H.+Q.+Lowauthor=M.+Shenauthor=Z.+F.+Zhaiauthor=Y.+Wangauthor=F.+Y.+Zhangauthor=S.+Yangauthor=J.+J.+Liuauthor=X.+J.+Zhang&title=Genome-wide+association+study+in+a+Chinese+Han+population+identifies+nine+new+susceptibility+loci+for+systemic+lupus+erythematosus&doi=10.1038%2Fng.472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus</span></div><div class="casAuthors">Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Xu, Jin-Hua; Cai, Zhi-Ming; Huang, Wei; Zhao, Guo-Ping; Xie, Hong-Fu; Fang, Hong; Lu, Qian-Jin; Xu, Jian-Hua; Li, Xiang-Pei; Pan, Yun-Feng; Deng, Dan-Qi; Zeng, Fan-Qin; Ye, Zhi-Zhong; Zhang, Xiao-Yan; Wang, Qing-Wen; Hao, Fei; Ma, Li; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Zuo, Xiao-Xia; Zhu, Wei-Fang; Gao, Fei; Zhang, Pei-Lian; Guo, Qing; Li, Bo; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Huang, Jian-Lin; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Li, Yi; Low, Hui Qi; Shen, Min; Zhai, Zhi-Fang; Wang, Ying; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1234-1237</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors performed a genome-wide assocn. study (GWAS) of systemic lupus erythematosus (SLE) in a Chinese Han population by genotyping 1047 cases and 1205 controls using Illumina Human610-Quad BeadChips and replicating 78 SNPs in two addnl. cohorts (3152 cases and 7050 controls).  The authors identified nine new susceptibility loci (ETS1, IKZF1, RASGRP3, SLC15A4, TNIP1, 7q11.23, 10q11.22, 11q23.3 and 16p11.2; 1.77 × 10-25 ≤ Pcombined ≤ 2.77 × 10-8) and confirmed seven previously reported loci (BLK, IRF5, STAT4, TNFAIP3, TNFSF4, 6q21 and 22q11.21; 5.17 × 10-42 ≤ Pcombined ≤ 5.18 × 10-12).  Comparison with previous GWAS findings highlighted the genetic heterogeneity of SLE susceptibility between Chinese Han and European populations.  This study not only advances understanding of the genetic basis of SLE but also highlights the value of performing GWAS in diverse ancestral populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5e-IL0gn9EbVg90H21EOLACvtfcHk0lgRa4YyDL4odA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ogsr3E&md5=f43a1211ff6a461772483cbb8490bf3e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1038%2Fng.472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.472%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DZheng%26aufirst%3DH.%2BF.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%2BD.%26aulast%3DYe%26aufirst%3DD.%2BQ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%2BH.%26aulast%3DCai%26aufirst%3DZ.%2BM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DG.%2BP.%26aulast%3DXie%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%2BJ.%26aulast%3DXu%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DX.%2BP.%26aulast%3DPan%26aufirst%3DY.%2BF.%26aulast%3DDeng%26aufirst%3DD.%2BQ.%26aulast%3DZeng%26aufirst%3DF.%2BQ.%26aulast%3DYe%26aufirst%3DZ.%2BZ.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DQ.%2BW.%26aulast%3DHao%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DX.%2BB.%26aulast%3DZhou%26aufirst%3DF.%2BS.%26aulast%3DDu%26aufirst%3DW.%2BH.%26aulast%3DCheng%26aufirst%3DY.%2BL.%26aulast%3DYang%26aufirst%3DJ.%2BQ.%26aulast%3DShen%26aufirst%3DS.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DY.%2BJ.%26aulast%3DZuo%26aufirst%3DX.%2BX.%26aulast%3DZhu%26aufirst%3DW.%2BF.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DP.%2BL.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DF.%2BL.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DK.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DW.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DS.%2BX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DY.%2BQ.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DP.%2BG.%26aulast%3DZhou%26aufirst%3DW.%2BM.%26aulast%3DLv%26aufirst%3DY.%2BM.%26aulast%3DZhang%26aufirst%3DA.%2BP.%26aulast%3DZhang%26aufirst%3DS.%2BQ.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLow%26aufirst%3DH.%2BQ.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DZhai%26aufirst%3DZ.%2BF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%2BY.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26atitle%3DGenome-wide%2520association%2520study%2520in%2520a%2520Chinese%2520Han%2520population%2520identifies%2520nine%2520new%2520susceptibility%2520loci%2520for%2520systemic%2520lupus%2520erythematosus%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26issue%3D11%26spage%3D1234%26epage%3D1237%26doi%3D10.1038%2Fng.472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">He, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span> </span><span class="NLM_article-title">TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population</span> <span class="citation_source-journal">Lupus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.1177/0961203310367918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1177%2F0961203310367918" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1181-1186&issue=10&author=C.+F.+Heauthor=Y.+S.+Liuauthor=Y.+L.+Chengauthor=J.+P.+Gaoauthor=T.+M.+Panauthor=J.+W.+Hanauthor=C.+Quanauthor=L.+D.+Sunauthor=H.+F.+Zhengauthor=X.+B.+Zuoauthor=S.+X.+Xuauthor=Y.+J.+Shengauthor=S.+Yaoauthor=W.+L.+Huauthor=Y.+Liauthor=Z.+Y.+Yuauthor=X.+Y.+Yinauthor=X.+J.+Zhangauthor=Y.+Cuiauthor=S.+Yang&title=TNIP1%2C+SLC15A4%2C+ETS1%2C+RasGRP3+and+IKZF1+are+associated+with+clinical+features+of+systemic+lupus+erythematosus+in+a+Chinese+Han+population&doi=10.1177%2F0961203310367918"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1177%2F0961203310367918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0961203310367918%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DC.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BL.%26aulast%3DGao%26aufirst%3DJ.%2BP.%26aulast%3DPan%26aufirst%3DT.%2BM.%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DL.%2BD.%26aulast%3DZheng%26aufirst%3DH.%2BF.%26aulast%3DZuo%26aufirst%3DX.%2BB.%26aulast%3DXu%26aufirst%3DS.%2BX.%26aulast%3DSheng%26aufirst%3DY.%2BJ.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DW.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DZ.%2BY.%26aulast%3DYin%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DTNIP1%252C%2520SLC15A4%252C%2520ETS1%252C%2520RasGRP3%2520and%2520IKZF1%2520are%2520associated%2520with%2520clinical%2520features%2520of%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520Chinese%2520Han%2520population%26jtitle%3DLupus%26date%3D2010%26volume%3D19%26issue%3D10%26spage%3D1181%26epage%3D1186%26doi%3D10.1177%2F0961203310367918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lessard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrianto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ice, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comeau, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeland, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundahl, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon-Riquelme, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaya, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boackle, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edberg, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilkeson, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberly, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewold, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons-Estel, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey-Goldman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reveille, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scofield, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyse, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeland, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langefeld, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, K. L.</span><span> </span><span class="NLM_article-title">Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1016/j.ajhg.2012.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1016%2Fj.ajhg.2012.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=22464253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVejur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=648-660&issue=4&author=C.+J.+Lessardauthor=I.+Adriantoauthor=J.+A.+Iceauthor=G.+B.+Wileyauthor=J.+A.+Kellyauthor=S.+B.+Glennauthor=A.+J.+Adlerauthor=H.+Liauthor=A.+Rasmussenauthor=A.+H.+Williamsauthor=J.+Zieglerauthor=M.+E.+Comeauauthor=M.+Marionauthor=B.+E.+Wakelandauthor=C.+Liangauthor=P.+S.+Ramosauthor=K.+M.+Grundahlauthor=C.+J.+Gallantauthor=M.+E.+Alarcon-Riquelmeauthor=G.+S.+Alarconauthor=J.+M.+Anayaauthor=S.+C.+Baeauthor=S.+A.+Boackleauthor=E.+E.+Brownauthor=D.+M.+Changauthor=S.+K.+Choauthor=L.+A.+Criswellauthor=J.+C.+Edbergauthor=B.+I.+Freedmanauthor=G.+S.+Gilkesonauthor=C.+O.+Jacobauthor=J.+A.+Jamesauthor=D.+L.+Kamenauthor=R.+P.+Kimberlyauthor=J.+H.+Kimauthor=J.+Martinauthor=J.+T.+Merrillauthor=T.+B.+Niewoldauthor=S.+Y.+Parkauthor=M.+A.+Petriauthor=B.+A.+Pons-Estelauthor=R.+Ramsey-Goldmanauthor=J.+D.+Reveilleauthor=R.+H.+Scofieldauthor=Y.+W.+Songauthor=A.+M.+Stevensauthor=B.+P.+Tsaoauthor=L.+M.+Vilaauthor=T.+J.+Vyseauthor=C.+Y.+Yuauthor=J.+M.+Guthridgeauthor=K.+M.+Kaufmanauthor=J.+B.+Harleyauthor=E.+K.+Wakelandauthor=C.+D.+Langefeldauthor=P.+M.+Gaffneyauthor=C.+G.+Montgomeryauthor=K.+L.+Moser&title=Identification+of+IRF8%2C+TMEM39A%2C+and+IKZF3-ZPBP2+as+susceptibility+loci+for+systemic+lupus+erythematosus+in+a+large-scale+multiracial+replication+study&doi=10.1016%2Fj.ajhg.2012.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication Study</span></div><div class="casAuthors">Lessard, Christopher J.; Adrianto, Indra; Ice, John A.; Wiley, Graham B.; Kelly, Jennifer A.; Glenn, Stuart B.; Adler, Adam J.; Li, He; Rasmussen, Astrid; Williams, Adrienne H.; Ziegler, Julie; Comeau, Mary E.; Marion, Miranda; Wakeland, Benjamin E.; Liang, Chaoying; Ramos, Paula S.; Grundahl, Kiely M.; Gallant, Caroline J.; Alarcon, Graciela S.; Anaya, Juan-Manuel; Bae, Sang-Cheol; Boackle, Susan A.; Brown, Elizabeth E.; Chang, Deh-Ming; Cho, Soo-Kyung; Criswell, Lindsey A.; Edberg, Jeffrey C.; Freedman, Barry I.; Gilkeson, Gary S.; Jacob, Chaim O.; James, Judith A.; Kamen, Diane L.; Kimberly, Robert P.; Kim, Jae-Hoon; Martin, Javier; Merrill, Joan T.; Niewold, Timothy B.; Park, So-Yeon; Petri, Michelle A.; Pons-Estel, Bernardo A.; Ramsey-Goldman, Rosalind; Reveille, John D.; Scofield, R. Hal; Song, Yeong Wook; Stevens, Anne M.; Tsao, Betty P.; Vila, Luis M.; Vyse, Timothy J.; Yu, Chack-Yung; Guthridge, Joel M.; Kaufman, Kenneth M.; Harley, John B.; Wakeland, Edward K.; Langefeld, Carl D.; Gaffney, Patrick M.; Montgomery, Courtney G.; Moser, Kathy L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-660</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Systemic lupus erythematosus (SLE) is a chronic heterogeneous autoimmune disorder characterized by the loss of tolerance to self-antigens and dysregulated interferon responses.  The etiol. of SLE is complex, involving both heritable and environmental factors.  Candidate-gene studies and genome-wide assocn. (GWA) scans have been successful in identifying new loci that contribute to disease susceptibility; however, much of the heritable risk has yet to be identified.  In this study, we sought to replicate 1,580 variants showing suggestive assocn. with SLE in a previously published GWA scan of European Americans; we tested a multiethnic population consisting of 7,998 SLE cases and 7,492 controls of European, African American, Asian, Hispanic, Gullah, and Amerindian ancestry to find assocn. with the disease.  Several genes relevant to immunol. pathways showed assocn. with SLE.  Three loci exceeded the genome-wide significance threshold: interferon regulatory factor 8 (IRF8; rs11644034; pmeta-Euro = 2.08 × 10-10), transmembrane protein 39A (TMEM39A; rs1132200; pmeta-all = 8.62 × 10-9), and 17q21 (rs1453560; pmeta-all = 3.48 × 10-10) between IKAROS family of zinc finger 3 (AIOLOS; IKZF3) and zona pellucida binding protein 2 (ZPBP2).  Fine mapping, resequencing, imputation, and haplotype anal. of IRF8 indicated that three independent effects tagged by rs8046526, rs450443, and rs4843869, resp., were required for risk in individuals of European ancestry.  Eleven addnl. replicated effects (5 × 10-8 < pmeta-Euro < 9.99 × 10-5) were obsd. with CFHR1, CADM2, LOC730109/IL12A, LPP, LOC63920, SLU7, ADAMTSL1, C10orf64, OR8D4, FAM19A2, and STXBP6.  The results of this study increase the no. of confirmed SLE risk loci and identify others warranting further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHE-yH1qzb27Vg90H21EOLACvtfcHk0liafLdy9cUQdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVejur8%253D&md5=d63d2687188d3cada8138d8c82284f32</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2012.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2012.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DLessard%26aufirst%3DC.%2BJ.%26aulast%3DAdrianto%26aufirst%3DI.%26aulast%3DIce%26aufirst%3DJ.%2BA.%26aulast%3DWiley%26aufirst%3DG.%2BB.%26aulast%3DKelly%26aufirst%3DJ.%2BA.%26aulast%3DGlenn%26aufirst%3DS.%2BB.%26aulast%3DAdler%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRasmussen%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DA.%2BH.%26aulast%3DZiegler%26aufirst%3DJ.%26aulast%3DComeau%26aufirst%3DM.%2BE.%26aulast%3DMarion%26aufirst%3DM.%26aulast%3DWakeland%26aufirst%3DB.%2BE.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DRamos%26aufirst%3DP.%2BS.%26aulast%3DGrundahl%26aufirst%3DK.%2BM.%26aulast%3DGallant%26aufirst%3DC.%2BJ.%26aulast%3DAlarcon-Riquelme%26aufirst%3DM.%2BE.%26aulast%3DAlarcon%26aufirst%3DG.%2BS.%26aulast%3DAnaya%26aufirst%3DJ.%2BM.%26aulast%3DBae%26aufirst%3DS.%2BC.%26aulast%3DBoackle%26aufirst%3DS.%2BA.%26aulast%3DBrown%26aufirst%3DE.%2BE.%26aulast%3DChang%26aufirst%3DD.%2BM.%26aulast%3DCho%26aufirst%3DS.%2BK.%26aulast%3DCriswell%26aufirst%3DL.%2BA.%26aulast%3DEdberg%26aufirst%3DJ.%2BC.%26aulast%3DFreedman%26aufirst%3DB.%2BI.%26aulast%3DGilkeson%26aufirst%3DG.%2BS.%26aulast%3DJacob%26aufirst%3DC.%2BO.%26aulast%3DJames%26aufirst%3DJ.%2BA.%26aulast%3DKamen%26aufirst%3DD.%2BL.%26aulast%3DKimberly%26aufirst%3DR.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DMerrill%26aufirst%3DJ.%2BT.%26aulast%3DNiewold%26aufirst%3DT.%2BB.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DPetri%26aufirst%3DM.%2BA.%26aulast%3DPons-Estel%26aufirst%3DB.%2BA.%26aulast%3DRamsey-Goldman%26aufirst%3DR.%26aulast%3DReveille%26aufirst%3DJ.%2BD.%26aulast%3DScofield%26aufirst%3DR.%2BH.%26aulast%3DSong%26aufirst%3DY.%2BW.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26aulast%3DTsao%26aufirst%3DB.%2BP.%26aulast%3DVila%26aufirst%3DL.%2BM.%26aulast%3DVyse%26aufirst%3DT.%2BJ.%26aulast%3DYu%26aufirst%3DC.%2BY.%26aulast%3DGuthridge%26aufirst%3DJ.%2BM.%26aulast%3DKaufman%26aufirst%3DK.%2BM.%26aulast%3DHarley%26aufirst%3DJ.%2BB.%26aulast%3DWakeland%26aufirst%3DE.%2BK.%26aulast%3DLangefeld%26aufirst%3DC.%2BD.%26aulast%3DGaffney%26aufirst%3DP.%2BM.%26aulast%3DMontgomery%26aufirst%3DC.%2BG.%26aulast%3DMoser%26aufirst%3DK.%2BL.%26atitle%3DIdentification%2520of%2520IRF8%252C%2520TMEM39A%252C%2520and%2520IKZF3-ZPBP2%2520as%2520susceptibility%2520loci%2520for%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520large-scale%2520multiracial%2520replication%2520study%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2012%26volume%3D90%26issue%3D4%26spage%3D648%26epage%3D660%26doi%3D10.1016%2Fj.ajhg.2012.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kronke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbach, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacBeth, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udeshi, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svinkina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConkey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullinger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span> </span><span class="NLM_article-title">Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">523</span><span class="NLM_x"> (</span><span class="NLM_issue">7559</span><span class="NLM_x">) </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1038/nature14610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature14610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=26131937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1entr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=183-188&issue=7559&author=J.+Kronkeauthor=E.+C.+Finkauthor=P.+W.+Hollenbachauthor=K.+J.+MacBethauthor=S.+N.+Hurstauthor=N.+D.+Udeshiauthor=P.+P.+Chamberlainauthor=D.+R.+Maniauthor=H.+W.+Manauthor=A.+K.+Gandhiauthor=T.+Svinkinaauthor=R.+K.+Schneiderauthor=M.+McConkeyauthor=M.+Jarasauthor=E.+Griffithsauthor=M.+Wetzlerauthor=L.+Bullingerauthor=B.+E.+Cathersauthor=S.+A.+Carrauthor=R.+Chopraauthor=B.+L.+Ebert&title=Lenalidomide+induces+ubiquitination+and+degradation+of+CK1alpha+in+del%285q%29+MDS&doi=10.1038%2Fnature14610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS</span></div><div class="casAuthors">Kronke, Jan; Fink, Emma C.; Hollenbach, Paul W.; MacBeth, Kyle J.; Hurst, Slater N.; Udeshi, Namrata D.; Chamberlain, Philip P.; Mani, D. R.; Man, Hon Wah; Gandhi, Anita K.; Svinkina, Tanya; Schneider, Rebekka K.; McConkey, Marie; Jaras, Marcus; Griffiths, Elizabeth; Wetzler, Meir; Bullinger, Lars; Cathers, Brian E.; Carr, Steven A.; Chopra, Rajesh; Ebert, Benjamin L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">7559</span>),
    <span class="NLM_cas:pages">183-188</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lenalidomide is a highly effective treatment for myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)).  Lenalidomide induces the ubiquitination of casein kinase 1A1 (CK1α) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN), resulting in CK1α degrdn.  CK1α is encoded by a gene within the common deleted region for del(5q) MDS and haplo-insufficient expression sensitizes cells to lenalidomide therapy, providing a mechanistic basis for the therapeutic window of lenalidomide in del(5q) MDS.  The authors found that mouse cells are resistant to lenalidomide but that changing a single amino acid in mouse Crbn to the corresponding human residue enables lenalidomide-dependent degrdn. of CK1α.  The authors further demonstrate that minor side chain modifications in thalidomide and a novel analog, CC-122, can modulate the spectrum of substrates targeted by CRL4CRBN.  These findings have implications for the clin. activity of lenalidomide and related compds., and demonstrate the therapeutic potential of novel modulators of E3 ubiquitin ligases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLiHx3FKesbVg90H21EOLACvtfcHk0liafLdy9cUQdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1entr%252FN&md5=9b20a91c13e888e6569223ffa25af2cd</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnature14610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14610%26sid%3Dliteratum%253Aachs%26aulast%3DKronke%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DE.%2BC.%26aulast%3DHollenbach%26aufirst%3DP.%2BW.%26aulast%3DMacBeth%26aufirst%3DK.%2BJ.%26aulast%3DHurst%26aufirst%3DS.%2BN.%26aulast%3DUdeshi%26aufirst%3DN.%2BD.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DMani%26aufirst%3DD.%2BR.%26aulast%3DMan%26aufirst%3DH.%2BW.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DSvinkina%26aufirst%3DT.%26aulast%3DSchneider%26aufirst%3DR.%2BK.%26aulast%3DMcConkey%26aufirst%3DM.%26aulast%3DJaras%26aufirst%3DM.%26aulast%3DGriffiths%26aufirst%3DE.%26aulast%3DWetzler%26aufirst%3DM.%26aulast%3DBullinger%26aufirst%3DL.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26atitle%3DLenalidomide%2520induces%2520ubiquitination%2520and%2520degradation%2520of%2520CK1alpha%2520in%2520del%25285q%2529%2520MDS%26jtitle%3DNature%26date%3D2015%26volume%3D523%26issue%3D7559%26spage%3D183%26epage%3D188%26doi%3D10.1038%2Fnature14610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Matyskiela, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagarigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchelman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, P. P.</span><span> </span><span class="NLM_article-title">A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x"> (</span><span class="NLM_issue">7611</span><span class="NLM_x">) </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1038/nature18611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature18611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=27338790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCltbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=252-257&issue=7611&author=M.+E.+Matyskielaauthor=G.+Luauthor=T.+Itoauthor=B.+Pagariganauthor=C.+C.+Luauthor=K.+Millerauthor=W.+Fangauthor=N.+Y.+Wangauthor=D.+Nguyenauthor=J.+Houstonauthor=G.+Carmelauthor=T.+Tranauthor=M.+Rileyauthor=L.+Nosakaauthor=G.+C.+Landerauthor=S.+Gaidarovaauthor=S.+Xuauthor=A.+L.+Ruchelmanauthor=H.+Handaauthor=J.+Carmichaelauthor=T.+O.+Danielauthor=B.+E.+Cathersauthor=A.+Lopez-Gironaauthor=P.+P.+Chamberlain&title=A+novel+cereblon+modulator+recruits+GSPT1+to+the+CRL4%28CRBN%29+ubiquitin+ligase&doi=10.1038%2Fnature18611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase</span></div><div class="casAuthors">Matyskiela, Mary E.; Lu, Gang; Ito, Takumi; Pagarigan, Barbra; Lu, Chin-Chun; Miller, Karen; Fang, Wei; Wang, Nai-Yu; Nguyen, Derek; Houston, Jack; Carmel, Gilles; Tran, Tam; Riley, Mariko; Nosaka, Lyn'Al; Lander, Gabriel C.; Gaidarova, Svetlana; Xu, Shuichan; Ruchelman, Alexander L.; Handa, Hiroshi; Carmichael, James; Daniel, Thomas O.; Cathers, Brian E.; Lopez-Girona, Antonia; Chamberlain, Philip P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7611</span>),
    <span class="NLM_cas:pages">252-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Immunomodulatory drugs bind to cereblon (CRBN) to confer differentiated substrate specificity on the CRL4CRBN E3 ubiquitin ligase.  Here we report the identification of a new cereblon modulator, CC-885, with potent anti-tumor activity.  The anti-tumor activity of CC-885 is mediated through the cereblon-dependent ubiquitination and degrdn. of the translation termination factor GSPT1.  Patient-derived acute myeloid leukemia tumor cells exhibit high sensitivity to CC-885, indicating the clin. potential of this mechanism.  Crystallog. studies of the CRBN-DDB1-CC-885-GSPT1 complex reveal that GSPT1 binds to cereblon through a surface turn contg. a glycine residue at a key position, interacting with both CC-885 and a 'hotspot' on the cereblon surface.  Although GSPT1 possesses no obvious structural, sequence or functional homol. to previously known cereblon substrates, mutational anal. and modeling indicate that the cereblon substrate Ikaros uses a similar structural feature to bind cereblon, suggesting a common motif for substrate recruitment.  These findings define a structural degron underlying cereblon 'neosubstrate' selectivity, and identify an anti-tumor target rendered druggable by cereblon modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgAWiXdlJgYLVg90H21EOLACvtfcHk0liafLdy9cUQdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCltbnI&md5=1d4e340416aa0b08fc0f123faf638c3f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnature18611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18611%26sid%3Dliteratum%253Aachs%26aulast%3DMatyskiela%26aufirst%3DM.%2BE.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DC.%2BC.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DN.%2BY.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DHouston%26aufirst%3DJ.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DRiley%26aufirst%3DM.%26aulast%3DNosaka%26aufirst%3DL.%26aulast%3DLander%26aufirst%3DG.%2BC.%26aulast%3DGaidarova%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26atitle%3DA%2520novel%2520cereblon%2520modulator%2520recruits%2520GSPT1%2520to%2520the%2520CRL4%2528CRBN%2529%2520ubiquitin%2520ligase%26jtitle%3DNature%26date%3D2016%26volume%3D535%26issue%3D7611%26spage%3D252%26epage%3D257%26doi%3D10.1038%2Fnature18611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chamberlain, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagarigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chie-Leon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B. E.</span><span> </span><span class="NLM_article-title">Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span><span class="refDoi"> DOI: 10.1038/nsmb.2874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnsmb.2874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=25108355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=803-809&issue=9&author=P.+P.+Chamberlainauthor=A.+Lopez-Gironaauthor=K.+Millerauthor=G.+Carmelauthor=B.+Pagariganauthor=B.+Chie-Leonauthor=E.+Rychakauthor=L.+G.+Corralauthor=Y.+J.+Renauthor=M.+Wangauthor=M.+Rileyauthor=S.+L.+Delkerauthor=T.+Itoauthor=H.+Andoauthor=T.+Moriauthor=Y.+Hiranoauthor=H.+Handaauthor=T.+Hakoshimaauthor=T.+O.+Danielauthor=B.+E.+Cathers&title=Structure+of+the+human+Cereblon-DDB1-lenalidomide+complex+reveals+basis+for+responsiveness+to+thalidomide+analogs&doi=10.1038%2Fnsmb.2874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs</span></div><div class="casAuthors">Chamberlain, Philip P.; Lopez-Girona, Antonia; Miller, Karen; Carmel, Gilles; Pagarigan, Barbra; Chie-Leon, Barbara; Rychak, Emily; Corral, Laura G.; Ren, Yan J.; Wang, Maria; Riley, Mariko; Delker, Silvia L.; Ito, Takumi; Ando, Hideki; Mori, Tomoyuki; Hirano, Yoshinori; Handa, Hiroshi; Hakoshima, Toshio; Daniel, Thomas O.; Cathers, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">803-809</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Cul4-Rbx1-DDB1-Cereblon E3 ubiquitin ligase complex is the target of thalidomide, lenalidomide and pomalidomide, therapeutically important drugs for multiple myeloma and other B-cell malignancies.  These drugs directly bind Cereblon (CRBN) and promote the recruitment of substrates Ikaros (IKZF1) and Aiolos (IKZF3) to the E3 complex, thus leading to substrate ubiquitination and degrdn.  Here we present the crystal structure of human CRBN bound to DDB1 and the drug lenalidomide.  A hydrophobic pocket in the thalidomide-binding domain (TBD) of CRBN accommodates the glutarimide moiety of lenalidomide, whereas the isoindolinone ring is exposed to solvent.  We also solved the structures of the mouse TBD in the apo state and with thalidomide or pomalidomide.  Site-directed mutagenesis in lentiviral-expression myeloma models showed that key drug-binding residues are crit. for antiproliferative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtN-ZCacB1m7Vg90H21EOLACvtfcHk0lip8O4WJ16GGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahurjI&md5=627fc3c8eae320059ca1cdc173bb56ed</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2874%26sid%3Dliteratum%253Aachs%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DChie-Leon%26aufirst%3DB.%26aulast%3DRychak%26aufirst%3DE.%26aulast%3DCorral%26aufirst%3DL.%2BG.%26aulast%3DRen%26aufirst%3DY.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DRiley%26aufirst%3DM.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DHirano%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DHakoshima%26aufirst%3DT.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26atitle%3DStructure%2520of%2520the%2520human%2520Cereblon-DDB1-lenalidomide%2520complex%2520reveals%2520basis%2520for%2520responsiveness%2520to%2520thalidomide%2520analogs%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D803%26epage%3D809%26doi%3D10.1038%2Fnsmb.2874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fischer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydeard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavadini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serluca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraju, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichkule, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schebesta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckwith, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, N. H.</span><span> </span><span class="NLM_article-title">Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">512</span><span class="NLM_x"> (</span><span class="NLM_issue">7512</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1038/nature13527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature13527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=25043012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=512&publication_year=2014&pages=49-53&issue=7512&author=E.+S.+Fischerauthor=K.+Bohmauthor=J.+R.+Lydeardauthor=H.+Yangauthor=M.+B.+Stadlerauthor=S.+Cavadiniauthor=J.+Nagelauthor=F.+Serlucaauthor=V.+Ackerauthor=G.+M.+Lingarajuauthor=R.+B.+Tichkuleauthor=M.+Schebestaauthor=W.+C.+Forresterauthor=M.+Schirleauthor=U.+Hassiepenauthor=J.+Ottlauthor=M.+Hildauthor=R.+E.+Beckwithauthor=J.+W.+Harperauthor=J.+L.+Jenkinsauthor=N.+H.+Thoma&title=Structure+of+the+DDB1-CRBN+E3+ubiquitin+ligase+in+complex+with+thalidomide&doi=10.1038%2Fnature13527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide</span></div><div class="casAuthors">Fischer, Eric S.; Bohm, Kerstin; Lydeard, John R.; Yang, Haidi; Stadler, Michael B.; Cavadini, Simone; Nagel, Jane; Serluca, Fabrizio; Acker, Vincent; Lingaraju, Gondichatnahalli M.; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hassiepen, Ulrich; Ottl, Johannes; Hild, Marc; Beckwith, Rohan E. J.; Harper, J. Wade; Jenkins, Jeremy L.; Thoma, Nicolas H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">512</span>
        (<span class="NLM_cas:issue">7512</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects.  Despite the teratogenicity of thalidomide and its derivs. lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-assocd. dysplasia.  IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4CRBN.  Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide.  The structure establishes that CRBN is a substrate receptor within CRL4CRBN and enantioselectively binds IMiDs.  Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4CRBN.  Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4CRBN while the ligase complex is recruiting IKZF1 or IKZF3 for degrdn.  This dual activity implies that small mols. can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGt2Y9GecKr7Vg90H21EOLACvtfcHk0lip8O4WJ16GGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP&md5=1c1eaa48bef87463cdd3f2b1e1bd400d</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1038%2Fnature13527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13527%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DBohm%26aufirst%3DK.%26aulast%3DLydeard%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStadler%26aufirst%3DM.%2BB.%26aulast%3DCavadini%26aufirst%3DS.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DAcker%26aufirst%3DV.%26aulast%3DLingaraju%26aufirst%3DG.%2BM.%26aulast%3DTichkule%26aufirst%3DR.%2BB.%26aulast%3DSchebesta%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DW.%2BC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DOttl%26aufirst%3DJ.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DBeckwith%26aufirst%3DR.%2BE.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DJenkins%26aufirst%3DJ.%2BL.%26aulast%3DThoma%26aufirst%3DN.%2BH.%26atitle%3DStructure%2520of%2520the%2520DDB1-CRBN%2520E3%2520ubiquitin%2520ligase%2520in%2520complex%2520with%2520thalidomide%26jtitle%3DNature%26date%3D2014%26volume%3D512%26issue%3D7512%26spage%3D49%26epage%3D53%26doi%3D10.1038%2Fnature13527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Petzold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, N. H.</span><span> </span><span class="NLM_article-title">Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">532</span><span class="NLM_x"> (</span><span class="NLM_issue">7597</span><span class="NLM_x">) </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1038/nature16979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature16979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=26909574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=127-130&issue=7597&author=G.+Petzoldauthor=E.+S.+Fischerauthor=N.+H.+Thoma&title=Structural+basis+of+lenalidomide-induced+CK1alpha+degradation+by+the+CRL4%28CRBN%29+ubiquitin+ligase&doi=10.1038%2Fnature16979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase</span></div><div class="casAuthors">Petzold, Georg; Fischer, Eric S.; Thoma, Nicolas H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7597</span>),
    <span class="NLM_cas:pages">127-130</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thalidomide and its derivs., lenalidomide and pomalidomide, are immune modulatory drugs (IMiDs) used in the treatment of hematol. malignancies.  IMiDs bind CRBN, the substrate receptor of the CUL4-RBX1-DDB1-CRBN (also known as CRL4CRBN) E3 ubiquitin ligase, and inhibit ubiquitination of endogenous CRL4CRBN substrates.  Unexpectedly, IMiDs also repurpose the ligase to target new proteins for degrdn.  Lenalidomide induces degrdn. of the lymphoid transcription factors Ikaros and Aiolos (also known as IKZF1 and IKZF3), and casein kinase 1α (CK1α), which contributes to its clin. efficacy in the treatment of multiple myeloma and 5q-deletion assocd. myelodysplastic syndrome (del(5q) MDS), resp.  How lenalidomide alters the specificity of the ligase to degrade these proteins remains elusive.  Here we present the 2.45 Å crystal structure of DDB1-CRBN bound to lenalidomide and CK1α.  CRBN and lenalidomide jointly provide the binding interface for a CK1α β-hairpin-loop located in the kinase N-lobe.  We show that CK1α binding to CRL4CRBN is strictly dependent on the presence of an IMiD.  Binding of IKZF1 to CRBN similarly requires the compd. and both, IKZF1 and CK1α, use a related binding mode.  Our study provides a mechanistic explanation for the selective efficacy of lenalidomide in del(5q) MDS therapy.  We anticipate that high-affinity protein-protein interactions induced by small mols. will provide opportunities for drug development, particularly for targeted protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4FxWriI1ObVg90H21EOLACvtfcHk0lhWYpQMzjp5mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOis78%253D&md5=320fc6ff811da335fa8e02feab2d702d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature16979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16979%26sid%3Dliteratum%253Aachs%26aulast%3DPetzold%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DThoma%26aufirst%3DN.%2BH.%26atitle%3DStructural%2520basis%2520of%2520lenalidomide-induced%2520CK1alpha%2520degradation%2520by%2520the%2520CRL4%2528CRBN%2529%2520ubiquitin%2520ligase%26jtitle%3DNature%26date%3D2016%26volume%3D532%26issue%3D7597%26spage%3D127%26epage%3D130%26doi%3D10.1038%2Fnature16979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sheard, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Nissan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span> </span><span class="NLM_article-title">Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x"> (</span><span class="NLM_issue">7322</span><span class="NLM_x">) </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span><span class="refDoi"> DOI: 10.1038/nature09430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature09430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=20927106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gju7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=400-405&issue=7322&author=L.+B.+Sheardauthor=X.+Tanauthor=H.+Maoauthor=J.+Withersauthor=G.+Ben-Nissanauthor=T.+R.+Hindsauthor=Y.+Kobayashiauthor=F.+F.+Hsuauthor=M.+Sharonauthor=J.+Browseauthor=S.+Y.+Heauthor=J.+Rizoauthor=G.+A.+Howeauthor=N.+Zheng&title=Jasmonate+perception+by+inositol-phosphate-potentiated+COI1-JAZ+co-receptor&doi=10.1038%2Fnature09430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor</span></div><div class="casAuthors">Sheard, Laura B.; Tan, Xu; Mao, Haibin; Withers, John; Ben-Nissan, Gili; Hinds, Thomas R.; Kobayashi, Yuichi; Hsu, Fong-Fu; Sharon, Michal; Browse, John; He, Sheng Yang; Rizo, Josep; Howe, Gregg A.; Zheng, Ning</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7322</span>),
    <span class="NLM_cas:pages">400-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Jasmonates are a family of plant hormones that regulate plant growth, development and responses to stress.  The F-box protein CORONATINE INSENSITIVE 1 (COI1) mediates jasmonate signaling by promoting hormone-dependent ubiquitylation and degrdn. of transcriptional repressor JAZ proteins.  Despite its importance, the mechanism of jasmonate perception remains unclear.  Here we present structural and pharmacol. data to show that the true Arabidopsis jasmonate receptor is a complex of both COI1 and JAZ.  COI1 contains an open pocket that recognizes the bioactive hormone (3R,7S)-jasmonoyl-L-isoleucine (JA-Ile) with high specificity.  High-affinity hormone binding requires a bipartite JAZ degron sequence consisting of a conserved α-helix for COI1 docking and a loop region to trap the hormone in its binding pocket.  In addn., we identify a third crit. component of the jasmonate co-receptor complex, inositol pentakisphosphate, which interacts with both COI1 and JAZ adjacent to the ligand.  Our results unravel the mechanism of jasmonate perception and highlight the ability of F-box proteins to evolve as multi-component signaling hubs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Hj6OLb0OoLVg90H21EOLACvtfcHk0lhWYpQMzjp5mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gju7rP&md5=cf4039c73f3a900f74b02bbaa9f5df34</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnature09430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09430%26sid%3Dliteratum%253Aachs%26aulast%3DSheard%26aufirst%3DL.%2BB.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DWithers%26aufirst%3DJ.%26aulast%3DBen-Nissan%26aufirst%3DG.%26aulast%3DHinds%26aufirst%3DT.%2BR.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DHsu%26aufirst%3DF.%2BF.%26aulast%3DSharon%26aufirst%3DM.%26aulast%3DBrowse%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DS.%2BY.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DHowe%26aufirst%3DG.%2BA.%26aulast%3DZheng%26aufirst%3DN.%26atitle%3DJasmonate%2520perception%2520by%2520inositol-phosphate-potentiated%2520COI1-JAZ%2520co-receptor%26jtitle%3DNature%26date%3D2010%26volume%3D468%26issue%3D7322%26spage%3D400%26epage%3D405%26doi%3D10.1038%2Fnature09430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon-Villalobos, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span> </span><span class="NLM_article-title">Mechanism of auxin perception by the TIR1 ubiquitin ligase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x"> (</span><span class="NLM_issue">7136</span><span class="NLM_x">) </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span><span class="refDoi"> DOI: 10.1038/nature05731</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature05731" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=640-645&issue=7136&author=X.+Tanauthor=L.+I.+Calderon-Villalobosauthor=M.+Sharonauthor=C.+Zhengauthor=C.+V.+Robinsonauthor=M.+Estelleauthor=N.+Zheng&title=Mechanism+of+auxin+perception+by+the+TIR1+ubiquitin+ligase&doi=10.1038%2Fnature05731"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fnature05731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05731%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.%26aulast%3DCalderon-Villalobos%26aufirst%3DL.%2BI.%26aulast%3DSharon%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DRobinson%26aufirst%3DC.%2BV.%26aulast%3DEstelle%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DN.%26atitle%3DMechanism%2520of%2520auxin%2520perception%2520by%2520the%2520TIR1%2520ubiquitin%2520ligase%26jtitle%3DNature%26date%3D2007%26volume%3D446%26issue%3D7136%26spage%3D640%26epage%3D645%26doi%3D10.1038%2Fnature05731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Protein degradation: Prime time for PROTACs</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1038/nchembio.1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnchembio.1887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=26284668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKntrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=634-635&issue=9&author=R.+J.+Deshaies&title=Protein+degradation%3A+Prime+time+for+PROTACs&doi=10.1038%2Fnchembio.1887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Protein degradation. Prime time for PROTACs</span></div><div class="casAuthors">Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">634-635</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  PROTACs (proteolysis-targeting chimeric mols.) are heterobifunctional small mols. that simultaneously bind a target protein and a ubiquitin ligase, enabling ubiquitination and degrdn. of the target.  Major progress in developing potent and specific PROTACs has recently been reported, invigorating prospects for novel PROTAC-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcMM05VgBV07Vg90H21EOLACvtfcHk0lhWYpQMzjp5mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKntrvF&md5=cea6459c9e7a6911b8368c544af23a1f</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1887%26sid%3Dliteratum%253Aachs%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520degradation%253A%2520Prime%2520time%2520for%2520PROTACs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D9%26spage%3D634%26epage%3D635%26doi%3D10.1038%2Fnchembio.1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Toure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-molecule PROTACS: new approaches to protein degradation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span><span class="refDoi"> DOI: 10.1002/anie.201507978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1002%2Fanie.201507978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1966-1973&issue=6&author=M.+Toureauthor=C.+M.+Crews&title=Small-molecule+PROTACS%3A+new+approaches+to+protein+degradation&doi=10.1002%2Fanie.201507978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule PROTACS: New Approaches to Protein Degradation</span></div><div class="casAuthors">Toure, Momar; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1966-1973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The current inhibitor-based approach to therapeutics has inherent limitations owing to its occupancy-based model: there is a need to maintain high systemic exposure to ensure sufficient in vivo inhibition, high in vivo concns. bring potential for off-target side effects, and there is a need to bind to an active site, thus limiting the drug target space.  As an alternative, induced protein degrdn. lacks these limitations.  Based on an event-driven model, this approach offers a novel catalytic mechanism to irreversibly inhibit protein function by targeting protein destruction through recruitment to the cellular quality control machinery.  Prior protein degrading strategies have lacked therapeutic potential.  However, recent reports of small-mol.-based proteolysis-targeting chimeras (PROTACs) have demonstrated that this technol. can effectively decrease the cellular levels of several protein classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdaqlIjCSsgrVg90H21EOLACvtfcHk0li7Cy6D66HDng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D&md5=47838cd15719757317cb8282c26cc59e</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507978%26sid%3Dliteratum%253Aachs%26aulast%3DToure%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520PROTACS%253A%2520new%2520approaches%2520to%2520protein%2520degradation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D6%26spage%3D1966%26epage%3D1973%26doi%3D10.1002%2Fanie.201507978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Man, H.; Muller, G. W.; Ruchelman, A. L.; Khalil, E. M.; Chen, R. S.; Zhang, W.</span>, <span> </span><span class="NLM_article-title">Arylmethoxy isoindolinone derivatives and compositions comprising and methods of using the same</span>. US Patent 8,518,972,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Man&author=G.+W.+Muller&author=A.+L.+Ruchelman&author=E.+M.+Khalil&author=R.+S.+Chen&author=W.+Zhang&title=Arylmethoxy+isoindolinone+derivatives+and+compositions+comprising+and+methods+of+using+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMan%26aufirst%3DH.%26atitle%3DArylmethoxy%2520isoindolinone%2520derivatives%2520and%2520compositions%2520comprising%2520and%2520methods%2520of%2520using%2520the%2520same%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Boichenko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deiss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez Alvarez, B.</span><span> </span><span class="NLM_article-title">A FRET-based assay for the identification and characterization of cereblon ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01735</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01735" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=770-774&issue=2&author=I.+Boichenkoauthor=S.+Deissauthor=K.+Barauthor=M.+D.+Hartmannauthor=B.+Hernandez+Alvarez&title=A+FRET-based+assay+for+the+identification+and+characterization+of+cereblon+ligands&doi=10.1021%2Facs.jmedchem.5b01735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A FRET-Based Assay for the Identification and Characterization of Cereblon Ligands</span></div><div class="casAuthors">Boichenko, Iuliia; Deiss, Silvia; Baer, Kerstin; Hartmann, Marcus D.; Hernandez Alvarez, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">770-774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cereblon serves as an ubiquitin ligase substrate receptor that can be tuned toward different target proteins by various cereblon-binding agents.  This offers one of the most promising avenues for targeted protein degrdn. in cancer therapy, but cereblon binding can also mediate teratogenic effects.  We present an effective assay that is suited for high-throughput screening of compd. libraries for off-target cereblon interactions but also can guide lead optimization and rational design of novel cereblon effector mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzkRpBLlhlVbVg90H21EOLACvtfcHk0li7Cy6D66HDng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yktg%253D%253D&md5=f0400506428f439e81f579204e0bd39d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01735%26sid%3Dliteratum%253Aachs%26aulast%3DBoichenko%26aufirst%3DI.%26aulast%3DDeiss%26aufirst%3DS.%26aulast%3DBar%26aufirst%3DK.%26aulast%3DHartmann%26aufirst%3DM.%2BD.%26aulast%3DHernandez%2BAlvarez%26aufirst%3DB.%26atitle%3DA%2520FRET-based%2520assay%2520for%2520the%2520identification%2520and%2520characterization%2520of%2520cereblon%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D2%26spage%3D770%26epage%3D774%26doi%3D10.1021%2Facs.jmedchem.5b01735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Katagiri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonezawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, T.</span><span> </span><span class="NLM_article-title">Two distinct human myeloma cell lines originating from one patient with myeloma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1002/ijc.2910360217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1002%2Fijc.2910360217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=3926660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A280%3ADyaL2M3mtVWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1985&pages=241-246&issue=2&author=S.+Katagiriauthor=T.+Yonezawaauthor=J.+Kuyamaauthor=Y.+Kanayamaauthor=T.+Tamakiauthor=M.+Ohnishiauthor=S.+Taruiauthor=K.+Nishidaauthor=T.+Abe&title=Two+distinct+human+myeloma+cell+lines+originating+from+one+patient+with+myeloma&doi=10.1002%2Fijc.2910360217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Two distinct human myeloma cell lines originating from one patient with myeloma</span></div><div class="casAuthors">Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-6</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Two distinct cell lines (OPM-1 and OPM-2) were established from the peripheral blood of a 56-year-old female myeloma patient at the stage of terminal leukemic evolution associated with loss of cytoplasmic immunoglobulin heavy chain (G lambda----lambda).  The lines grew in suspension with a doubling time of 36-42 hr and 30-36 hr, respectively.  EBNA was absent from both lines.  The lines synthesized cytoplasmic lambda-chain, but had no detectable surface immunoglobulins.  Fc receptors and complement receptors could not be detected in either line.  The lines had very complex chromosomal abnormalities, but the patterns of chromosomes differed greatly between the two lines.  The two lines, together with the RPMI 8226 line established by Matsuoka et al. (1967), were analyzed for phenotypic expression as defined by a panel of monoclonal antibodies to B cells (B1, BA-1, BA-2, BA-3, OKIa-1 and OKT10/BMA0100).  Neither OPM-1 nor OPM-2 reacted with any of the antibodies tested except OKT10.  OPM-1 cells reacted weakly (less than 30%) with OKT10/BMA0100, while OPM-2 cells showed a fluctuating reactivity, ranging from 40 to 80%, with OKT10/BMA0100.  In contrast, RPMI 8226 reacted strongly with OKT10 and BA-2.  These results demonstrate the presence of phenotypic heterogeneity in all 3 myeloma cell lines, suggesting that the lines might represent different stages of terminal B-cell development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_-dVNKy-ESisZ1x6zOs0vfW6udTcc2eZ_ToleOIh70bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3mtVWnsw%253D%253D&md5=bf38cf9b35f120a08ab881db395c8f30</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910360217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910360217%26sid%3Dliteratum%253Aachs%26aulast%3DKatagiri%26aufirst%3DS.%26aulast%3DYonezawa%26aufirst%3DT.%26aulast%3DKuyama%26aufirst%3DJ.%26aulast%3DKanayama%26aufirst%3DY.%26aulast%3DTamaki%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DM.%26aulast%3DTarui%26aufirst%3DS.%26aulast%3DNishida%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DT.%26atitle%3DTwo%2520distinct%2520human%2520myeloma%2520cell%2520lines%2520originating%2520from%2520one%2520patient%2520with%2520myeloma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1985%26volume%3D36%26issue%3D2%26spage%3D241%26epage%3D246%26doi%3D10.1002%2Fijc.2910360217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgcNzYQ3BkS1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&issue=4&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lgcNzYQ3BkS1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3D4%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 77 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Guoqiang Dong, Yu Ding, Shipeng He, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00895%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252BGlues%252Bfor%252BTargeted%252BProtein%252BDegradation%25253A%252BFrom%252BSerendipity%252Bto%252BRational%252BDiscovery%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2021%26date%3D2021%26date%3D18052021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gisele Nishiguchi, Fatemeh Keramatnia, Jaeki Min, Yunchao Chang, Barbara Jonchere, Sourav Das, Marisa Actis, Jeanine Price, Divyabharathi Chepyala, Brandon Young, Kevin McGowan, P. Jake Slavish, Anand Mayasundari, Jamie A. Jarusiewicz, Lei Yang, Yong Li, Xiang Fu, Shalandus H. Garrett, James B. Papizan, Kiran Kodali, Junmin Peng, Shondra M. Pruett Miller, Martine F. Roussel, Charles Mullighan, Marcus Fischer, <span class="NLM_string-name hlFld-ContribAuthor">Zoran Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7296-7311. <a href="https://doi.org/10.1021/acs.jmedchem.0c01313" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01313%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BSmall-Molecule%252BGSPT1%25252F2%252BDegraders%252Bfrom%252Ba%252BFocused%252BLibrary%252Bof%252BCereblon%252BModulators%26aulast%3DNishiguchi%26aufirst%3DGisele%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28072020%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7296%26epage%3D7311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel Maiwald, Christopher Heim, Birte Hernandez Alvarez, <span class="NLM_string-name hlFld-ContribAuthor">Marcus D. Hartmann</span>. </span><span class="cited-content_cbyCitation_article-title">Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 74-81. <a href="https://doi.org/10.1021/acsmedchemlett.0c00440" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00440%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSweet%252Band%252BBlind%252BSpots%252Bin%252BE3%252BLigase%252BLigand%252BSpace%252BRevealed%252Bby%252Ba%252BThermophoresis-Based%252BAssay%26aulast%3DMaiwald%26aufirst%3DSamuel%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12082020%26date%3D25112020%26date%3D04122020%26volume%3D12%26issue%3D1%26spage%3D74%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wenwei Lin, Yongtao Li, Jaeki Min, Jiuyu Liu, Lei Yang, Richard E. Lee, <span class="NLM_string-name hlFld-ContribAuthor">Taosheng Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Development of BODIPY FL Thalidomide As a High-Affinity Fluorescent Probe for Cereblon in a Time-Resolved Fluorescence Resonance Energy Transfer Assay. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2020,</strong> <em>31 </em>
                                    (11)
                                     , 2564-2575. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00507" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00507</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00507%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDevelopment%252Bof%252BBODIPY%252BFL%252BThalidomide%252BAs%252Ba%252BHigh-Affinity%252BFluorescent%252BProbe%252Bfor%252BCereblon%252Bin%252Ba%252BTime-Resolved%252BFluorescence%252BResonance%252BEnergy%252BTransfer%252BAssay%26aulast%3DLin%26aufirst%3DWenwei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13092020%26date%3D05102020%26date%3D18102020%26volume%3D31%26issue%3D11%26spage%3D2564%26epage%3D2575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emily J. Hanan, Jun Liang, Xiaojing Wang, Robert A. Blake, Nicole Blaquiere, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Monomeric Targeted Protein Degraders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11330-11361. <a href="https://doi.org/10.1021/acs.jmedchem.0c00093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMonomeric%252BTargeted%252BProtein%252BDegraders%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17012020%26date%3D15062020%26date%3D30042020%26volume%3D63%26issue%3D20%26spage%3D11330%26epage%3D11361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chelsea E. Powell, Guangyan Du, Jianwei Che, Zhixiang He, Katherine A. Donovan, Hong Yue, Eric S. Wang, Radosław P. Nowak, Tinghu Zhang, Eric S. Fischer, <span class="NLM_string-name hlFld-ContribAuthor">Nathanael S. Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 2722-2730. <a href="https://doi.org/10.1021/acschembio.0c00520" title="DOI URL">https://doi.org/10.1021/acschembio.0c00520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00520%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSelective%252BDegradation%252Bof%252BGSPT1%252Bby%252BCereblon%252BModulators%252BIdentified%252Bvia%252Ba%252BFocused%252BCombinatorial%252BLibrary%26aulast%3DPowell%26aufirst%3DChelsea%2BE.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27062020%26date%3D31082020%26date%3D28092020%26date%3D31082020%26volume%3D15%26issue%3D10%26spage%3D2722%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Philip P. Chamberlain, Laura A. D’Agostino, J. Michael Ellis, Joshua D. Hansen, Mary E. Matyskiela, Joseph J. McDonald, Jennifer R. Riggs, <span class="NLM_string-name hlFld-ContribAuthor">Lawrence G. Hamann</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 1592-1602. <a href="https://doi.org/10.1021/acsmedchemlett.9b00425" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00425%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvolution%252Bof%252BCereblon-Mediated%252BProtein%252BDegradation%252Bas%252Ba%252BTherapeutic%252BModality%26aulast%3DChamberlain%26aufirst%3DPhilip%2BP.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15092019%26date%3D12112019%26date%3D25112019%26date%3D12112019%26volume%3D10%26issue%3D12%26spage%3D1592%26epage%3D1602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher Heim, Dimanthi Pliatsika, Farnoush Mousavizadeh, Kerstin Bär, Birte Hernandez Alvarez, Athanassios Giannis, <span class="NLM_string-name hlFld-ContribAuthor">Marcus D. Hartmann</span>. </span><span class="cited-content_cbyCitation_article-title">De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6615-6629. <a href="https://doi.org/10.1021/acs.jmedchem.9b00454" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDe-Novo%252BDesign%252Bof%252BCereblon%252B%252528CRBN%252529%252BEffectors%252BGuided%252Bby%252BNatural%252BHydrolysis%252BProducts%252Bof%252BThalidomide%252BDerivatives%26aulast%3DHeim%26aufirst%3DChristopher%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15032019%26date%3D12072019%26date%3D28062019%26volume%3D62%26issue%3D14%26spage%3D6615%26epage%3D6629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian Steinebach, Stefanie Lindner, Namrata D. Udeshi, Deepak C. Mani, Hannes Kehm, Simon Köpff, Steven A. Carr, Michael Gütschow, <span class="NLM_string-name hlFld-ContribAuthor">Jan Krönke</span>. </span><span class="cited-content_cbyCitation_article-title">Homo-PROTACs for the Chemical Knockdown of Cereblon. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (9)
                                     , 2771-2782. <a href="https://doi.org/10.1021/acschembio.8b00693" title="DOI URL">https://doi.org/10.1021/acschembio.8b00693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00693%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DHomo-PROTACs%252Bfor%252Bthe%252BChemical%252BKnockdown%252Bof%252BCereblon%26aulast%3DSteinebach%26aufirst%3DChristian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25072018%26date%3D17082018%26date%3D05092018%26date%3D17082018%26volume%3D13%26issue%3D9%26spage%3D2771%26epage%3D2782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig M.  Crews</span> (<span class="NLM_role">Guest Editor</span>). </span><span class="cited-content_cbyCitation_article-title">Inducing Protein Degradation as a Therapeutic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (2)
                                     , 403-404. <a href="https://doi.org/10.1021/acs.jmedchem.7b01333" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01333%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInducing%252BProtein%252BDegradation%252Bas%252Ba%252BTherapeutic%252BStrategy%26aulast%3DCrews%26aufirst%3DCraig%2BM.%26date%3D2018%26date%3D2017%26date%3D13092017%26date%3D22112017%26date%3D25012018%26volume%3D61%26issue%3D2%26spage%3D403%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George M.  Burslem</span> and <span class="hlFld-ContribAuthor ">Craig M.  Crews</span>  . </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Modulation of Protein Homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2017,</strong> <em>117 </em>
                                    (17)
                                     , 11269-11301. <a href="https://doi.org/10.1021/acs.chemrev.7b00077" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00077%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSmall-Molecule%252BModulation%252Bof%252BProtein%252BHomeostasis%26aulast%3DBurslem%26aufirst%3DGeorge%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D02022017%26date%3D04082017%26date%3D13092017%26volume%3D117%26issue%3D17%26spage%3D11269%26epage%3D11301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Ira  Tandon</span>, <span class="hlFld-ContribAuthor ">Suzhen  Wu</span>, <span class="hlFld-ContribAuthor ">Peng  Teng</span>, <span class="hlFld-ContribAuthor ">Jianhua  Liao</span>, <span class="hlFld-ContribAuthor ">Weiping  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113425. <a href="https://doi.org/10.1016/j.ejmech.2021.113425" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113425%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BMDM2%252Bdegraders%252Bbased%252Bon%252Bligands%252Bderived%252Bfrom%252BUgi%252Breactions%25253A%252BLessons%252Band%252Bdiscoveries%26aulast%3DWang%26aufirst%3DBo%26date%3D2021%26volume%3D219%26spage%3D113425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Max  Jan</span>, <span class="hlFld-ContribAuthor ">Adam S.  Sperling</span>, <span class="hlFld-ContribAuthor ">Benjamin L.  Ebert</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Clinical Oncology</span><span> <strong>2021,</strong> <em>18 </em>
                                    (7)
                                     , 401-417. <a href="https://doi.org/10.1038/s41571-021-00479-z" title="DOI URL">https://doi.org/10.1038/s41571-021-00479-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41571-021-00479-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41571-021-00479-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Clinical%2520Oncology%26atitle%3DCancer%252Btherapies%252Bbased%252Bon%252Btargeted%252Bprotein%252Bdegradation%252B%2525E2%252580%252594%252Blessons%252Blearned%252Bwith%252Blenalidomide%26aulast%3DJan%26aufirst%3DMax%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D7%26spage%3D401%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Shu</span>, <span class="hlFld-ContribAuthor ">Teng-Fei  Li</span>, <span class="hlFld-ContribAuthor ">Duo  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Qiu  Li</span>, <span class="hlFld-ContribAuthor ">Xing-Hua  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">A sensitive and validated LC-MS/MS method for high-throughput determination of pomalidomide in human plasma and pharmacokinetic studies. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>87 </em><a href="https://doi.org/10.1016/j.cclet.2021.07.009" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DA%252Bsensitive%252Band%252Bvalidated%252BLC-MS%25252FMS%252Bmethod%252Bfor%252Bhigh-throughput%252Bdetermination%252Bof%252Bpomalidomide%252Bin%252Bhuman%252Bplasma%252Band%252Bpharmacokinetic%252Bstudies%26aulast%3DShu%26aufirst%3DChang%26date%3D2021%26volume%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuzanna  Kozicka</span>, <span class="hlFld-ContribAuthor ">Nicolas Holger  Thomä</span>. </span><span class="cited-content_cbyCitation_article-title">Haven't got a glue: Protein surface variation for the design of molecular glue degraders. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (7)
                                     , 1032-1047. <a href="https://doi.org/10.1016/j.chembiol.2021.04.009" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DHaven%252527t%252Bgot%252Ba%252Bglue%25253A%252BProtein%252Bsurface%252Bvariation%252Bfor%252Bthe%252Bdesign%252Bof%252Bmolecular%252Bglue%252Bdegraders%26aulast%3DKozicka%26aufirst%3DZuzanna%26date%3D2021%26volume%3D28%26issue%3D7%26spage%3D1032%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takumi  Ito</span>, <span class="hlFld-ContribAuthor ">Yuki  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Handa</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (7)
                                     , 987-999. <a href="https://doi.org/10.1016/j.chembiol.2021.04.012" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DExploiting%252Bubiquitin%252Bligase%252Bcereblon%252Bas%252Ba%252Btarget%252Bfor%252Bsmall-molecule%252Bcompounds%252Bin%252Bmedicine%252Band%252Bchemical%252Bbiology%26aulast%3DIto%26aufirst%3DTakumi%26date%3D2021%26volume%3D28%26issue%3D7%26spage%3D987%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon  Dale</span>, <span class="hlFld-ContribAuthor ">Meng  Cheng</span>, <span class="hlFld-ContribAuthor ">Kwang-Su  Park</span>, <span class="hlFld-ContribAuthor ">H. Ümit  Kaniskan</span>, <span class="hlFld-ContribAuthor ">Yue  Xiong</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Advancing targeted protein degradation for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2021,</strong> <em>170 </em><a href="https://doi.org/10.1038/s41568-021-00365-x" title="DOI URL">https://doi.org/10.1038/s41568-021-00365-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41568-021-00365-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41568-021-00365-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DAdvancing%252Btargeted%252Bprotein%252Bdegradation%252Bfor%252Bcancer%252Btherapy%26aulast%3DDale%26aufirst%3DBrandon%26date%3D2021%26date%3D2021%26volume%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Ye</span>, <span class="hlFld-ContribAuthor ">Allison  Gaudy</span>, <span class="hlFld-ContribAuthor ">Peter  Schafer</span>, <span class="hlFld-ContribAuthor ">Michael  Thomas</span>, <span class="hlFld-ContribAuthor ">Daniel  Weiss</span>, <span class="hlFld-ContribAuthor ">Nianhang  Chen</span>, <span class="hlFld-ContribAuthor ">Liangang  Liu</span>, <span class="hlFld-ContribAuthor ">Yongjun  Xue</span>, <span class="hlFld-ContribAuthor ">Leon  Carayannopoulos</span>, <span class="hlFld-ContribAuthor ">Maria  Palmisano</span>. </span><span class="cited-content_cbyCitation_article-title">First‐in‐Human, Single‐ and Multiple‐Ascending‐Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 471-485. <a href="https://doi.org/10.1002/cpdd.869" title="DOI URL">https://doi.org/10.1002/cpdd.869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.869%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DFirst%2525E2%252580%252590in%2525E2%252580%252590Human%25252C%252BSingle%2525E2%252580%252590%252Band%252BMultiple%2525E2%252580%252590Ascending%2525E2%252580%252590Dose%252BStudies%252Bin%252BHealthy%252BSubjects%252Bto%252BAssess%252BPharmacokinetics%25252C%252BPharmacodynamics%25252C%252Band%252BSafety%25252FTolerability%252Bof%252BIberdomide%25252C%252Ba%252BNovel%252BCereblon%252BE3%252BLigase%252BModulator%26aulast%3DYe%26aufirst%3DYing%26date%3D2021%26date%3D2020%26volume%3D10%26issue%3D5%26spage%3D471%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erika  Araujo</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer Targets Involving the Ubiquitin Proteasome System. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-27. <a href="https://doi.org/10.1002/0471266949.bmc282" title="DOI URL">https://doi.org/10.1002/0471266949.bmc282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc282%26sid%3Dliteratum%253Aachs%26atitle%3DCancer%252BTargets%252BInvolving%252Bthe%252BUbiquitin%252BProteasome%252BSystem%26aulast%3DAraujo%26aufirst%3DErika%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D27%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarath  Ramachandran</span>, <span class="hlFld-ContribAuthor ">Alessio  Ciulli</span>. </span><span class="cited-content_cbyCitation_article-title">Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Structural Biology</span><span> <strong>2021,</strong> <em>67 </em>, 110-119. <a href="https://doi.org/10.1016/j.sbi.2020.10.009" title="DOI URL">https://doi.org/10.1016/j.sbi.2020.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.sbi.2020.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.sbi.2020.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Structural%2520Biology%26atitle%3DBuilding%252Bubiquitination%252Bmachineries%25253A%252BE3%252Bligase%252Bmulti-subunit%252Bassembly%252Band%252Bsubstrate%252Btargeting%252Bby%252BPROTACs%252Band%252Bmolecular%252Bglues%26aulast%3DRamachandran%26aufirst%3DSarath%26date%3D2021%26volume%3D67%26spage%3D110%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonne A.  Nagel</span>, <span class="hlFld-ContribAuthor ">Adrian  Britschgi</span>, <span class="hlFld-ContribAuthor ">Antonio  Ricci</span>. </span><span class="cited-content_cbyCitation_article-title">From Degraders to Molecular Glues: New Ways of Breaking Down Disease‐Associated Proteins. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 47-85. <a href="https://doi.org/10.1002/9783527826872.ch2" title="DOI URL">https://doi.org/10.1002/9783527826872.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527826872.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527826872.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BDegraders%252Bto%252BMolecular%252BGlues%25253A%252BNew%252BWays%252Bof%252BBreaking%252BDown%252BDisease%2525E2%252580%252590Associated%252BProteins%26aulast%3DNagel%26aufirst%3DYvonne%2BA.%26date%3D2021%26date%3D2021%26spage%3D47%26epage%3D85%26pub%3DWiley%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2021%26date%3D2021%26volume%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tyler B.  Faust</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Philip P.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Approaches to Targeted Protein Degradation. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Cancer Biology</span><span> <strong>2021,</strong> <em>5 </em>
                                    (1)
                                     , 181-201. <a href="https://doi.org/10.1146/annurev-cancerbio-051420-114114" title="DOI URL">https://doi.org/10.1146/annurev-cancerbio-051420-114114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-cancerbio-051420-114114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-cancerbio-051420-114114%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Cancer%2520Biology%26atitle%3DSmall-Molecule%252BApproaches%252Bto%252BTargeted%252BProtein%252BDegradation%26aulast%3DFaust%26aufirst%3DTyler%2BB.%26date%3D2021%26volume%3D5%26issue%3D1%26spage%3D181%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felice  Rivellese</span>, <span class="hlFld-ContribAuthor ">Sotiria  Manou-Stathopoulou</span>, <span class="hlFld-ContribAuthor ">Daniele  Mauro</span>, <span class="hlFld-ContribAuthor ">Katriona  Goldmann</span>, <span class="hlFld-ContribAuthor ">Debasish  Pyne</span>, <span class="hlFld-ContribAuthor ">Ravindra  Rajakariar</span>, <span class="hlFld-ContribAuthor ">Patrick  Gordon</span>, <span class="hlFld-ContribAuthor ">Peter  Schafer</span>, <span class="hlFld-ContribAuthor ">Michele  Bombardieri</span>, <span class="hlFld-ContribAuthor ">Costantino  Pitzalis</span>, <span class="hlFld-ContribAuthor ">Myles J  Lewis</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus. </span><span class="cited-content_cbyCitation_journal-name">Lupus Science & Medicine</span><span> <strong>2021,</strong> <em>8 </em>
                                    (1)
                                     , e000445. <a href="https://doi.org/10.1136/lupus-2020-000445" title="DOI URL">https://doi.org/10.1136/lupus-2020-000445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/lupus-2020-000445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Flupus-2020-000445%26sid%3Dliteratum%253Aachs%26jtitle%3DLupus%2520Science%2520%2526%2520Medicine%26atitle%3DEffects%252Bof%252Btargeting%252Bthe%252Btranscription%252Bfactors%252BIkaros%252Band%252BAiolos%252Bon%252BB%252Bcell%252Bactivation%252Band%252Bdifferentiation%252Bin%252Bsystemic%252Blupus%252Berythematosus%26aulast%3DRivellese%26aufirst%3DFelice%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D1%26spage%3De000445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Caro</span>, <span class="hlFld-ContribAuthor ">Samer  Al Hadidi</span>, <span class="hlFld-ContribAuthor ">Saad  Usmani</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Yee</span>, <span class="hlFld-ContribAuthor ">Noopur  Raje</span>, <span class="hlFld-ContribAuthor ">Faith E.  Davies</span>. </span><span class="cited-content_cbyCitation_article-title">How to Treat High-Risk Myeloma at Diagnosis and Relapse. </span><span class="cited-content_cbyCitation_journal-name">American Society of Clinical Oncology Educational Book</span><span> <strong>2021,</strong> <em>85 </em>
                                    (41)
                                     , 291-309. <a href="https://doi.org/10.1200/EDBK_320105" title="DOI URL">https://doi.org/10.1200/EDBK_320105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/EDBK_320105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FEDBK_320105%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Society%2520of%2520Clinical%2520Oncology%2520Educational%2520Book%26atitle%3DHow%252Bto%252BTreat%252BHigh-Risk%252BMyeloma%252Bat%252BDiagnosis%252Band%252BRelapse%26aulast%3DCaro%26aufirst%3DJessica%26date%3D2021%26volume%3D85%26issue%3D41%26spage%3D291%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Surka</span>, <span class="hlFld-ContribAuthor ">Liqing  Jin</span>, <span class="hlFld-ContribAuthor ">Nathan  Mbong</span>, <span class="hlFld-ContribAuthor ">Chin-Chun  Lu</span>, <span class="hlFld-ContribAuthor ">In Sock  Jang</span>, <span class="hlFld-ContribAuthor ">Emily  Rychak</span>, <span class="hlFld-ContribAuthor ">Derek  Mendy</span>, <span class="hlFld-ContribAuthor ">Thomas  Clayton</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Tindall</span>, <span class="hlFld-ContribAuthor ">Christy  Hsu</span>, <span class="hlFld-ContribAuthor ">Celia  Fontanillo</span>, <span class="hlFld-ContribAuthor ">Eileen  Tran</span>, <span class="hlFld-ContribAuthor ">Adrian  Contreras</span>, <span class="hlFld-ContribAuthor ">Stanley W. K.  Ng</span>, <span class="hlFld-ContribAuthor ">Mary  Matyskiela</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Philip  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Brian  Cathers</span>, <span class="hlFld-ContribAuthor ">James  Carmichael</span>, <span class="hlFld-ContribAuthor ">Joshua  Hansen</span>, <span class="hlFld-ContribAuthor ">Jean C. Y.  Wang</span>, <span class="hlFld-ContribAuthor ">Mark D.  Minden</span>, <span class="hlFld-ContribAuthor ">Jinhong  Fan</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Pierce</span>, <span class="hlFld-ContribAuthor ">Michael  Pourdehnad</span>, <span class="hlFld-ContribAuthor ">Mark  Rolfe</span>, <span class="hlFld-ContribAuthor ">Antonia  Lopez-Girona</span>, <span class="hlFld-ContribAuthor ">John E.  Dick</span>, <span class="hlFld-ContribAuthor ">Gang  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2021,</strong> <em>137 </em>
                                    (5)
                                     , 661-677. <a href="https://doi.org/10.1182/blood.2020008676" title="DOI URL">https://doi.org/10.1182/blood.2020008676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood.2020008676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood.2020008676%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DCC-90009%25252C%252Ba%252Bnovel%252Bcereblon%252BE3%252Bligase%252Bmodulator%25252C%252Btargets%252Bacute%252Bmyeloid%252Bleukemia%252Bblasts%252Band%252Bleukemia%252Bstem%252Bcells%26aulast%3DSurka%26aufirst%3DChristine%26date%3D2021%26volume%3D137%26issue%3D5%26spage%3D661%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison  Gaudy</span>, <span class="hlFld-ContribAuthor ">Christian  Atsriku</span>, <span class="hlFld-ContribAuthor ">Ying  Ye</span>, <span class="hlFld-ContribAuthor ">Kimberly  MacGorman</span>, <span class="hlFld-ContribAuthor ">Liangang  Liu</span>, <span class="hlFld-ContribAuthor ">Yongjun  Xue</span>, <span class="hlFld-ContribAuthor ">Sekhar  Surapaneni</span>, <span class="hlFld-ContribAuthor ">Maria  Palmisano</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>77 </em>
                                    (2)
                                     , 223-231. <a href="https://doi.org/10.1007/s00228-020-03004-w" title="DOI URL">https://doi.org/10.1007/s00228-020-03004-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00228-020-03004-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00228-020-03004-w%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DEvaluation%252Bof%252Biberdomide%252Band%252Bcytochrome%252Bp450%252Bdrug-drug%252Binteraction%252Bpotential%252Bin%252Bvitro%252Band%252Bin%252Ba%252Bphase%252B1%252Bstudy%252Bin%252Bhealthy%252Bsubjects%26aulast%3DGaudy%26aufirst%3DAllison%26date%3D2021%26date%3D2020%26volume%3D77%26issue%3D2%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Cippitelli</span>, <span class="hlFld-ContribAuthor ">Helena  Stabile</span>, <span class="hlFld-ContribAuthor ">Andrea  Kosta</span>, <span class="hlFld-ContribAuthor ">Sara  Petillo</span>, <span class="hlFld-ContribAuthor ">Angela  Gismondi</span>, <span class="hlFld-ContribAuthor ">Angela  Santoni</span>, <span class="hlFld-ContribAuthor ">Cinzia  Fionda</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 1103. <a href="https://doi.org/10.3390/ijms22031103" title="DOI URL">https://doi.org/10.3390/ijms22031103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22031103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22031103%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DRole%252Bof%252BAiolos%252Band%252BIkaros%252Bin%252Bthe%252BAntitumor%252Band%252BImmunomodulatory%252BActivity%252Bof%252BIMiDs%252Bin%252BMultiple%252BMyeloma%25253A%252BBetter%252Bto%252BLose%252BThan%252Bto%252BFind%252BThem%26aulast%3DCippitelli%26aufirst%3DMarco%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shelton R.  Boyd</span>, <span class="hlFld-ContribAuthor ">Lyra  Chang</span>, <span class="hlFld-ContribAuthor ">Wanderson  Rezende</span>, <span class="hlFld-ContribAuthor ">Idris O.  Raji</span>, <span class="hlFld-ContribAuthor ">Prasanna  Kandel</span>, <span class="hlFld-ContribAuthor ">Secondra L.  Holmes</span>, <span class="hlFld-ContribAuthor ">Damian W.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Applications of Bifunctional Small Molecules in Biology. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2021,</strong> <em>1869 </em>
                                    (1)
                                     , 140534. <a href="https://doi.org/10.1016/j.bbapap.2020.140534" title="DOI URL">https://doi.org/10.1016/j.bbapap.2020.140534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2020.140534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2020.140534%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DDesign%252Band%252BApplications%252Bof%252BBifunctional%252BSmall%252BMolecules%252Bin%252BBiology%26aulast%3DBoyd%26aufirst%3DShelton%2BR.%26date%3D2021%26volume%3D1869%26issue%3D1%26spage%3D140534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teru  Hideshima</span>, <span class="hlFld-ContribAuthor ">Daisuke  Ogiya</span>, <span class="hlFld-ContribAuthor ">Jiye  Liu</span>, <span class="hlFld-ContribAuthor ">Takeshi  Harada</span>, <span class="hlFld-ContribAuthor ">Keiji  Kurata</span>, <span class="hlFld-ContribAuthor ">Jooeun  Bae</span>, <span class="hlFld-ContribAuthor ">Walter  Massefski</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  Anderson</span>. </span><span class="cited-content_cbyCitation_article-title">Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2021,</strong> <em>35 </em>
                                    (1)
                                     , 177-188. <a href="https://doi.org/10.1038/s41375-020-0809-x" title="DOI URL">https://doi.org/10.1038/s41375-020-0809-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-020-0809-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-020-0809-x%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DImmunomodulatory%252Bdrugs%252Bactivate%252BNK%252Bcells%252Bvia%252Bboth%252BZap-70%252Band%252Bcereblon-dependent%252Bpathways%26aulast%3DHideshima%26aufirst%3DTeru%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D177%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaobing  Gao</span>, <span class="hlFld-ContribAuthor ">Shichao  Wang</span>, <span class="hlFld-ContribAuthor ">Yongping  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Novel immunomodulatory drugs and neo-substrates. </span><span class="cited-content_cbyCitation_journal-name">Biomarker Research</span><span> <strong>2020,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40364-020-0182-y" title="DOI URL">https://doi.org/10.1186/s40364-020-0182-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40364-020-0182-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40364-020-0182-y%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomarker%2520Research%26atitle%3DNovel%252Bimmunomodulatory%252Bdrugs%252Band%252Bneo-substrates%26aulast%3DGao%26aufirst%3DShaobing%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Megan L.  Peach</span>, <span class="hlFld-ContribAuthor ">Shaunna L.  Beedie</span>, <span class="hlFld-ContribAuthor ">Cindy H.  Chau</span>, <span class="hlFld-ContribAuthor ">Matthew K.  Collins</span>, <span class="hlFld-ContribAuthor ">Suzana  Markolovic</span>, <span class="hlFld-ContribAuthor ">Weiming  Luo</span>, <span class="hlFld-ContribAuthor ">David  Tweedie</span>, <span class="hlFld-ContribAuthor ">Christian  Steinebach</span>, <span class="hlFld-ContribAuthor ">Nigel H.  Greig</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Neil  Vargesson</span>, <span class="hlFld-ContribAuthor ">Marc C.  Nicklaus</span>, <span class="hlFld-ContribAuthor ">William D.  Figg</span>. </span><span class="cited-content_cbyCitation_article-title">Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5683. <a href="https://doi.org/10.3390/molecules25235683" title="DOI URL">https://doi.org/10.3390/molecules25235683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235683%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAntiangiogenic%252BActivity%252Band%252Bin%252BSilico%252BCereblon%252BBinding%252BAnalysis%252Bof%252BNovel%252BThalidomide%252BAnalogs%26aulast%3DPeach%26aufirst%3DMegan%2BL.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergio  Martinez-Høyer</span>, <span class="hlFld-ContribAuthor ">Aly  Karsan</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of lenalidomide sensitivity and resistance. </span><span class="cited-content_cbyCitation_journal-name">Experimental Hematology</span><span> <strong>2020,</strong> <em>91 </em>, 22-31. <a href="https://doi.org/10.1016/j.exphem.2020.09.196" title="DOI URL">https://doi.org/10.1016/j.exphem.2020.09.196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.exphem.2020.09.196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.exphem.2020.09.196%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Hematology%26atitle%3DMechanisms%252Bof%252Blenalidomide%252Bsensitivity%252Band%252Bresistance%26aulast%3DMartinez-H%25C3%25B8yer%26aufirst%3DSergio%26date%3D2020%26volume%3D91%26spage%3D22%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Slavisa  Ninkovic</span>, <span class="hlFld-ContribAuthor ">Hang  Quach</span>. </span><span class="cited-content_cbyCitation_article-title">Shaping the Treatment Paradigm Based on the Current Understanding of the Pathobiology of Multiple Myeloma: An Overview. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (11)
                                     , 3488. <a href="https://doi.org/10.3390/cancers12113488" title="DOI URL">https://doi.org/10.3390/cancers12113488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12113488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12113488%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DShaping%252Bthe%252BTreatment%252BParadigm%252BBased%252Bon%252Bthe%252BCurrent%252BUnderstanding%252Bof%252Bthe%252BPathobiology%252Bof%252BMultiple%252BMyeloma%25253A%252BAn%252BOverview%26aulast%3DNinkovic%26aufirst%3DSlavisa%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D11%26spage%3D3488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisy  Yan</span>, <span class="hlFld-ContribAuthor ">Robert  Borucki</span>, <span class="hlFld-ContribAuthor ">Richard D  Sontheimer</span>, <span class="hlFld-ContribAuthor ">Victoria P  Werth</span>. </span><span class="cited-content_cbyCitation_article-title">Candidate drug replacements for quinacrine in cutaneous lupus erythematosus. </span><span class="cited-content_cbyCitation_journal-name">Lupus Science & Medicine</span><span> <strong>2020,</strong> <em>7 </em>
                                    (1)
                                     , e000430. <a href="https://doi.org/10.1136/lupus-2020-000430" title="DOI URL">https://doi.org/10.1136/lupus-2020-000430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/lupus-2020-000430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Flupus-2020-000430%26sid%3Dliteratum%253Aachs%26jtitle%3DLupus%2520Science%2520%2526%2520Medicine%26atitle%3DCandidate%252Bdrug%252Breplacements%252Bfor%252Bquinacrine%252Bin%252Bcutaneous%252Blupus%252Berythematosus%26aulast%3DYan%26aufirst%3DDaisy%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D1%26spage%3De000430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Bertamini</span>, <span class="hlFld-ContribAuthor ">Francesca  Bonello</span>, <span class="hlFld-ContribAuthor ">Mario  Boccadoro</span>, <span class="hlFld-ContribAuthor ">Sara  Bringhen</span>. </span><span class="cited-content_cbyCitation_article-title">New drugs in early development for treating multiple myeloma: all that glitters is not gold. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2020,</strong> <em>29 </em>
                                    (9)
                                     , 989-1004. <a href="https://doi.org/10.1080/13543784.2020.1772753" title="DOI URL">https://doi.org/10.1080/13543784.2020.1772753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2020.1772753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2020.1772753%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DNew%252Bdrugs%252Bin%252Bearly%252Bdevelopment%252Bfor%252Btreating%252Bmultiple%252Bmyeloma%25253A%252Ball%252Bthat%252Bglitters%252Bis%252Bnot%252Bgold%26aulast%3DBertamini%26aufirst%3DLuca%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D9%26spage%3D989%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianxuan  Zou</span>, <span class="hlFld-ContribAuthor ">Richard J.  Jones</span>, <span class="hlFld-ContribAuthor ">Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Isere  Kuiatse</span>, <span class="hlFld-ContribAuthor ">Fazal  Shirazi</span>, <span class="hlFld-ContribAuthor ">Elisabet E.  Manasanch</span>, <span class="hlFld-ContribAuthor ">Hans C.  Lee</span>, <span class="hlFld-ContribAuthor ">Robert  Sullivan</span>, <span class="hlFld-ContribAuthor ">Leah  Fung</span>, <span class="hlFld-ContribAuthor ">Normand  Richard</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Eduardo  Torres</span>, <span class="hlFld-ContribAuthor ">David  Hecht</span>, <span class="hlFld-ContribAuthor ">Imelda  Lam</span>, <span class="hlFld-ContribAuthor ">Brooke  McElwee</span>, <span class="hlFld-ContribAuthor ">Aparajita H.  Chourasia</span>, <span class="hlFld-ContribAuthor ">Kyle W. H.  Chan</span>, <span class="hlFld-ContribAuthor ">Frank  Mercurio</span>, <span class="hlFld-ContribAuthor ">David I.  Stirling</span>, <span class="hlFld-ContribAuthor ">Robert Z.  Orlowski</span>. </span><span class="cited-content_cbyCitation_article-title">The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Medicine</span><span> <strong>2020,</strong> <em>98 </em>
                                    (8)
                                     , 1161-1173. <a href="https://doi.org/10.1007/s00109-020-01943-6" title="DOI URL">https://doi.org/10.1007/s00109-020-01943-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00109-020-01943-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00109-020-01943-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Medicine%26atitle%3DThe%252Bnovel%252Bprotein%252Bhomeostatic%252Bmodulator%252BBTX306%252Bis%252Bactive%252Bin%252Bmyeloma%252Band%252Bovercomes%252Bbortezomib%252Band%252Blenalidomide%252Bresistance%26aulast%3DZou%26aufirst%3DJianxuan%26date%3D2020%26date%3D2020%26volume%3D98%26issue%3D8%26spage%3D1161%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yilin  Chen</span>, <span class="hlFld-ContribAuthor ">Jianping  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">The application of ubiquitin ligases in the PROTAC drug design. </span><span class="cited-content_cbyCitation_journal-name">Acta Biochimica et Biophysica Sinica</span><span> <strong>2020,</strong> <em>52 </em>
                                    (7)
                                     , 776-790. <a href="https://doi.org/10.1093/abbs/gmaa053" title="DOI URL">https://doi.org/10.1093/abbs/gmaa053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/abbs/gmaa053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fabbs%2Fgmaa053%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Biochimica%2520et%2520Biophysica%2520Sinica%26atitle%3DThe%252Bapplication%252Bof%252Bubiquitin%252Bligases%252Bin%252Bthe%252BPROTAC%252Bdrug%252Bdesign%26aulast%3DChen%26aufirst%3DYilin%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D7%26spage%3D776%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donghuai  Xiao</span>, <span class="hlFld-ContribAuthor ">Yu‐jie  Wang</span>, <span class="hlFld-ContribAuthor ">Han‐lin  Wang</span>, <span class="hlFld-ContribAuthor ">Yu‐bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Jiyu  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new lenalidomide analogs via Suzuki cross‐coupling reaction. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (7)
                                     , 1900376. <a href="https://doi.org/10.1002/ardp.201900376" title="DOI URL">https://doi.org/10.1002/ardp.201900376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900376%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252Blenalidomide%252Banalogs%252Bvia%252BSuzuki%252Bcross%2525E2%252580%252590coupling%252Breaction%26aulast%3DXiao%26aufirst%3DDonghuai%26date%3D2020%26date%3D2020%26volume%3D353%26issue%3D7%26spage%3D1900376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Wu</span>, <span class="hlFld-ContribAuthor ">Hojong  Yoon</span>, <span class="hlFld-ContribAuthor ">Yuan  Xiong</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Dixon-Clarke</span>, <span class="hlFld-ContribAuthor ">Radosław P.  Nowak</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted protein degradation as a powerful research tool in basic biology and drug target discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Structural & Molecular Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (7)
                                     , 605-614. <a href="https://doi.org/10.1038/s41594-020-0438-0" title="DOI URL">https://doi.org/10.1038/s41594-020-0438-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41594-020-0438-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41594-020-0438-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Structural%2520%2526%2520Molecular%2520Biology%26atitle%3DTargeted%252Bprotein%252Bdegradation%252Bas%252Ba%252Bpowerful%252Bresearch%252Btool%252Bin%252Bbasic%252Bbiology%252Band%252Bdrug%252Btarget%252Bdiscovery%26aulast%3DWu%26aufirst%3DTao%26date%3D2020%26date%3D2020%26volume%3D27%26issue%3D7%26spage%3D605%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ka  Yang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Xueqing  Nie</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Chelsi M.  Almodovar-Rivera</span>, <span class="hlFld-ContribAuthor ">Haibo  Xie</span>, <span class="hlFld-ContribAuthor ">Weiping  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">A Cell-Based Target Engagement Assay for the Identification of Cereblon E3 Ubiquitin Ligase Ligands and Their Application in HDAC6 Degraders. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (7)
                                     , 866-876.e8. <a href="https://doi.org/10.1016/j.chembiol.2020.04.008" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DA%252BCell-Based%252BTarget%252BEngagement%252BAssay%252Bfor%252Bthe%252BIdentification%252Bof%252BCereblon%252BE3%2525C2%2525A0Ubiquitin%252BLigase%252BLigands%252Band%252BTheir%252BApplication%252Bin%252BHDAC6%252BDegraders%26aulast%3DYang%26aufirst%3DKa%26date%3D2020%26volume%3D27%26issue%3D7%26spage%3D866%26epage%3D876.e8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taro  Tochigi</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Kiwamu  Hatakeyama</span>, <span class="hlFld-ContribAuthor ">Teppei  Sakoda</span>, <span class="hlFld-ContribAuthor ">Daisuke  Ishihara</span>, <span class="hlFld-ContribAuthor ">Hidetoshi  Irifune</span>, <span class="hlFld-ContribAuthor ">Takahiro  Shima</span>, <span class="hlFld-ContribAuthor ">Koji  Kato</span>, <span class="hlFld-ContribAuthor ">Takahiro  Maeda</span>, <span class="hlFld-ContribAuthor ">Takumi  Ito</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Handa</span>, <span class="hlFld-ContribAuthor ">Koichi  Akashi</span>, <span class="hlFld-ContribAuthor ">Yoshikane  Kikushige</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug–induced thrombocytopenia. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2020,</strong> <em>135 </em>
                                    (24)
                                     , 2146-2158. <a href="https://doi.org/10.1182/blood.2019003749" title="DOI URL">https://doi.org/10.1182/blood.2019003749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood.2019003749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood.2019003749%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DAromatase%252Bis%252Ba%252Bnovel%252Bneosubstrate%252Bof%252Bcereblon%252Bresponsible%252Bfor%252Bimmunomodulatory%252Bdrug%2525E2%252580%252593induced%252Bthrombocytopenia%26aulast%3DTochigi%26aufirst%3DTaro%26date%3D2020%26volume%3D135%26issue%3D24%26spage%3D2146%26epage%3D2158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takumi  ITO</span>, <span class="hlFld-ContribAuthor ">Hiroshi  HANDA</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanisms of thalidomide and its derivatives. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the Japan Academy, Series B</span><span> <strong>2020,</strong> <em>96 </em>
                                    (6)
                                     , 189-203. <a href="https://doi.org/10.2183/pjab.96.016" title="DOI URL">https://doi.org/10.2183/pjab.96.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2183/pjab.96.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2183%2Fpjab.96.016%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520Japan%2520Academy%252C%2520Series%2520B%26atitle%3DMolecular%252Bmechanisms%252Bof%252Bthalidomide%252Band%252Bits%252Bderivatives%26aulast%3DITO%26aufirst%3DTakumi%26date%3D2020%26volume%3D96%26issue%3D6%26spage%3D189%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daria  Kotlarek</span>, <span class="hlFld-ContribAuthor ">Agata  Pawlik</span>, <span class="hlFld-ContribAuthor ">Maria  Sagan</span>, <span class="hlFld-ContribAuthor ">Marta  Sowała</span>, <span class="hlFld-ContribAuthor ">Alina  Zawiślak-Architek</span>, <span class="hlFld-ContribAuthor ">Michał J.  Walczak</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Protein Degradation: "The Gold Rush is On!". </span><span class="cited-content_cbyCitation_journal-name">Technology Transfer and Entrepreneurship</span><span> <strong>2020,</strong> <em>7 </em>
                                    (1)
                                     , 4-16. <a href="https://doi.org/10.2174/2213809907666200130111436" title="DOI URL">https://doi.org/10.2174/2213809907666200130111436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/2213809907666200130111436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F2213809907666200130111436%26sid%3Dliteratum%253Aachs%26jtitle%3DTechnology%2520Transfer%2520and%2520Entrepreneurship%26atitle%3DTargeted%252BProtein%252BDegradation%25253A%252B%252522The%252BGold%252BRush%252Bis%252BOn%252521%252522%26aulast%3DKotlarek%26aufirst%3DDaria%26date%3D2020%26volume%3D7%26issue%3D1%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Qiaoli  Wang</span>, <span class="hlFld-ContribAuthor ">Guo‐Kai  Feng</span>, <span class="hlFld-ContribAuthor ">Mu‐Sheng  Zeng</span>. </span><span class="cited-content_cbyCitation_article-title">Significance of Selective Protein Degradation in the Development of Novel Targeted Drugs and Its Implications in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Advanced Therapeutics</span><span> <strong>2020,</strong> <em>3 </em>
                                    (6)
                                     , 1900210. <a href="https://doi.org/10.1002/adtp.201900210" title="DOI URL">https://doi.org/10.1002/adtp.201900210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adtp.201900210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadtp.201900210%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Therapeutics%26atitle%3DSignificance%252Bof%252BSelective%252BProtein%252BDegradation%252Bin%252Bthe%252BDevelopment%252Bof%252BNovel%252BTargeted%252BDrugs%252Band%252BIts%252BImplications%252Bin%252BCancer%252BTherapy%26aulast%3DYang%26aufirst%3DJie%26date%3D2020%26date%3D2020%26volume%3D3%26issue%3D6%26spage%3D1900210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoko  Asatsuma-Okumura</span>, <span class="hlFld-ContribAuthor ">Takumi  Ito</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Handa</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanisms of the Teratogenic Effects of Thalidomide. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (5)
                                     , 95. <a href="https://doi.org/10.3390/ph13050095" title="DOI URL">https://doi.org/10.3390/ph13050095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13050095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13050095%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DMolecular%252BMechanisms%252Bof%252Bthe%252BTeratogenic%252BEffects%252Bof%252BThalidomide%26aulast%3DAsatsuma-Okumura%26aufirst%3DTomoko%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D5%26spage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chad C.  Bjorklund</span>, <span class="hlFld-ContribAuthor ">Jian  Kang</span>, <span class="hlFld-ContribAuthor ">Michael  Amatangelo</span>, <span class="hlFld-ContribAuthor ">Ann  Polonskaia</span>, <span class="hlFld-ContribAuthor ">Mark  Katz</span>, <span class="hlFld-ContribAuthor ">Hsiling  Chiu</span>, <span class="hlFld-ContribAuthor ">Suzana  Couto</span>, <span class="hlFld-ContribAuthor ">Maria  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Ren</span>, <span class="hlFld-ContribAuthor ">Maria  Ortiz</span>, <span class="hlFld-ContribAuthor ">Fadi  Towfic</span>, <span class="hlFld-ContribAuthor ">J. Erin  Flynt</span>, <span class="hlFld-ContribAuthor ">William  Pierceall</span>, <span class="hlFld-ContribAuthor ">Anjan  Thakurta</span>. </span><span class="cited-content_cbyCitation_article-title">Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2020,</strong> <em>34 </em>
                                    (4)
                                     , 1197-1201. <a href="https://doi.org/10.1038/s41375-019-0620-8" title="DOI URL">https://doi.org/10.1038/s41375-019-0620-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-019-0620-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-019-0620-8%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DIberdomide%252B%252528CC-220%252529%252Bis%252Ba%252Bpotent%252Bcereblon%252BE3%252Bligase%252Bmodulator%252Bwith%252Bantitumor%252Band%252Bimmunostimulatory%252Bactivities%252Bin%252Blenalidomide-%252Band%252Bpomalidomide-resistant%252Bmultiple%252Bmyeloma%252Bcells%252Bwith%252Bdysregulated%252BCRBN%26aulast%3DBjorklund%26aufirst%3DChad%2BC.%26date%3D2020%26date%3D2019%26volume%3D34%26issue%3D4%26spage%3D1197%26epage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Congbao  Kang</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Keller</span>. </span><span class="cited-content_cbyCitation_article-title">Probing biological mechanisms with chemical tools. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>153 </em>, 104656. <a href="https://doi.org/10.1016/j.phrs.2020.104656" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.104656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.104656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.104656%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProbing%252Bbiological%252Bmechanisms%252Bwith%252Bchemical%252Btools%26aulast%3DKang%26aufirst%3DCongbao%26date%3D2020%26volume%3D153%26spage%3D104656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Degradation of proteins by PROTACs and other strategies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 207-238. <a href="https://doi.org/10.1016/j.apsb.2019.08.001" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDegradation%252Bof%252Bproteins%252Bby%252BPROTACs%252Band%252Bother%252Bstrategies%26aulast%3DWang%26aufirst%3DYang%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D207%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert  Oriol</span>, <span class="hlFld-ContribAuthor ">Laura  Abril</span>, <span class="hlFld-ContribAuthor ">Gladys  Ibarra</span>, <span class="hlFld-ContribAuthor ">Alicia  Senin</span>. </span><span class="cited-content_cbyCitation_article-title">Limited treatment options in refractory multiple myeloma: promising therapeutic developments. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     , 31-44. <a href="https://doi.org/10.1080/14737140.2020.1708721" title="DOI URL">https://doi.org/10.1080/14737140.2020.1708721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2020.1708721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2020.1708721%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DLimited%252Btreatment%252Boptions%252Bin%252Brefractory%252Bmultiple%252Bmyeloma%25253A%252Bpromising%252Btherapeutic%252Bdevelopments%26aulast%3DOriol%26aufirst%3DAlbert%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D1%26spage%3D31%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markella  Konstantinidou</span>, <span class="hlFld-ContribAuthor ">Jingyao  Li</span>, <span class="hlFld-ContribAuthor ">Bidong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zefeng  Wang</span>, <span class="hlFld-ContribAuthor ">Shabnam  Shaabani</span>, <span class="hlFld-ContribAuthor ">Frans  Ter Brake</span>, <span class="hlFld-ContribAuthor ">Khaled  Essa</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">PROTACs– a game-changing technology. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (12)
                                     , 1255-1268. <a href="https://doi.org/10.1080/17460441.2019.1659242" title="DOI URL">https://doi.org/10.1080/17460441.2019.1659242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1659242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1659242%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DPROTACs%2525E2%252580%252593%252Ba%252Bgame-changing%252Btechnology%26aulast%3DKonstantinidou%26aufirst%3DMarkella%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D12%26spage%3D1255%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthieu  Schapira</span>, <span class="hlFld-ContribAuthor ">Matthew F.  Calabrese</span>, <span class="hlFld-ContribAuthor ">Alex N.  Bullock</span>, <span class="hlFld-ContribAuthor ">Craig M.  Crews</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted protein degradation: expanding the toolbox. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (12)
                                     , 949-963. <a href="https://doi.org/10.1038/s41573-019-0047-y" title="DOI URL">https://doi.org/10.1038/s41573-019-0047-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0047-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0047-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTargeted%252Bprotein%252Bdegradation%25253A%252Bexpanding%252Bthe%252Btoolbox%26aulast%3DSchapira%26aufirst%3DMatthieu%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D12%26spage%3D949%26epage%3D963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoko  Asatsuma-Okumura</span>, <span class="hlFld-ContribAuthor ">Hideki  Ando</span>, <span class="hlFld-ContribAuthor ">Marco  De Simone</span>, <span class="hlFld-ContribAuthor ">Junichi  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Tomomi  Sato</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Shimizu</span>, <span class="hlFld-ContribAuthor ">Kazuhide  Asakawa</span>, <span class="hlFld-ContribAuthor ">Yuki  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Takumi  Ito</span>, <span class="hlFld-ContribAuthor ">Luisa  Guerrini</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Handa</span>. </span><span class="cited-content_cbyCitation_article-title">p63 is a cereblon substrate involved in thalidomide teratogenicity. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2019,</strong> <em>15 </em>
                                    (11)
                                     , 1077-1084. <a href="https://doi.org/10.1038/s41589-019-0366-7" title="DOI URL">https://doi.org/10.1038/s41589-019-0366-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-019-0366-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-019-0366-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3Dp63%252Bis%252Ba%252Bcereblon%252Bsubstrate%252Binvolved%252Bin%252Bthalidomide%252Bteratogenicity%26aulast%3DAsatsuma-Okumura%26aufirst%3DTomoko%26date%3D2019%26date%3D2019%26volume%3D15%26issue%3D11%26spage%3D1077%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan E.  Wilson</span>, <span class="hlFld-ContribAuthor ">Joshua  Garvey</span>, <span class="hlFld-ContribAuthor ">Kennedy M.  Taveras</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of isoindolinones: Intramolecular [4+2] cycloaddition/retro [4+2] of pyridone propiolamides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (41)
                                     , 151105. <a href="https://doi.org/10.1016/j.tetlet.2019.151105" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151105%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bisoindolinones%25253A%252BIntramolecular%252B%25255B4%25252B2%25255D%252Bcycloaddition%25252Fretro%252B%25255B4%25252B2%25255D%252Bof%252Bpyridone%252Bpropiolamides%26aulast%3DWilson%26aufirst%3DJonathan%2BE.%26date%3D2019%26volume%3D60%26issue%3D41%26spage%3D151105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip P.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Hamann</span>. </span><span class="cited-content_cbyCitation_article-title">Development of targeted protein degradation therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2019,</strong> <em>15 </em>
                                    (10)
                                     , 937-944. <a href="https://doi.org/10.1038/s41589-019-0362-y" title="DOI URL">https://doi.org/10.1038/s41589-019-0362-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-019-0362-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-019-0362-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DDevelopment%252Bof%252Btargeted%252Bprotein%252Bdegradation%252Btherapeutics%26aulast%3DChamberlain%26aufirst%3DPhilip%2BP.%26date%3D2019%26date%3D2019%26volume%3D15%26issue%3D10%26spage%3D937%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoko  Asatsuma-Okumura</span>, <span class="hlFld-ContribAuthor ">Takumi  Ito</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Handa</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanisms of cereblon-based drugs. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>202 </em>, 132-139. <a href="https://doi.org/10.1016/j.pharmthera.2019.06.004" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DMolecular%252Bmechanisms%252Bof%252Bcereblon-based%252Bdrugs%26aulast%3DAsatsuma-Okumura%26aufirst%3DTomoko%26date%3D2019%26volume%3D202%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donghuai  Xiao</span>, <span class="hlFld-ContribAuthor ">Yu-jie  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-bei  Hu</span>, <span class="hlFld-ContribAuthor ">Wei-juan  Kan</span>, <span class="hlFld-ContribAuthor ">Qiumeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Yu-bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of the thioether-containing lenalidomide analogs with anti-proliferative activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 419-430. <a href="https://doi.org/10.1016/j.ejmech.2019.05.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bthe%252Bthioether-containing%252Blenalidomide%252Banalogs%252Bwith%252Banti-proliferative%252Bactivities%26aulast%3DXiao%26aufirst%3DDonghuai%26date%3D2019%26volume%3D176%26spage%3D419%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew R.  Branagan</span>, <span class="hlFld-ContribAuthor ">Matthew  Lei</span>, <span class="hlFld-ContribAuthor ">Carolyn  Tracey</span>, <span class="hlFld-ContribAuthor ">Noopur S.  Raje</span>. </span><span class="cited-content_cbyCitation_article-title">Updates and rationale of clinical trials in multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">ADVANCES IN CELL AND GENE THERAPY</span><span> <strong>2019,</strong> <em>2 </em>
                                    (3)
                                     <a href="https://doi.org/10.1002/acg2.59" title="DOI URL">https://doi.org/10.1002/acg2.59</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/acg2.59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Facg2.59%26sid%3Dliteratum%253Aachs%26jtitle%3DADVANCES%2520IN%2520CELL%2520AND%2520GENE%2520THERAPY%26atitle%3DUpdates%252Band%252Brationale%252Bof%252Bclinical%252Btrials%252Bin%252Bmultiple%252Bmyeloma%26aulast%3DBranagan%26aufirst%3DAndrew%2BR.%26date%3D2019%26date%3D2019%26volume%3D2%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip P.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Brian E.  Cathers</span>. </span><span class="cited-content_cbyCitation_article-title">Cereblon modulators: Low molecular weight inducers of protein degradation. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2019,</strong> <em>31 </em>, 29-34. <a href="https://doi.org/10.1016/j.ddtec.2019.02.004" title="DOI URL">https://doi.org/10.1016/j.ddtec.2019.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2019.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DCereblon%252Bmodulators%25253A%252BLow%252Bmolecular%252Bweight%252Binducers%252Bof%252Bprotein%252Bdegradation%26aulast%3DChamberlain%26aufirst%3DPhilip%2BP.%26date%3D2019%26volume%3D31%26spage%3D29%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark Y.  Jeng</span>, <span class="hlFld-ContribAuthor ">Maxwell R.  Mumbach</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Granja</span>, <span class="hlFld-ContribAuthor ">Ansuman T.  Satpathy</span>, <span class="hlFld-ContribAuthor ">Howard Y.  Chang</span>, <span class="hlFld-ContribAuthor ">Anne Lynn S.  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2019,</strong> <em>139 </em>
                                    (3)
                                     , 605-614. <a href="https://doi.org/10.1016/j.jid.2018.09.011" title="DOI URL">https://doi.org/10.1016/j.jid.2018.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jid.2018.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jid.2018.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DEnhancer%252BConnectome%252BNominates%252BTarget%252BGenes%2525C2%2525A0of%252BInherited%252BRisk%252BVariants%252Bfrom%252BInflammatory%252BSkin%252BDisorders%26aulast%3DJeng%26aufirst%3DMark%2BY.%26date%3D2019%26volume%3D139%26issue%3D3%26spage%3D605%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung‐hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Alan  List</span>, <span class="hlFld-ContribAuthor ">David A.  Sallman</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular pathogenesis of myelodysplastic syndromes with deletion 5q. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Haematology</span><span> <strong>2019,</strong> <em>102 </em>
                                    (3)
                                     , 203-209. <a href="https://doi.org/10.1111/ejh.13207" title="DOI URL">https://doi.org/10.1111/ejh.13207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ejh.13207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fejh.13207%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Haematology%26atitle%3DMolecular%252Bpathogenesis%252Bof%252Bmyelodysplastic%252Bsyndromes%252Bwith%252Bdeletion%252B5q%26aulast%3DLee%26aufirst%3DJung%25E2%2580%2590hoon%26date%3D2019%26date%3D2019%26volume%3D102%26issue%3D3%26spage%3D203%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ingrid E.  Wertz</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">From Discovery to Bedside: Targeting the Ubiquitin System. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (2)
                                     , 156-177. <a href="https://doi.org/10.1016/j.chembiol.2018.10.022" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DFrom%252BDiscovery%252Bto%252BBedside%25253A%252BTargeting%252Bthe%252BUbiquitin%252BSystem%26aulast%3DWertz%26aufirst%3DIngrid%2BE.%26date%3D2019%26volume%3D26%26issue%3D2%26spage%3D156%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ota  Fuchs</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs. </span><span class="cited-content_cbyCitation_journal-name">Cardiovascular & Hematological Disorders-Drug Targets</span><span> <strong>2019,</strong> <em>19 </em>
                                    (1)
                                     , 51-78. <a href="https://doi.org/10.2174/1871529X18666180522073855" title="DOI URL">https://doi.org/10.2174/1871529X18666180522073855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871529X18666180522073855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871529X18666180522073855%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiovascular%2520%2526%2520Hematological%2520Disorders-Drug%2520Targets%26atitle%3DTreatment%252Bof%252BLymphoid%252Band%252BMyeloid%252BMalignancies%252Bby%252BImmunomodulatory%252BDrugs%26aulast%3DFuchs%26aufirst%3DOta%26date%3D2019%26volume%3D19%26issue%3D1%26spage%3D51%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chutima  Kunacheewa</span>, <span class="hlFld-ContribAuthor ">Robert Z.  Orlowski</span>. </span><span class="cited-content_cbyCitation_article-title">New Drugs in Multiple Myeloma. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Medicine</span><span> <strong>2019,</strong> <em>70 </em>
                                    (1)
                                     , 521-547. <a href="https://doi.org/10.1146/annurev-med-112017-091045" title="DOI URL">https://doi.org/10.1146/annurev-med-112017-091045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-med-112017-091045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-med-112017-091045%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Medicine%26atitle%3DNew%252BDrugs%252Bin%252BMultiple%252BMyeloma%26aulast%3DKunacheewa%26aufirst%3DChutima%26date%3D2019%26volume%3D70%26issue%3D1%26spage%3D521%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin F.  Chong</span>, <span class="hlFld-ContribAuthor ">Victoria P.  Werth</span>. </span><span class="cited-content_cbyCitation_article-title">Management of Cutaneous Lupus Erythematosus. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 719-726. <a href="https://doi.org/10.1016/B978-0-323-47927-1.00058-X" title="DOI URL">https://doi.org/10.1016/B978-0-323-47927-1.00058-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-47927-1.00058-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-47927-1.00058-X%26sid%3Dliteratum%253Aachs%26atitle%3DManagement%252Bof%252BCutaneous%252BLupus%252BErythematosus%26aulast%3DChong%26aufirst%3DBenjamin%2BF.%26date%3D2019%26spage%3D719%26epage%3D726%26pub%3DElsevier%26atitle%3DDubois%252527%252BLupus%252BErythematosus%252Band%252BRelated%252BSyndromes%26date%3D2019%26volume%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajay K.  Nooka</span>, <span class="hlFld-ContribAuthor ">Sagar  Lonial</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma. </span><span class="cited-content_cbyCitation_journal-name">The Cancer Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (1)
                                     , 19-31. <a href="https://doi.org/10.1097/PPO.0000000000000354" title="DOI URL">https://doi.org/10.1097/PPO.0000000000000354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/PPO.0000000000000354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FPPO.0000000000000354%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Cancer%2520Journal%26atitle%3DMechanism%252Bof%252BAction%252Band%252BNovel%252BIMiD-Based%252BCompounds%252Band%252BCombinations%252Bin%252BMultiple%252BMyeloma%26aulast%3DNooka%26aufirst%3DAjay%2BK.%26date%3D2019%26volume%3D25%26issue%3D1%26spage%3D19%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Quinlan L.  Sievers</span>, <span class="hlFld-ContribAuthor ">Georg  Petzold</span>, <span class="hlFld-ContribAuthor ">Richard D.  Bunker</span>, <span class="hlFld-ContribAuthor ">Aline  Renneville</span>, <span class="hlFld-ContribAuthor ">Mikołaj  Słabicki</span>, <span class="hlFld-ContribAuthor ">Brian J.  Liddicoat</span>, <span class="hlFld-ContribAuthor ">Wassim  Abdulrahman</span>, <span class="hlFld-ContribAuthor ">Tarjei  Mikkelsen</span>, <span class="hlFld-ContribAuthor ">Benjamin L.  Ebert</span>, <span class="hlFld-ContribAuthor ">Nicolas H.  Thomä</span>. </span><span class="cited-content_cbyCitation_article-title">Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2018,</strong> <em>362 </em>
                                    (6414)
                                     , eaat0572. <a href="https://doi.org/10.1126/science.aat0572" title="DOI URL">https://doi.org/10.1126/science.aat0572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aat0572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aat0572%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DDefining%252Bthe%252Bhuman%252BC2H2%252Bzinc%252Bfinger%252Bdegrome%252Btargeted%252Bby%252Bthalidomide%252Banalogs%252Bthrough%252BCRBN%26aulast%3DSievers%26aufirst%3DQuinlan%2BL.%26date%3D2018%26date%3D2018%26volume%3D362%26issue%3D6414%26spage%3Deaat0572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasa Reddy  Bonam</span>, <span class="hlFld-ContribAuthor ">Fengjuan  Wang</span>, <span class="hlFld-ContribAuthor ">Sylviane  Muller</span>. </span><span class="cited-content_cbyCitation_article-title">Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. </span><span class="cited-content_cbyCitation_journal-name">Journal of Autoimmunity</span><span> <strong>2018,</strong> <em>94 </em>, 16-32. <a href="https://doi.org/10.1016/j.jaut.2018.08.009" title="DOI URL">https://doi.org/10.1016/j.jaut.2018.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jaut.2018.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jaut.2018.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Autoimmunity%26atitle%3DAutophagy%25253A%252BA%252Bnew%252Bconcept%252Bin%252Bautoimmunity%252Bregulation%252Band%252Ba%252Bnovel%252Btherapeutic%252Boption%26aulast%3DBonam%26aufirst%3DSrinivasa%2BReddy%26date%3D2018%26volume%3D94%26spage%3D16%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary E.  Matyskiela</span>, <span class="hlFld-ContribAuthor ">Suzana  Couto</span>, <span class="hlFld-ContribAuthor ">Xinde  Zheng</span>, <span class="hlFld-ContribAuthor ">Gang  Lu</span>, <span class="hlFld-ContribAuthor ">Julia  Hui</span>, <span class="hlFld-ContribAuthor ">Katie  Stamp</span>, <span class="hlFld-ContribAuthor ">Clifton  Drew</span>, <span class="hlFld-ContribAuthor ">Yan  Ren</span>, <span class="hlFld-ContribAuthor ">Maria  Wang</span>, <span class="hlFld-ContribAuthor ">Aaron  Carpenter</span>, <span class="hlFld-ContribAuthor ">Chung-Wein  Lee</span>, <span class="hlFld-ContribAuthor ">Thomas  Clayton</span>, <span class="hlFld-ContribAuthor ">Wei  Fang</span>, <span class="hlFld-ContribAuthor ">Chin-Chun  Lu</span>, <span class="hlFld-ContribAuthor ">Mariko  Riley</span>, <span class="hlFld-ContribAuthor ">Polat  Abdubek</span>, <span class="hlFld-ContribAuthor ">Kate  Blease</span>, <span class="hlFld-ContribAuthor ">James  Hartke</span>, <span class="hlFld-ContribAuthor ">Gondi  Kumar</span>, <span class="hlFld-ContribAuthor ">Rupert  Vessey</span>, <span class="hlFld-ContribAuthor ">Mark  Rolfe</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Hamann</span>, <span class="hlFld-ContribAuthor ">Philip P.  Chamberlain</span>. </span><span class="cited-content_cbyCitation_article-title">SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2018,</strong> <em>14 </em>
                                    (10)
                                     , 981-987. <a href="https://doi.org/10.1038/s41589-018-0129-x" title="DOI URL">https://doi.org/10.1038/s41589-018-0129-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-018-0129-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-018-0129-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DSALL4%252Bmediates%252Bteratogenicity%252Bas%252Ba%252Bthalidomide-dependent%252Bcereblon%252Bsubstrate%26aulast%3DMatyskiela%26aufirst%3DMary%2BE.%26date%3D2018%26date%3D2018%26volume%3D14%26issue%3D10%26spage%3D981%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter H  Schafer</span>, <span class="hlFld-ContribAuthor ">Ying  Ye</span>, <span class="hlFld-ContribAuthor ">Lei  Wu</span>, <span class="hlFld-ContribAuthor ">Jolanta  Kosek</span>, <span class="hlFld-ContribAuthor ">Garth  Ringheim</span>, <span class="hlFld-ContribAuthor ">Zhihong  Yang</span>, <span class="hlFld-ContribAuthor ">Liangang  Liu</span>, <span class="hlFld-ContribAuthor ">Michael  Thomas</span>, <span class="hlFld-ContribAuthor ">Maria  Palmisano</span>, <span class="hlFld-ContribAuthor ">Rajesh  Chopra</span>. </span><span class="cited-content_cbyCitation_article-title">Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus. </span><span class="cited-content_cbyCitation_journal-name">Annals of the Rheumatic Diseases</span><span> <strong>2018,</strong> <em>77 </em>
                                    (10)
                                     , 1516-1523. <a href="https://doi.org/10.1136/annrheumdis-2017-212916" title="DOI URL">https://doi.org/10.1136/annrheumdis-2017-212916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/annrheumdis-2017-212916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fannrheumdis-2017-212916%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520Rheumatic%2520Diseases%26atitle%3DCereblon%252Bmodulator%252Biberdomide%252Binduces%252Bdegradation%252Bof%252Bthe%252Btranscription%252Bfactors%252BIkaros%252Band%252BAiolos%25253A%252Bimmunomodulation%252Bin%252Bhealthy%252Bvolunteers%252Band%252Brelevance%252Bto%252Bsystemic%252Blupus%252Berythematosus%26aulast%3DSchafer%26aufirst%3DPeter%2BH%26date%3D2018%26date%3D2018%26volume%3D77%26issue%3D10%26spage%3D1516%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Lu</span>, <span class="hlFld-ContribAuthor ">Stephanie  Weng</span>, <span class="hlFld-ContribAuthor ">Mary  Matyskiela</span>, <span class="hlFld-ContribAuthor ">Xinde  Zheng</span>, <span class="hlFld-ContribAuthor ">Wei  Fang</span>, <span class="hlFld-ContribAuthor ">Scott  Wood</span>, <span class="hlFld-ContribAuthor ">Christine  Surka</span>, <span class="hlFld-ContribAuthor ">Reina  Mizukoshi</span>, <span class="hlFld-ContribAuthor ">Chin-Chun  Lu</span>, <span class="hlFld-ContribAuthor ">Derek  Mendy</span>, <span class="hlFld-ContribAuthor ">In Sock  Jang</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Mathieu  Marella</span>, <span class="hlFld-ContribAuthor ">Suzana  Couto</span>, <span class="hlFld-ContribAuthor ">Brian  Cathers</span>, <span class="hlFld-ContribAuthor ">James  Carmichael</span>, <span class="hlFld-ContribAuthor ">Philip  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Mark  Rolfe</span>. </span><span class="cited-content_cbyCitation_article-title">UBE2G1 governs the destruction of cereblon neomorphic substrates. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2018,</strong> <em>7 </em><a href="https://doi.org/10.7554/eLife.40958" title="DOI URL">https://doi.org/10.7554/eLife.40958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.40958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.40958%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DUBE2G1%252Bgoverns%252Bthe%252Bdestruction%252Bof%252Bcereblon%252Bneomorphic%252Bsubstrates%26aulast%3DLu%26aufirst%3DGang%26date%3D2018%26date%3D2018%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanley N.  Abramson</span>. </span><span class="cited-content_cbyCitation_article-title">The Multiple Myeloma Drug Pipeline—2018: A Review of Small Molecules and Their Therapeutic Targets. </span><span class="cited-content_cbyCitation_journal-name">Clinical Lymphoma Myeloma and Leukemia</span><span> <strong>2018,</strong> <em>18 </em>
                                    (9)
                                     , 611-627. <a href="https://doi.org/10.1016/j.clml.2018.06.015" title="DOI URL">https://doi.org/10.1016/j.clml.2018.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clml.2018.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clml.2018.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Lymphoma%2520Myeloma%2520and%2520Leukemia%26atitle%3DThe%252BMultiple%252BMyeloma%252BDrug%252BPipeline%2525E2%252580%2525942018%25253A%252BA%2525C2%2525A0Review%252Bof%252BSmall%252BMolecules%252Band%252BTheir%252BTherapeutic%252BTargets%26aulast%3DAbramson%26aufirst%3DHanley%2BN.%26date%3D2018%26volume%3D18%26issue%3D9%26spage%3D611%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krzysztof Z  Łączkowski</span>, <span class="hlFld-ContribAuthor ">Angelika  Baranowska-Łączkowska</span>. </span><span class="cited-content_cbyCitation_article-title">Recent studies on the thalidomide and its derivatives. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (18)
                                     , 2133-2136. <a href="https://doi.org/10.4155/fmc-2018-0217" title="DOI URL">https://doi.org/10.4155/fmc-2018-0217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0217%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bstudies%252Bon%252Bthe%252Bthalidomide%252Band%252Bits%252Bderivatives%26aulast%3D%25C5%2581%25C4%2585czkowski%26aufirst%3DKrzysztof%2BZ%26date%3D2018%26volume%3D10%26issue%3D18%26spage%3D2133%26epage%3D2136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George M.  Burslem</span>, <span class="hlFld-ContribAuthor ">Philipp  Ottis</span>, <span class="hlFld-ContribAuthor ">Saul  Jaime-Figueroa</span>, <span class="hlFld-ContribAuthor ">Alicia  Morgan</span>, <span class="hlFld-ContribAuthor ">Philipp M.  Cromm</span>, <span class="hlFld-ContribAuthor ">Momar  Toure</span>, <span class="hlFld-ContribAuthor ">Craig M.  Crews</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure-Degradation Relationships. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1508-1512. <a href="https://doi.org/10.1002/cmdc.201800271" title="DOI URL">https://doi.org/10.1002/cmdc.201800271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800271%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DEfficient%252BSynthesis%252Bof%252BImmunomodulatory%252BDrug%252BAnalogues%252BEnables%252BExploration%252Bof%252BStructure-Degradation%252BRelationships%26aulast%3DBurslem%26aufirst%3DGeorge%2BM.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1508%26epage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Che</span>, <span class="hlFld-ContribAuthor ">Adam M.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Veerabahu  Shanmugasundaram</span>, <span class="hlFld-ContribAuthor ">Mark C.  Noe</span>. </span><span class="cited-content_cbyCitation_article-title">Inducing protein-protein interactions with molecular glues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (15)
                                     , 2585-2592. <a href="https://doi.org/10.1016/j.bmcl.2018.04.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInducing%252Bprotein-protein%252Binteractions%252Bwith%252Bmolecular%252Bglues%26aulast%3DChe%26aufirst%3DYe%26date%3D2018%26volume%3D28%26issue%3D15%26spage%3D2585%26epage%3D2592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah A.  Holstein</span>, <span class="hlFld-ContribAuthor ">Jens  Hillengass</span>, <span class="hlFld-ContribAuthor ">Philip L.  McCarthy</span>. </span><span class="cited-content_cbyCitation_article-title">Next-Generation Drugs Targeting the Cereblon Ubiquitin Ligase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Oncology</span><span> <strong>2018,</strong> <em>36 </em>
                                    (20)
                                     , 2101-2104. <a href="https://doi.org/10.1200/JCO.2018.77.9637" title="DOI URL">https://doi.org/10.1200/JCO.2018.77.9637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/JCO.2018.77.9637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FJCO.2018.77.9637%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Oncology%26atitle%3DNext-Generation%252BDrugs%252BTargeting%252Bthe%252BCereblon%252BUbiquitin%252BLigase%26aulast%3DHolstein%26aufirst%3DSarah%2BA.%26date%3D2018%26volume%3D36%26issue%3D20%26spage%3D2101%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gareth J.  Morgan</span>, <span class="hlFld-ContribAuthor ">Leo  Rasche</span>. </span><span class="cited-content_cbyCitation_article-title">Maintaining therapeutic progress in multiple myeloma by integrating genetic and biological advances into the clinic. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Hematology</span><span> <strong>2018,</strong> <em>11 </em>
                                    (7)
                                     , 513-523. <a href="https://doi.org/10.1080/17474086.2018.1489718" title="DOI URL">https://doi.org/10.1080/17474086.2018.1489718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17474086.2018.1489718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17474086.2018.1489718%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Hematology%26atitle%3DMaintaining%252Btherapeutic%252Bprogress%252Bin%252Bmultiple%252Bmyeloma%252Bby%252Bintegrating%252Bgenetic%252Band%252Bbiological%252Badvances%252Binto%252Bthe%252Bclinic%26aulast%3DMorgan%26aufirst%3DGareth%2BJ.%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D7%26spage%3D513%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fleur M.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitors: the road ahead. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2018,</strong> <em>17 </em>
                                    (5)
                                     , 353-377. <a href="https://doi.org/10.1038/nrd.2018.21" title="DOI URL">https://doi.org/10.1038/nrd.2018.21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2018.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2018.21%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DKinase%252Binhibitors%25253A%252Bthe%252Broad%252Bahead%26aulast%3DFerguson%26aufirst%3DFleur%2BM.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D5%26spage%3D353%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Chemical structures of selected clinical stage cereblon modulators including compound <b>6</b>. (b) Determination of the relative cereblon binding affinities for compound <b>6</b>, lenalidomide, and pomalidomide by TR-FRET. IC<sub>50</sub>s under these conditions were 1.5 μM for lenalidomide (circles), 1.2 μM for pomalidomide (diamonds), and 60 nM for compound <b>6</b> (squares).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Quantitation of Ikaros degradation with chemiluminescent cell-based assay. EC<sub>50</sub>s determined were 67 nM for lenalidomide (circles), 24 nM for pomalidomide (diamonds), and 1 nM for compound <b>6</b> (squares). (b) Quantitation of Aiolos degradation with chemiluminescent cell-based assay. EC<sub>50</sub>s determined were 87 nM for lenalidomide (circles), 22 nM for pomalidomide (diamonds), and 0.5 nM for compound <b>6</b> (squares). (c) Immunoblot analysis of whole-cell extracts of DF15 and OPM2 cells incubated for 5 h with DMSO, lenalidomide, pomalidomide, or compound <b>6</b> at the indicated concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) The crystal structure of cereblon (blue) in complex with DDB1 (green) and compound <b>6</b> (yellow sticks). Inset: detail of bound compound <b>6</b>, with the glutarimide ring docked in the tri-trp pocket and the phenyl ring extending from the isoindolinone positioned in a groove formed by E377, H378, P352, and H353 of cereblon. (b) Comparison of the binding surface interactions of lenalidomide (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZ4">4TZ4</a>, left panel) and compound <b>6</b> (yellow, this study, right panel) with cereblon (blue, surface representation). Cereblon surface residues that were previously shown to mediate binding to Ikaros by mutational studies are shown in orange.<a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> The amino acid side chain F150 is labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/medium/jm-2016-01921a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01921/20180119/images/large/jm-2016-01921a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01921&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 16 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Dimopoulos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Current treatment landscape for relapsed and/or refractory multiple myeloma</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1038/nrclinonc.2014.200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnrclinonc.2014.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=25421279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2nu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=42-54&issue=1&author=M.+A.+Dimopoulosauthor=P.+G.+Richardsonauthor=P.+Moreauauthor=K.+C.+Anderson&title=Current+treatment+landscape+for+relapsed+and%2For+refractory+multiple+myeloma&doi=10.1038%2Fnrclinonc.2014.200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current treatment landscape for relapsed and/or refractory multiple myeloma</span></div><div class="casAuthors">Dimopoulos, Meletios A.; Richardson, Paul G.; Moreau, Philippe; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-54</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent developments in the treatment of multiple myeloma have led to improvements in response rates and to increased survival; however, relapse is inevitable in almost all patients.  Recurrence of myeloma is typically more aggressive with each relapse, leading to the development of treatment-refractory disease, which is assocd. with a shorter survival.  Several phase II and III trials have demonstrated the efficacy of recently approved agents in the setting of relapsed and/or refractory multiple myeloma, including immunomodulatory agents, such as lenalidomide and pomalidomide, and proteasome inhibitors, such as bortezomib and carfilzomib.  Currently, however, there is no std. treatment for patients with relapsed and/or refractory disease.  This Review discusses the current treatment landscape for patients with relapsed and/or refractory multiple myeloma and highlights disease-related and patient-related factors-such as pre-existing comorbidities or toxicities-that are important considerations for clinicians when selecting an appropriate treatment regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM2K0P45qZfbVg90H21EOLACvtfcHk0lgsrRON4WHeIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2nu7fM&md5=cf51cf7abe3a77cc2cf4697280ee9ac7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2014.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2014.200%26sid%3Dliteratum%253Aachs%26aulast%3DDimopoulos%26aufirst%3DM.%2BA.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DMoreau%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DCurrent%2520treatment%2520landscape%2520for%2520relapsed%2520and%252For%2520refractory%2520multiple%2520myeloma%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D12%26issue%3D1%26spage%3D42%26epage%3D54%26doi%3D10.1038%2Fnrclinonc.2014.200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span> </span><span class="NLM_article-title">Identification of a primary target of thalidomide teratogenicity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x"> (</span><span class="NLM_issue">5971</span><span class="NLM_x">) </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span><span class="refDoi"> DOI: 10.1126/science.1177319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1126%2Fscience.1177319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=20223979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=1345-1350&issue=5971&author=T.+Itoauthor=H.+Andoauthor=T.+Suzukiauthor=T.+Oguraauthor=K.+Hottaauthor=Y.+Imamuraauthor=Y.+Yamaguchiauthor=H.+Handa&title=Identification+of+a+primary+target+of+thalidomide+teratogenicity&doi=10.1126%2Fscience.1177319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Primary Target of Thalidomide Teratogenicity</span></div><div class="casAuthors">Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5971</span>),
    <span class="NLM_cas:pages">1345-1350</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects.  Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown.  Here, we identified cereblon (CRBN) as a thalidomide-binding protein.  CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.  Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the assocd. ubiquitin ligase activity.  This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivs. without teratogenic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPC_7RXLkfabVg90H21EOLACvtfcHk0lid-wMO4sVMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D&md5=4565a67837e0ec34ede2c93c1036f312</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1177319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1177319%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520primary%2520target%2520of%2520thalidomide%2520teratogenicity%26jtitle%3DScience%26date%3D2010%26volume%3D327%26issue%3D5971%26spage%3D1345%26epage%3D1350%26doi%3D10.1126%2Fscience.1177319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span> </span><span class="NLM_article-title">Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2326</span><span class="NLM_x">–</span> <span class="NLM_lpage">2335</span><span class="refDoi"> DOI: 10.1038/leu.2012.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fleu.2012.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=22552008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2326-2335&issue=11&author=A.+Lopez-Gironaauthor=D.+Mendyauthor=T.+Itoauthor=K.+Millerauthor=A.+K.+Gandhiauthor=J.+Kangauthor=S.+Karasawaauthor=G.+Carmelauthor=P.+Jacksonauthor=M.+Abbasianauthor=A.+Mahmoudiauthor=B.+Cathersauthor=E.+Rychakauthor=S.+Gaidarovaauthor=R.+Chenauthor=P.+H.+Schaferauthor=H.+Handaauthor=T.+O.+Danielauthor=J.+F.+Evansauthor=R.+Chopra&title=Cereblon+is+a+direct+protein+target+for+immunomodulatory+and+antiproliferative+activities+of+lenalidomide+and+pomalidomide&doi=10.1038%2Fleu.2012.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide</span></div><div class="casAuthors">Lopez-Girona, A.; Mendy, D.; Ito, T.; Miller, K.; Gandhi, A. K.; Kang, J.; Karasawa, S.; Carmel, G.; Jackson, P.; Abbasian, M.; Mahmoudi, A.; Cathers, B.; Rychak, E.; Gaidarova, S.; Chen, R.; Schafer, P. H.; Handa, H.; Daniel, T. O.; Evans, J. F.; Chopra, R.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2326-2335</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thalidomide and the immunomodulatory drug, lenalidomide, are therapeutically active in hematol. malignancies.  The ubiquitously expressed E3 ligase protein cereblon (CRBN) has been identified as the primary teratogenic target of thalidomide.  Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.  CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells, as well as lenalidomide- and pomalidomide-induced cytokine prodn. in T cells.  Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBNYW/AA.  Overexpression of CRBN wild-type protein, but not CRBNYW/AA mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated redns. in c-myc and IRF4 expression and increases in p21WAF-1 expression.  Long-term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a redn. in CRBN, while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide, CRBN protein was undetectable.  Our biophys., biochem. and gene silencing studies show that CRBN is a proximate, therapeutically important mol. target of lenalidomide and pomalidomide.  Leukemia (2012) 26, 2326-2335; doi:10.1038/leu.2012.119; published online 15 June 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp85RvB33HGjbVg90H21EOLACvtfcHk0lid-wMO4sVMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI&md5=81f83b5f6c4c043a35a049df3b4d63ae</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fleu.2012.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2012.119%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMendy%26aufirst%3DD.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKarasawa%26aufirst%3DS.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DP.%26aulast%3DAbbasian%26aufirst%3DM.%26aulast%3DMahmoudi%26aufirst%3DA.%26aulast%3DCathers%26aufirst%3DB.%26aulast%3DRychak%26aufirst%3DE.%26aulast%3DGaidarova%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DChopra%26aufirst%3DR.%26atitle%3DCereblon%2520is%2520a%2520direct%2520protein%2520target%2520for%2520immunomodulatory%2520and%2520antiproliferative%2520activities%2520of%2520lenalidomide%2520and%2520pomalidomide%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26issue%3D11%26spage%3D2326%26epage%3D2335%26doi%3D10.1038%2Fleu.2012.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4771</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span><span class="refDoi"> DOI: 10.1182/blood-2011-05-356063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1182%2Fblood-2011-05-356063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=4771-4779&issue=18&author=Y.+X.+Zhuauthor=E.+Braggioauthor=C.+X.+Shiauthor=L.+A.+Bruinsauthor=J.+E.+Schmidtauthor=S.+Van+Wierauthor=X.+B.+Changauthor=C.+C.+Bjorklundauthor=R.+Fonsecaauthor=P.+L.+Bergsagelauthor=R.+Z.+Orlowskiauthor=A.+K.+Stewart&title=Cereblon+expression+is+required+for+the+antimyeloma+activity+of+lenalidomide+and+pomalidomide&doi=10.1182%2Fblood-2011-05-356063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-05-356063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-05-356063%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DBraggio%26aufirst%3DE.%26aulast%3DShi%26aufirst%3DC.%2BX.%26aulast%3DBruins%26aufirst%3DL.%2BA.%26aulast%3DSchmidt%26aufirst%3DJ.%2BE.%26aulast%3DVan%2BWier%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DX.%2BB.%26aulast%3DBjorklund%26aufirst%3DC.%2BC.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DCereblon%2520expression%2520is%2520required%2520for%2520the%2520antimyeloma%2520activity%2520of%2520lenalidomide%2520and%2520pomalidomide%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26issue%3D18%26spage%3D4771%26epage%3D4779%26doi%3D10.1182%2Fblood-2011-05-356063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kronke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udeshi, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConkey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svinkina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciarlo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span> </span><span class="NLM_article-title">Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x"> (</span><span class="NLM_issue">6168</span><span class="NLM_x">) </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1126/science.1244851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1126%2Fscience.1244851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=24292625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A280%3ADC%252BC2c3itFajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=301-305&issue=6168&author=J.+Kronkeauthor=N.+D.+Udeshiauthor=A.+Narlaauthor=P.+Graumanauthor=S.+N.+Hurstauthor=M.+McConkeyauthor=T.+Svinkinaauthor=D.+Hecklauthor=E.+Comerauthor=X.+Liauthor=C.+Ciarloauthor=E.+Hartmanauthor=N.+Munshiauthor=M.+Schenoneauthor=S.+L.+Schreiberauthor=S.+A.+Carrauthor=B.+L.+Ebert&title=Lenalidomide+causes+selective+degradation+of+IKZF1+and+IKZF3+in+multiple+myeloma+cells&doi=10.1126%2Fscience.1244851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells</span></div><div class="casAuthors">Kronke Jan; Udeshi Namrata D; Narla Anupama; Grauman Peter; Hurst Slater N; McConkey Marie; Svinkina Tanya; Heckl Dirk; Comer Eamon; Li Xiaoyu; Ciarlo Christie; Hartman Emily; Munshi Nikhil; Schenone Monica; Schreiber Stuart L; Carr Steven A; Ebert Benjamin L</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6168</span>),
    <span class="NLM_cas:pages">301-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lenalidomide is a drug with clinical efficacy in multiple myeloma and other B cell neoplasms, but its mechanism of action is unknown.  Using quantitative proteomics, we found that lenalidomide causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase.  IKZF1 and IKZF3 are essential transcription factors in multiple myeloma.  A single amino acid substitution of IKZF3 conferred resistance to lenalidomide-induced degradation and rescued lenalidomide-induced inhibition of cell growth.  Similarly, we found that lenalidomide-induced interleukin-2 production in T cells is due to depletion of IKZF1 and IKZF3.  These findings reveal a previously unknown mechanism of action for a therapeutic agent: alteration of the activity of an E3 ubiquitin ligase, leading to selective degradation of specific targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQiiGR0Yx7nuYFEOhA_Im3cfW6udTcc2eYafEaSeQAP7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3itFajsQ%253D%253D&md5=8cae3e554399308493aa38f0d05ed610</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1244851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1244851%26sid%3Dliteratum%253Aachs%26aulast%3DKronke%26aufirst%3DJ.%26aulast%3DUdeshi%26aufirst%3DN.%2BD.%26aulast%3DNarla%26aufirst%3DA.%26aulast%3DGrauman%26aufirst%3DP.%26aulast%3DHurst%26aufirst%3DS.%2BN.%26aulast%3DMcConkey%26aufirst%3DM.%26aulast%3DSvinkina%26aufirst%3DT.%26aulast%3DHeckl%26aufirst%3DD.%26aulast%3DComer%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCiarlo%26aufirst%3DC.%26aulast%3DHartman%26aufirst%3DE.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DSchenone%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26atitle%3DLenalidomide%2520causes%2520selective%2520degradation%2520of%2520IKZF1%2520and%2520IKZF3%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DScience%26date%3D2014%26volume%3D343%26issue%3D6168%26spage%3D301%26epage%3D305%26doi%3D10.1126%2Fscience.1244851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naniong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaelin, W. G.,  Jr.</span><span> </span><span class="NLM_article-title">The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x"> (</span><span class="NLM_issue">6168</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1126/science.1244917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1126%2Fscience.1244917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=24292623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtV2ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=305-309&issue=6168&author=G.+Luauthor=R.+E.+Middletonauthor=H.+Sunauthor=M.+Naniongauthor=C.+J.+Ottauthor=C.+S.+Mitsiadesauthor=K.+K.+Wongauthor=J.+E.+Bradnerauthor=W.+G.+Kaelin&title=The+myeloma+drug+lenalidomide+promotes+the+cereblon-dependent+destruction+of+Ikaros+proteins&doi=10.1126%2Fscience.1244917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins</span></div><div class="casAuthors">Lu, Gang; Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Ott, Christopher J.; Mitsiades, Constantine S.; Wong, Kwok-Kin; Bradner, James E.; Kaelin, William G., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6168</span>),
    <span class="NLM_cas:pages">305-309</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Thalidomide-like drugs such as lenalidomide are clin. important treatments for multiple myeloma and show promise for other B cell malignancies.  The biochem. mechanisms underlying their antitumor activity are unknown.  Thalidomide was recently shown to bind to, and inhibit, the cereblon ubiquitin ligase.  Cereblon loss in zebrafish causes fin defects reminiscent of the limb defects seen in children exposed to thalidomide in utero.  Here we show that lenalidomide-bound cereblon acquires the ability to target for proteasomal degrdn. two specific B cell transcription factors, Ikaros family zinc finger proteins 1 and 3 (IKZF1 and IKZF3).  Anal. of myeloma cell lines revealed that loss of IKZF1 and IKZF3 is both necessary and sufficient for lenalidomide's therapeutic effect, suggesting that the antitumor and teratogenic activities of thalidomide-like drugs are dissociable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0froz4Kipu7Vg90H21EOLACvtfcHk0liBoOIDq0yuNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtV2ktg%253D%253D&md5=a9df5bbde0f676b92b1bec48fdbbb502</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1244917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1244917%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DG.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNaniong%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DC.%2BJ.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DThe%2520myeloma%2520drug%2520lenalidomide%2520promotes%2520the%2520cereblon-dependent%2520destruction%2520of%2520Ikaros%2520proteins%26jtitle%3DScience%26date%3D2014%26volume%3D343%26issue%3D6168%26spage%3D305%26epage%3D309%26doi%3D10.1126%2Fscience.1244917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havens, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakurta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klippel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span> </span><span class="NLM_article-title">Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.)</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1111/bjh.12708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1111%2Fbjh.12708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=24328678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslWmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2014&pages=811-821&issue=6&author=A.+K.+Gandhiauthor=J.+Kangauthor=C.+G.+Havensauthor=T.+Conklinauthor=Y.+Ningauthor=L.+Wuauthor=T.+Itoauthor=H.+Andoauthor=M.+F.+Waldmanauthor=A.+Thakurtaauthor=A.+Klippelauthor=H.+Handaauthor=T.+O.+Danielauthor=P.+H.+Schaferauthor=R.+Chopra&title=Immunomodulatory+agents+lenalidomide+and+pomalidomide+co-stimulate+T+cells+by+inducing+degradation+of+T+cell+repressors+Ikaros+and+Aiolos+via+modulation+of+the+E3+ubiquitin+ligase+complex+CRL4%28CRBN.%29&doi=10.1111%2Fbjh.12708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN</span></div><div class="casAuthors">Gandhi, Anita K.; Kang, Jian; Havens, Courtney G.; Conklin, Thomas; Ning, Yuhong; Wu, Lei; Ito, Takumi; Ando, Hideki; Waldman, Michelle F.; Thakurta, Anjan; Klippel, Anke; Handa, Hiroshi; Daniel, Thomas O.; Schafer, Peter H.; Chopra, Rajesh</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-821</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cereblon (CRBN), the mol. target of lenalidomide and pomalidomide, is a substrate receptor of the cullin ring E3 ubiquitin ligase complex, CRL4CRBN.  T cell co-stimulation by lenalidomide or pomalidomide is cereblon dependent: however, the CRL4CRBN substrates responsible for T cell co-stimulation have yet to be identified.  Here we demonstrate that interaction of the transcription factors Ikaros (IKZF1, encoded by the IKZF1 gene) and Aiolos (IKZF3, encoded by the IKZF3 gene) with CRL4CRBN is induced by lenalidomide or pomalidomide.  Each agent promotes Aiolos and Ikaros binding to CRL4CRBN with enhanced ubiquitination leading to cereblon-dependent proteosomal degrdn. in T lymphocytes.  We confirm that Aiolos and Ikaros are transcriptional repressors of interleukin-2 expression.  The findings link lenalidomide- or pomalidomide-induced degrdn. of these transcriptional suppressors to well documented T cell activation.  Importantly, Aiolos could serve as a proximal pharmacodynamic marker for lenalidomide and pomalidomide, as healthy human subjects administered lenalidomide demonstrated Aiolos degrdn. in their peripheral T cells.  In conclusion, we present a mol. model in which drug binding to cereblon results in the interaction of Ikaros and Aiolos to CRL4CRBN, leading to their ubiquitination, subsequent proteasomal degrdn. and T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNm80s9sQNeLVg90H21EOLACvtfcHk0liTRDBSy9oe0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslWmu74%253D&md5=8ddf00ec1e3c1b1176603f22e8832f58</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1111%2Fbjh.12708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjh.12708%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DHavens%26aufirst%3DC.%2BG.%26aulast%3DConklin%26aufirst%3DT.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%2BF.%26aulast%3DThakurta%26aufirst%3DA.%26aulast%3DKlippel%26aufirst%3DA.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DChopra%26aufirst%3DR.%26atitle%3DImmunomodulatory%2520agents%2520lenalidomide%2520and%2520pomalidomide%2520co-stimulate%2520T%2520cells%2520by%2520inducing%2520degradation%2520of%2520T%2520cell%2520repressors%2520Ikaros%2520and%2520Aiolos%2520via%2520modulation%2520of%2520the%2520E3%2520ubiquitin%2520ligase%2520complex%2520CRL4%2528CRBN.%2529%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2014%26volume%3D164%26issue%3D6%26spage%3D811%26epage%3D821%26doi%3D10.1111%2Fbjh.12708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dijon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabannon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnelle, C.</span><span> </span><span class="NLM_article-title">The role of Ikaros in human erythroid differentiation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span><span class="refDoi"> DOI: 10.1182/blood-2007-07-098202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1182%2Fblood-2007-07-098202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=1138-1146&issue=3&author=M.+Dijonauthor=F.+Bardinauthor=A.+Muratiauthor=M.+Batozauthor=C.+Chabannonauthor=C.+Tonnelle&title=The+role+of+Ikaros+in+human+erythroid+differentiation&doi=10.1182%2Fblood-2007-07-098202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-07-098202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-07-098202%26sid%3Dliteratum%253Aachs%26aulast%3DDijon%26aufirst%3DM.%26aulast%3DBardin%26aufirst%3DF.%26aulast%3DMurati%26aufirst%3DA.%26aulast%3DBatoz%26aufirst%3DM.%26aulast%3DChabannon%26aufirst%3DC.%26aulast%3DTonnelle%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520Ikaros%2520in%2520human%2520erythroid%2520differentiation%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26issue%3D3%26spage%3D1138%26epage%3D1146%26doi%3D10.1182%2Fblood-2007-07-098202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">John, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. C.</span><span> </span><span class="NLM_article-title">The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">9–10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span><span class="refDoi"> DOI: 10.1016/j.molimm.2011.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1016%2Fj.molimm.2011.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=21477865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksleks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=1272-1278&issue=9%E2%80%9310&author=L.+B.+Johnauthor=A.+C.+Ward&title=The+Ikaros+gene+family%3A+transcriptional+regulators+of+hematopoiesis+and+immunity&doi=10.1016%2Fj.molimm.2011.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity</span></div><div class="casAuthors">John, Liza B.; Ward, Alister C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">1272-1278</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The Ikaros family of proteins - comprising Ikaros, Aiolos, Helios, Eos and Pegasus - are zinc finger transcription factors.  These proteins participate in a complex network of interactions with gene regulatory elements, other family members and a raft of other transcriptional regulators to control gene expression including via chromatin remodelling.  In this way, Ikaros family members regulate important cell-fate decisions during hematopoiesis, particularly in the development of the adaptive immune system.  Mutation of several family members results in hematol. malignancies,esp. those of a lymphoid nature.  This review describes the key roles of Ikaros proteins in development and disease, their mechanisms of action and gene targets, as well as explaining their evolutionary origins and role in the emergence of adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3sGG4yL_iZ7Vg90H21EOLACvtfcHk0liiqOyQ3mZugw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksleks7Y%253D&md5=9fd077ecc5088d9a451ed8d13652acc9</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2011.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2011.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DL.%2BB.%26aulast%3DWard%26aufirst%3DA.%2BC.%26atitle%3DThe%2520Ikaros%2520gene%2520family%253A%2520transcriptional%2520regulators%2520of%2520hematopoiesis%2520and%2520immunity%26jtitle%3DMol.%2520Immunol.%26date%3D2011%26volume%3D48%26issue%3D9%25E2%2580%259310%26spage%3D1272%26epage%3D1278%26doi%3D10.1016%2Fj.molimm.2011.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bjorklund, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havens, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amatangelo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klippel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakurta, A. G.</span><span> </span><span class="NLM_article-title">Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4</span> <span class="citation_source-journal">Blood Cancer Journal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e354</span><span class="refDoi"> DOI: 10.1038/bcj.2015.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fbcj.2015.66" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=e354&author=C.+C.+Bjorklundauthor=L.+Luauthor=J.+Kangauthor=P.+R.+Hagnerauthor=C.+G.+Havensauthor=M.+Amatangeloauthor=M.+Wangauthor=Y.+Renauthor=S.+Coutoauthor=M.+Breiderauthor=Y.+Ningauthor=A.+K.+Gandhiauthor=T.+O.+Danielauthor=R.+Chopraauthor=A.+Klippelauthor=A.+G.+Thakurta&title=Rate+of+CRL4%28CRBN%29+substrate+Ikaros+and+Aiolos+degradation+underlies+differential+activity+of+lenalidomide+and+pomalidomide+in+multiple+myeloma+cells+by+regulation+of+c-Myc+and+IRF4&doi=10.1038%2Fbcj.2015.66"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2015.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2015.66%26sid%3Dliteratum%253Aachs%26aulast%3DBjorklund%26aufirst%3DC.%2BC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DHagner%26aufirst%3DP.%2BR.%26aulast%3DHavens%26aufirst%3DC.%2BG.%26aulast%3DAmatangelo%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DCouto%26aufirst%3DS.%26aulast%3DBreider%26aufirst%3DM.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DKlippel%26aufirst%3DA.%26aulast%3DThakurta%26aufirst%3DA.%2BG.%26atitle%3DRate%2520of%2520CRL4%2528CRBN%2529%2520substrate%2520Ikaros%2520and%2520Aiolos%2520degradation%2520underlies%2520differential%2520activity%2520of%2520lenalidomide%2520and%2520pomalidomide%2520in%2520multiple%2520myeloma%2520cells%2520by%2520regulation%2520of%2520c-Myc%2520and%2520IRF4%26jtitle%3DBlood%2520Cancer%2520Journal%26date%3D2015%26volume%3D5%26spage%3De354%26doi%3D10.1038%2Fbcj.2015.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span> </span><span class="NLM_article-title">Association between polymorphisms of the IKZF3 gene and systemic lupus erythematosus in a Chinese Han population</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e108661</span><span class="refDoi"> DOI: 10.1371/journal.pone.0108661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1371%2Fjournal.pone.0108661" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e108661&issue=10&author=X.+Caiauthor=Y.+Qiaoauthor=C.+Diaoauthor=X.+Xuauthor=Y.+Chenauthor=S.+Duauthor=X.+Liuauthor=N.+Liuauthor=S.+Yuauthor=D.+Chenauthor=Y.+Jiang&title=Association+between+polymorphisms+of+the+IKZF3+gene+and+systemic+lupus+erythematosus+in+a+Chinese+Han+population&doi=10.1371%2Fjournal.pone.0108661"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108661%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DDiao%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DAssociation%2520between%2520polymorphisms%2520of%2520the%2520IKZF3%2520gene%2520and%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520Chinese%2520Han%2520population%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26issue%3D10%26spage%3De108661%26doi%3D10.1371%2Fjournal.pone.0108661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cunninghame Graham, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syvanen, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronnblom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyse, T. J.</span><span> </span><span class="NLM_article-title">Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus</span> <span class="citation_source-journal">PLoS Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1002341</span><span class="refDoi"> DOI: 10.1371/journal.pgen.1002341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1371%2Fjournal.pgen.1002341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002341&issue=10&author=D.+S.+Cunninghame+Grahamauthor=D.+L.+Morrisauthor=T.+R.+Bhangaleauthor=L.+A.+Criswellauthor=A.+C.+Syvanenauthor=L.+Ronnblomauthor=T.+W.+Behrensauthor=R.+R.+Grahamauthor=T.+J.+Vyse&title=Association+of+NCF2%2C+IKZF1%2C+IRF8%2C+IFIH1%2C+and+TYK2+with+systemic+lupus+erythematosus&doi=10.1371%2Fjournal.pgen.1002341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1002341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1002341%26sid%3Dliteratum%253Aachs%26aulast%3DCunninghame%2BGraham%26aufirst%3DD.%2BS.%26aulast%3DMorris%26aufirst%3DD.%2BL.%26aulast%3DBhangale%26aufirst%3DT.%2BR.%26aulast%3DCriswell%26aufirst%3DL.%2BA.%26aulast%3DSyvanen%26aufirst%3DA.%2BC.%26aulast%3DRonnblom%26aufirst%3DL.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DVyse%26aufirst%3DT.%2BJ.%26atitle%3DAssociation%2520of%2520NCF2%252C%2520IKZF1%252C%2520IRF8%252C%2520IFIH1%252C%2520and%2520TYK2%2520with%2520systemic%2520lupus%2520erythematosus%26jtitle%3DPLoS%2520Genet.%26date%3D2011%26volume%3D7%26issue%3D10%26spage%3De1002341%26doi%3D10.1371%2Fjournal.pgen.1002341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, F. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Z. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. J.</span><span> </span><span class="NLM_article-title">Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1234</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span><span class="refDoi"> DOI: 10.1038/ng.472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fng.472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=19838193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ogsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1234-1237&issue=11&author=J.+W.+Hanauthor=H.+F.+Zhengauthor=Y.+Cuiauthor=L.+D.+Sunauthor=D.+Q.+Yeauthor=Z.+Huauthor=J.+H.+Xuauthor=Z.+M.+Caiauthor=W.+Huangauthor=G.+P.+Zhaoauthor=H.+F.+Xieauthor=H.+Fangauthor=Q.+J.+Luauthor=J.+H.+Xuauthor=X.+P.+Liauthor=Y.+F.+Panauthor=D.+Q.+Dengauthor=F.+Q.+Zengauthor=Z.+Z.+Yeauthor=X.+Y.+Zhangauthor=Q.+W.+Wangauthor=F.+Haoauthor=L.+Maauthor=X.+B.+Zuoauthor=F.+S.+Zhouauthor=W.+H.+Duauthor=Y.+L.+Chengauthor=J.+Q.+Yangauthor=S.+K.+Shenauthor=J.+Liauthor=Y.+J.+Shengauthor=X.+X.+Zuoauthor=W.+F.+Zhuauthor=F.+Gaoauthor=P.+L.+Zhangauthor=Q.+Guoauthor=B.+Liauthor=M.+Gaoauthor=F.+L.+Xiaoauthor=C.+Quanauthor=C.+Zhangauthor=Z.+Zhangauthor=K.+J.+Zhuauthor=Y.+Liauthor=D.+Y.+Huauthor=W.+S.+Luauthor=J.+L.+Huangauthor=S.+X.+Liuauthor=H.+Liauthor=Y.+Q.+Renauthor=Z.+X.+Wangauthor=C.+J.+Yangauthor=P.+G.+Wangauthor=W.+M.+Zhouauthor=Y.+M.+Lvauthor=A.+P.+Zhangauthor=S.+Q.+Zhangauthor=D.+Linauthor=Y.+Liauthor=H.+Q.+Lowauthor=M.+Shenauthor=Z.+F.+Zhaiauthor=Y.+Wangauthor=F.+Y.+Zhangauthor=S.+Yangauthor=J.+J.+Liuauthor=X.+J.+Zhang&title=Genome-wide+association+study+in+a+Chinese+Han+population+identifies+nine+new+susceptibility+loci+for+systemic+lupus+erythematosus&doi=10.1038%2Fng.472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus</span></div><div class="casAuthors">Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Xu, Jin-Hua; Cai, Zhi-Ming; Huang, Wei; Zhao, Guo-Ping; Xie, Hong-Fu; Fang, Hong; Lu, Qian-Jin; Xu, Jian-Hua; Li, Xiang-Pei; Pan, Yun-Feng; Deng, Dan-Qi; Zeng, Fan-Qin; Ye, Zhi-Zhong; Zhang, Xiao-Yan; Wang, Qing-Wen; Hao, Fei; Ma, Li; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Zuo, Xiao-Xia; Zhu, Wei-Fang; Gao, Fei; Zhang, Pei-Lian; Guo, Qing; Li, Bo; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Huang, Jian-Lin; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Li, Yi; Low, Hui Qi; Shen, Min; Zhai, Zhi-Fang; Wang, Ying; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1234-1237</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors performed a genome-wide assocn. study (GWAS) of systemic lupus erythematosus (SLE) in a Chinese Han population by genotyping 1047 cases and 1205 controls using Illumina Human610-Quad BeadChips and replicating 78 SNPs in two addnl. cohorts (3152 cases and 7050 controls).  The authors identified nine new susceptibility loci (ETS1, IKZF1, RASGRP3, SLC15A4, TNIP1, 7q11.23, 10q11.22, 11q23.3 and 16p11.2; 1.77 × 10-25 ≤ Pcombined ≤ 2.77 × 10-8) and confirmed seven previously reported loci (BLK, IRF5, STAT4, TNFAIP3, TNFSF4, 6q21 and 22q11.21; 5.17 × 10-42 ≤ Pcombined ≤ 5.18 × 10-12).  Comparison with previous GWAS findings highlighted the genetic heterogeneity of SLE susceptibility between Chinese Han and European populations.  This study not only advances understanding of the genetic basis of SLE but also highlights the value of performing GWAS in diverse ancestral populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5e-IL0gn9EbVg90H21EOLACvtfcHk0lj6bFZMgl_t7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ogsr3E&md5=f43a1211ff6a461772483cbb8490bf3e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1038%2Fng.472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.472%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DZheng%26aufirst%3DH.%2BF.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DL.%2BD.%26aulast%3DYe%26aufirst%3DD.%2BQ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%2BH.%26aulast%3DCai%26aufirst%3DZ.%2BM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DG.%2BP.%26aulast%3DXie%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%2BJ.%26aulast%3DXu%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DX.%2BP.%26aulast%3DPan%26aufirst%3DY.%2BF.%26aulast%3DDeng%26aufirst%3DD.%2BQ.%26aulast%3DZeng%26aufirst%3DF.%2BQ.%26aulast%3DYe%26aufirst%3DZ.%2BZ.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DQ.%2BW.%26aulast%3DHao%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DX.%2BB.%26aulast%3DZhou%26aufirst%3DF.%2BS.%26aulast%3DDu%26aufirst%3DW.%2BH.%26aulast%3DCheng%26aufirst%3DY.%2BL.%26aulast%3DYang%26aufirst%3DJ.%2BQ.%26aulast%3DShen%26aufirst%3DS.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DY.%2BJ.%26aulast%3DZuo%26aufirst%3DX.%2BX.%26aulast%3DZhu%26aufirst%3DW.%2BF.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DP.%2BL.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DF.%2BL.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DK.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DW.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DS.%2BX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DY.%2BQ.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DC.%2BJ.%26aulast%3DWang%26aufirst%3DP.%2BG.%26aulast%3DZhou%26aufirst%3DW.%2BM.%26aulast%3DLv%26aufirst%3DY.%2BM.%26aulast%3DZhang%26aufirst%3DA.%2BP.%26aulast%3DZhang%26aufirst%3DS.%2BQ.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLow%26aufirst%3DH.%2BQ.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DZhai%26aufirst%3DZ.%2BF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%2BY.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26atitle%3DGenome-wide%2520association%2520study%2520in%2520a%2520Chinese%2520Han%2520population%2520identifies%2520nine%2520new%2520susceptibility%2520loci%2520for%2520systemic%2520lupus%2520erythematosus%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26issue%3D11%26spage%3D1234%26epage%3D1237%26doi%3D10.1038%2Fng.472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">He, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span> </span><span class="NLM_article-title">TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population</span> <span class="citation_source-journal">Lupus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1181</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.1177/0961203310367918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1177%2F0961203310367918" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1181-1186&issue=10&author=C.+F.+Heauthor=Y.+S.+Liuauthor=Y.+L.+Chengauthor=J.+P.+Gaoauthor=T.+M.+Panauthor=J.+W.+Hanauthor=C.+Quanauthor=L.+D.+Sunauthor=H.+F.+Zhengauthor=X.+B.+Zuoauthor=S.+X.+Xuauthor=Y.+J.+Shengauthor=S.+Yaoauthor=W.+L.+Huauthor=Y.+Liauthor=Z.+Y.+Yuauthor=X.+Y.+Yinauthor=X.+J.+Zhangauthor=Y.+Cuiauthor=S.+Yang&title=TNIP1%2C+SLC15A4%2C+ETS1%2C+RasGRP3+and+IKZF1+are+associated+with+clinical+features+of+systemic+lupus+erythematosus+in+a+Chinese+Han+population&doi=10.1177%2F0961203310367918"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1177%2F0961203310367918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0961203310367918%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DC.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BL.%26aulast%3DGao%26aufirst%3DJ.%2BP.%26aulast%3DPan%26aufirst%3DT.%2BM.%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DL.%2BD.%26aulast%3DZheng%26aufirst%3DH.%2BF.%26aulast%3DZuo%26aufirst%3DX.%2BB.%26aulast%3DXu%26aufirst%3DS.%2BX.%26aulast%3DSheng%26aufirst%3DY.%2BJ.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DW.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DZ.%2BY.%26aulast%3DYin%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.%26atitle%3DTNIP1%252C%2520SLC15A4%252C%2520ETS1%252C%2520RasGRP3%2520and%2520IKZF1%2520are%2520associated%2520with%2520clinical%2520features%2520of%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520Chinese%2520Han%2520population%26jtitle%3DLupus%26date%3D2010%26volume%3D19%26issue%3D10%26spage%3D1181%26epage%3D1186%26doi%3D10.1177%2F0961203310367918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lessard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrianto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ice, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comeau, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeland, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundahl, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon-Riquelme, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaya, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boackle, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edberg, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilkeson, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberly, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewold, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons-Estel, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey-Goldman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reveille, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scofield, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyse, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harley, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeland, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langefeld, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moser, K. L.</span><span> </span><span class="NLM_article-title">Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1016/j.ajhg.2012.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1016%2Fj.ajhg.2012.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=22464253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVejur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=648-660&issue=4&author=C.+J.+Lessardauthor=I.+Adriantoauthor=J.+A.+Iceauthor=G.+B.+Wileyauthor=J.+A.+Kellyauthor=S.+B.+Glennauthor=A.+J.+Adlerauthor=H.+Liauthor=A.+Rasmussenauthor=A.+H.+Williamsauthor=J.+Zieglerauthor=M.+E.+Comeauauthor=M.+Marionauthor=B.+E.+Wakelandauthor=C.+Liangauthor=P.+S.+Ramosauthor=K.+M.+Grundahlauthor=C.+J.+Gallantauthor=M.+E.+Alarcon-Riquelmeauthor=G.+S.+Alarconauthor=J.+M.+Anayaauthor=S.+C.+Baeauthor=S.+A.+Boackleauthor=E.+E.+Brownauthor=D.+M.+Changauthor=S.+K.+Choauthor=L.+A.+Criswellauthor=J.+C.+Edbergauthor=B.+I.+Freedmanauthor=G.+S.+Gilkesonauthor=C.+O.+Jacobauthor=J.+A.+Jamesauthor=D.+L.+Kamenauthor=R.+P.+Kimberlyauthor=J.+H.+Kimauthor=J.+Martinauthor=J.+T.+Merrillauthor=T.+B.+Niewoldauthor=S.+Y.+Parkauthor=M.+A.+Petriauthor=B.+A.+Pons-Estelauthor=R.+Ramsey-Goldmanauthor=J.+D.+Reveilleauthor=R.+H.+Scofieldauthor=Y.+W.+Songauthor=A.+M.+Stevensauthor=B.+P.+Tsaoauthor=L.+M.+Vilaauthor=T.+J.+Vyseauthor=C.+Y.+Yuauthor=J.+M.+Guthridgeauthor=K.+M.+Kaufmanauthor=J.+B.+Harleyauthor=E.+K.+Wakelandauthor=C.+D.+Langefeldauthor=P.+M.+Gaffneyauthor=C.+G.+Montgomeryauthor=K.+L.+Moser&title=Identification+of+IRF8%2C+TMEM39A%2C+and+IKZF3-ZPBP2+as+susceptibility+loci+for+systemic+lupus+erythematosus+in+a+large-scale+multiracial+replication+study&doi=10.1016%2Fj.ajhg.2012.02.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication Study</span></div><div class="casAuthors">Lessard, Christopher J.; Adrianto, Indra; Ice, John A.; Wiley, Graham B.; Kelly, Jennifer A.; Glenn, Stuart B.; Adler, Adam J.; Li, He; Rasmussen, Astrid; Williams, Adrienne H.; Ziegler, Julie; Comeau, Mary E.; Marion, Miranda; Wakeland, Benjamin E.; Liang, Chaoying; Ramos, Paula S.; Grundahl, Kiely M.; Gallant, Caroline J.; Alarcon, Graciela S.; Anaya, Juan-Manuel; Bae, Sang-Cheol; Boackle, Susan A.; Brown, Elizabeth E.; Chang, Deh-Ming; Cho, Soo-Kyung; Criswell, Lindsey A.; Edberg, Jeffrey C.; Freedman, Barry I.; Gilkeson, Gary S.; Jacob, Chaim O.; James, Judith A.; Kamen, Diane L.; Kimberly, Robert P.; Kim, Jae-Hoon; Martin, Javier; Merrill, Joan T.; Niewold, Timothy B.; Park, So-Yeon; Petri, Michelle A.; Pons-Estel, Bernardo A.; Ramsey-Goldman, Rosalind; Reveille, John D.; Scofield, R. Hal; Song, Yeong Wook; Stevens, Anne M.; Tsao, Betty P.; Vila, Luis M.; Vyse, Timothy J.; Yu, Chack-Yung; Guthridge, Joel M.; Kaufman, Kenneth M.; Harley, John B.; Wakeland, Edward K.; Langefeld, Carl D.; Gaffney, Patrick M.; Montgomery, Courtney G.; Moser, Kathy L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">648-660</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Systemic lupus erythematosus (SLE) is a chronic heterogeneous autoimmune disorder characterized by the loss of tolerance to self-antigens and dysregulated interferon responses.  The etiol. of SLE is complex, involving both heritable and environmental factors.  Candidate-gene studies and genome-wide assocn. (GWA) scans have been successful in identifying new loci that contribute to disease susceptibility; however, much of the heritable risk has yet to be identified.  In this study, we sought to replicate 1,580 variants showing suggestive assocn. with SLE in a previously published GWA scan of European Americans; we tested a multiethnic population consisting of 7,998 SLE cases and 7,492 controls of European, African American, Asian, Hispanic, Gullah, and Amerindian ancestry to find assocn. with the disease.  Several genes relevant to immunol. pathways showed assocn. with SLE.  Three loci exceeded the genome-wide significance threshold: interferon regulatory factor 8 (IRF8; rs11644034; pmeta-Euro = 2.08 × 10-10), transmembrane protein 39A (TMEM39A; rs1132200; pmeta-all = 8.62 × 10-9), and 17q21 (rs1453560; pmeta-all = 3.48 × 10-10) between IKAROS family of zinc finger 3 (AIOLOS; IKZF3) and zona pellucida binding protein 2 (ZPBP2).  Fine mapping, resequencing, imputation, and haplotype anal. of IRF8 indicated that three independent effects tagged by rs8046526, rs450443, and rs4843869, resp., were required for risk in individuals of European ancestry.  Eleven addnl. replicated effects (5 × 10-8 < pmeta-Euro < 9.99 × 10-5) were obsd. with CFHR1, CADM2, LOC730109/IL12A, LPP, LOC63920, SLU7, ADAMTSL1, C10orf64, OR8D4, FAM19A2, and STXBP6.  The results of this study increase the no. of confirmed SLE risk loci and identify others warranting further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHE-yH1qzb27Vg90H21EOLACvtfcHk0lgPGtS-IgrhlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVejur8%253D&md5=d63d2687188d3cada8138d8c82284f32</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2012.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2012.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DLessard%26aufirst%3DC.%2BJ.%26aulast%3DAdrianto%26aufirst%3DI.%26aulast%3DIce%26aufirst%3DJ.%2BA.%26aulast%3DWiley%26aufirst%3DG.%2BB.%26aulast%3DKelly%26aufirst%3DJ.%2BA.%26aulast%3DGlenn%26aufirst%3DS.%2BB.%26aulast%3DAdler%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRasmussen%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DA.%2BH.%26aulast%3DZiegler%26aufirst%3DJ.%26aulast%3DComeau%26aufirst%3DM.%2BE.%26aulast%3DMarion%26aufirst%3DM.%26aulast%3DWakeland%26aufirst%3DB.%2BE.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DRamos%26aufirst%3DP.%2BS.%26aulast%3DGrundahl%26aufirst%3DK.%2BM.%26aulast%3DGallant%26aufirst%3DC.%2BJ.%26aulast%3DAlarcon-Riquelme%26aufirst%3DM.%2BE.%26aulast%3DAlarcon%26aufirst%3DG.%2BS.%26aulast%3DAnaya%26aufirst%3DJ.%2BM.%26aulast%3DBae%26aufirst%3DS.%2BC.%26aulast%3DBoackle%26aufirst%3DS.%2BA.%26aulast%3DBrown%26aufirst%3DE.%2BE.%26aulast%3DChang%26aufirst%3DD.%2BM.%26aulast%3DCho%26aufirst%3DS.%2BK.%26aulast%3DCriswell%26aufirst%3DL.%2BA.%26aulast%3DEdberg%26aufirst%3DJ.%2BC.%26aulast%3DFreedman%26aufirst%3DB.%2BI.%26aulast%3DGilkeson%26aufirst%3DG.%2BS.%26aulast%3DJacob%26aufirst%3DC.%2BO.%26aulast%3DJames%26aufirst%3DJ.%2BA.%26aulast%3DKamen%26aufirst%3DD.%2BL.%26aulast%3DKimberly%26aufirst%3DR.%2BP.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DMerrill%26aufirst%3DJ.%2BT.%26aulast%3DNiewold%26aufirst%3DT.%2BB.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DPetri%26aufirst%3DM.%2BA.%26aulast%3DPons-Estel%26aufirst%3DB.%2BA.%26aulast%3DRamsey-Goldman%26aufirst%3DR.%26aulast%3DReveille%26aufirst%3DJ.%2BD.%26aulast%3DScofield%26aufirst%3DR.%2BH.%26aulast%3DSong%26aufirst%3DY.%2BW.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26aulast%3DTsao%26aufirst%3DB.%2BP.%26aulast%3DVila%26aufirst%3DL.%2BM.%26aulast%3DVyse%26aufirst%3DT.%2BJ.%26aulast%3DYu%26aufirst%3DC.%2BY.%26aulast%3DGuthridge%26aufirst%3DJ.%2BM.%26aulast%3DKaufman%26aufirst%3DK.%2BM.%26aulast%3DHarley%26aufirst%3DJ.%2BB.%26aulast%3DWakeland%26aufirst%3DE.%2BK.%26aulast%3DLangefeld%26aufirst%3DC.%2BD.%26aulast%3DGaffney%26aufirst%3DP.%2BM.%26aulast%3DMontgomery%26aufirst%3DC.%2BG.%26aulast%3DMoser%26aufirst%3DK.%2BL.%26atitle%3DIdentification%2520of%2520IRF8%252C%2520TMEM39A%252C%2520and%2520IKZF3-ZPBP2%2520as%2520susceptibility%2520loci%2520for%2520systemic%2520lupus%2520erythematosus%2520in%2520a%2520large-scale%2520multiracial%2520replication%2520study%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2012%26volume%3D90%26issue%3D4%26spage%3D648%26epage%3D660%26doi%3D10.1016%2Fj.ajhg.2012.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kronke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbach, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacBeth, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udeshi, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svinkina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConkey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullinger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span> </span><span class="NLM_article-title">Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">523</span><span class="NLM_x"> (</span><span class="NLM_issue">7559</span><span class="NLM_x">) </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1038/nature14610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature14610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=26131937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1entr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=183-188&issue=7559&author=J.+Kronkeauthor=E.+C.+Finkauthor=P.+W.+Hollenbachauthor=K.+J.+MacBethauthor=S.+N.+Hurstauthor=N.+D.+Udeshiauthor=P.+P.+Chamberlainauthor=D.+R.+Maniauthor=H.+W.+Manauthor=A.+K.+Gandhiauthor=T.+Svinkinaauthor=R.+K.+Schneiderauthor=M.+McConkeyauthor=M.+Jarasauthor=E.+Griffithsauthor=M.+Wetzlerauthor=L.+Bullingerauthor=B.+E.+Cathersauthor=S.+A.+Carrauthor=R.+Chopraauthor=B.+L.+Ebert&title=Lenalidomide+induces+ubiquitination+and+degradation+of+CK1alpha+in+del%285q%29+MDS&doi=10.1038%2Fnature14610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS</span></div><div class="casAuthors">Kronke, Jan; Fink, Emma C.; Hollenbach, Paul W.; MacBeth, Kyle J.; Hurst, Slater N.; Udeshi, Namrata D.; Chamberlain, Philip P.; Mani, D. R.; Man, Hon Wah; Gandhi, Anita K.; Svinkina, Tanya; Schneider, Rebekka K.; McConkey, Marie; Jaras, Marcus; Griffiths, Elizabeth; Wetzler, Meir; Bullinger, Lars; Cathers, Brian E.; Carr, Steven A.; Chopra, Rajesh; Ebert, Benjamin L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">7559</span>),
    <span class="NLM_cas:pages">183-188</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lenalidomide is a highly effective treatment for myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)).  Lenalidomide induces the ubiquitination of casein kinase 1A1 (CK1α) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN), resulting in CK1α degrdn.  CK1α is encoded by a gene within the common deleted region for del(5q) MDS and haplo-insufficient expression sensitizes cells to lenalidomide therapy, providing a mechanistic basis for the therapeutic window of lenalidomide in del(5q) MDS.  The authors found that mouse cells are resistant to lenalidomide but that changing a single amino acid in mouse Crbn to the corresponding human residue enables lenalidomide-dependent degrdn. of CK1α.  The authors further demonstrate that minor side chain modifications in thalidomide and a novel analog, CC-122, can modulate the spectrum of substrates targeted by CRL4CRBN.  These findings have implications for the clin. activity of lenalidomide and related compds., and demonstrate the therapeutic potential of novel modulators of E3 ubiquitin ligases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLiHx3FKesbVg90H21EOLACvtfcHk0lgFT9ome6qZvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1entr%252FN&md5=9b20a91c13e888e6569223ffa25af2cd</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnature14610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14610%26sid%3Dliteratum%253Aachs%26aulast%3DKronke%26aufirst%3DJ.%26aulast%3DFink%26aufirst%3DE.%2BC.%26aulast%3DHollenbach%26aufirst%3DP.%2BW.%26aulast%3DMacBeth%26aufirst%3DK.%2BJ.%26aulast%3DHurst%26aufirst%3DS.%2BN.%26aulast%3DUdeshi%26aufirst%3DN.%2BD.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DMani%26aufirst%3DD.%2BR.%26aulast%3DMan%26aufirst%3DH.%2BW.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DSvinkina%26aufirst%3DT.%26aulast%3DSchneider%26aufirst%3DR.%2BK.%26aulast%3DMcConkey%26aufirst%3DM.%26aulast%3DJaras%26aufirst%3DM.%26aulast%3DGriffiths%26aufirst%3DE.%26aulast%3DWetzler%26aufirst%3DM.%26aulast%3DBullinger%26aufirst%3DL.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26atitle%3DLenalidomide%2520induces%2520ubiquitination%2520and%2520degradation%2520of%2520CK1alpha%2520in%2520del%25285q%2529%2520MDS%26jtitle%3DNature%26date%3D2015%26volume%3D523%26issue%3D7559%26spage%3D183%26epage%3D188%26doi%3D10.1038%2Fnature14610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Matyskiela, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagarigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchelman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, P. P.</span><span> </span><span class="NLM_article-title">A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x"> (</span><span class="NLM_issue">7611</span><span class="NLM_x">) </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span><span class="refDoi"> DOI: 10.1038/nature18611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature18611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=27338790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCltbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=252-257&issue=7611&author=M.+E.+Matyskielaauthor=G.+Luauthor=T.+Itoauthor=B.+Pagariganauthor=C.+C.+Luauthor=K.+Millerauthor=W.+Fangauthor=N.+Y.+Wangauthor=D.+Nguyenauthor=J.+Houstonauthor=G.+Carmelauthor=T.+Tranauthor=M.+Rileyauthor=L.+Nosakaauthor=G.+C.+Landerauthor=S.+Gaidarovaauthor=S.+Xuauthor=A.+L.+Ruchelmanauthor=H.+Handaauthor=J.+Carmichaelauthor=T.+O.+Danielauthor=B.+E.+Cathersauthor=A.+Lopez-Gironaauthor=P.+P.+Chamberlain&title=A+novel+cereblon+modulator+recruits+GSPT1+to+the+CRL4%28CRBN%29+ubiquitin+ligase&doi=10.1038%2Fnature18611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase</span></div><div class="casAuthors">Matyskiela, Mary E.; Lu, Gang; Ito, Takumi; Pagarigan, Barbra; Lu, Chin-Chun; Miller, Karen; Fang, Wei; Wang, Nai-Yu; Nguyen, Derek; Houston, Jack; Carmel, Gilles; Tran, Tam; Riley, Mariko; Nosaka, Lyn'Al; Lander, Gabriel C.; Gaidarova, Svetlana; Xu, Shuichan; Ruchelman, Alexander L.; Handa, Hiroshi; Carmichael, James; Daniel, Thomas O.; Cathers, Brian E.; Lopez-Girona, Antonia; Chamberlain, Philip P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7611</span>),
    <span class="NLM_cas:pages">252-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Immunomodulatory drugs bind to cereblon (CRBN) to confer differentiated substrate specificity on the CRL4CRBN E3 ubiquitin ligase.  Here we report the identification of a new cereblon modulator, CC-885, with potent anti-tumor activity.  The anti-tumor activity of CC-885 is mediated through the cereblon-dependent ubiquitination and degrdn. of the translation termination factor GSPT1.  Patient-derived acute myeloid leukemia tumor cells exhibit high sensitivity to CC-885, indicating the clin. potential of this mechanism.  Crystallog. studies of the CRBN-DDB1-CC-885-GSPT1 complex reveal that GSPT1 binds to cereblon through a surface turn contg. a glycine residue at a key position, interacting with both CC-885 and a 'hotspot' on the cereblon surface.  Although GSPT1 possesses no obvious structural, sequence or functional homol. to previously known cereblon substrates, mutational anal. and modeling indicate that the cereblon substrate Ikaros uses a similar structural feature to bind cereblon, suggesting a common motif for substrate recruitment.  These findings define a structural degron underlying cereblon 'neosubstrate' selectivity, and identify an anti-tumor target rendered druggable by cereblon modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgAWiXdlJgYLVg90H21EOLACvtfcHk0lgFT9ome6qZvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCltbnI&md5=1d4e340416aa0b08fc0f123faf638c3f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnature18611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18611%26sid%3Dliteratum%253Aachs%26aulast%3DMatyskiela%26aufirst%3DM.%2BE.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DC.%2BC.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DN.%2BY.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DHouston%26aufirst%3DJ.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DRiley%26aufirst%3DM.%26aulast%3DNosaka%26aufirst%3DL.%26aulast%3DLander%26aufirst%3DG.%2BC.%26aulast%3DGaidarova%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26atitle%3DA%2520novel%2520cereblon%2520modulator%2520recruits%2520GSPT1%2520to%2520the%2520CRL4%2528CRBN%2529%2520ubiquitin%2520ligase%26jtitle%3DNature%26date%3D2016%26volume%3D535%26issue%3D7611%26spage%3D252%26epage%3D257%26doi%3D10.1038%2Fnature18611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chamberlain, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagarigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chie-Leon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corral, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B. E.</span><span> </span><span class="NLM_article-title">Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span><span class="refDoi"> DOI: 10.1038/nsmb.2874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnsmb.2874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=25108355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlahurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=803-809&issue=9&author=P.+P.+Chamberlainauthor=A.+Lopez-Gironaauthor=K.+Millerauthor=G.+Carmelauthor=B.+Pagariganauthor=B.+Chie-Leonauthor=E.+Rychakauthor=L.+G.+Corralauthor=Y.+J.+Renauthor=M.+Wangauthor=M.+Rileyauthor=S.+L.+Delkerauthor=T.+Itoauthor=H.+Andoauthor=T.+Moriauthor=Y.+Hiranoauthor=H.+Handaauthor=T.+Hakoshimaauthor=T.+O.+Danielauthor=B.+E.+Cathers&title=Structure+of+the+human+Cereblon-DDB1-lenalidomide+complex+reveals+basis+for+responsiveness+to+thalidomide+analogs&doi=10.1038%2Fnsmb.2874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs</span></div><div class="casAuthors">Chamberlain, Philip P.; Lopez-Girona, Antonia; Miller, Karen; Carmel, Gilles; Pagarigan, Barbra; Chie-Leon, Barbara; Rychak, Emily; Corral, Laura G.; Ren, Yan J.; Wang, Maria; Riley, Mariko; Delker, Silvia L.; Ito, Takumi; Ando, Hideki; Mori, Tomoyuki; Hirano, Yoshinori; Handa, Hiroshi; Hakoshima, Toshio; Daniel, Thomas O.; Cathers, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">803-809</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Cul4-Rbx1-DDB1-Cereblon E3 ubiquitin ligase complex is the target of thalidomide, lenalidomide and pomalidomide, therapeutically important drugs for multiple myeloma and other B-cell malignancies.  These drugs directly bind Cereblon (CRBN) and promote the recruitment of substrates Ikaros (IKZF1) and Aiolos (IKZF3) to the E3 complex, thus leading to substrate ubiquitination and degrdn.  Here we present the crystal structure of human CRBN bound to DDB1 and the drug lenalidomide.  A hydrophobic pocket in the thalidomide-binding domain (TBD) of CRBN accommodates the glutarimide moiety of lenalidomide, whereas the isoindolinone ring is exposed to solvent.  We also solved the structures of the mouse TBD in the apo state and with thalidomide or pomalidomide.  Site-directed mutagenesis in lentiviral-expression myeloma models showed that key drug-binding residues are crit. for antiproliferative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtN-ZCacB1m7Vg90H21EOLACvtfcHk0lhXlM80G1K5Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahurjI&md5=627fc3c8eae320059ca1cdc173bb56ed</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2874%26sid%3Dliteratum%253Aachs%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DChie-Leon%26aufirst%3DB.%26aulast%3DRychak%26aufirst%3DE.%26aulast%3DCorral%26aufirst%3DL.%2BG.%26aulast%3DRen%26aufirst%3DY.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DRiley%26aufirst%3DM.%26aulast%3DDelker%26aufirst%3DS.%2BL.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DHirano%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DHakoshima%26aufirst%3DT.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DCathers%26aufirst%3DB.%2BE.%26atitle%3DStructure%2520of%2520the%2520human%2520Cereblon-DDB1-lenalidomide%2520complex%2520reveals%2520basis%2520for%2520responsiveness%2520to%2520thalidomide%2520analogs%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D21%26issue%3D9%26spage%3D803%26epage%3D809%26doi%3D10.1038%2Fnsmb.2874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fischer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydeard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavadini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serluca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraju, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichkule, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schebesta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckwith, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, N. H.</span><span> </span><span class="NLM_article-title">Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">512</span><span class="NLM_x"> (</span><span class="NLM_issue">7512</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1038/nature13527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature13527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=25043012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=512&publication_year=2014&pages=49-53&issue=7512&author=E.+S.+Fischerauthor=K.+Bohmauthor=J.+R.+Lydeardauthor=H.+Yangauthor=M.+B.+Stadlerauthor=S.+Cavadiniauthor=J.+Nagelauthor=F.+Serlucaauthor=V.+Ackerauthor=G.+M.+Lingarajuauthor=R.+B.+Tichkuleauthor=M.+Schebestaauthor=W.+C.+Forresterauthor=M.+Schirleauthor=U.+Hassiepenauthor=J.+Ottlauthor=M.+Hildauthor=R.+E.+Beckwithauthor=J.+W.+Harperauthor=J.+L.+Jenkinsauthor=N.+H.+Thoma&title=Structure+of+the+DDB1-CRBN+E3+ubiquitin+ligase+in+complex+with+thalidomide&doi=10.1038%2Fnature13527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide</span></div><div class="casAuthors">Fischer, Eric S.; Bohm, Kerstin; Lydeard, John R.; Yang, Haidi; Stadler, Michael B.; Cavadini, Simone; Nagel, Jane; Serluca, Fabrizio; Acker, Vincent; Lingaraju, Gondichatnahalli M.; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hassiepen, Ulrich; Ottl, Johannes; Hild, Marc; Beckwith, Rohan E. J.; Harper, J. Wade; Jenkins, Jeremy L.; Thoma, Nicolas H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">512</span>
        (<span class="NLM_cas:issue">7512</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects.  Despite the teratogenicity of thalidomide and its derivs. lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-assocd. dysplasia.  IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4CRBN.  Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide.  The structure establishes that CRBN is a substrate receptor within CRL4CRBN and enantioselectively binds IMiDs.  Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4CRBN.  Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4CRBN while the ligase complex is recruiting IKZF1 or IKZF3 for degrdn.  This dual activity implies that small mols. can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGt2Y9GecKr7Vg90H21EOLACvtfcHk0lgpZblt0lqtzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP&md5=1c1eaa48bef87463cdd3f2b1e1bd400d</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1038%2Fnature13527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13527%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DBohm%26aufirst%3DK.%26aulast%3DLydeard%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStadler%26aufirst%3DM.%2BB.%26aulast%3DCavadini%26aufirst%3DS.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DAcker%26aufirst%3DV.%26aulast%3DLingaraju%26aufirst%3DG.%2BM.%26aulast%3DTichkule%26aufirst%3DR.%2BB.%26aulast%3DSchebesta%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DW.%2BC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DOttl%26aufirst%3DJ.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DBeckwith%26aufirst%3DR.%2BE.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DJenkins%26aufirst%3DJ.%2BL.%26aulast%3DThoma%26aufirst%3DN.%2BH.%26atitle%3DStructure%2520of%2520the%2520DDB1-CRBN%2520E3%2520ubiquitin%2520ligase%2520in%2520complex%2520with%2520thalidomide%26jtitle%3DNature%26date%3D2014%26volume%3D512%26issue%3D7512%26spage%3D49%26epage%3D53%26doi%3D10.1038%2Fnature13527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Petzold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, N. H.</span><span> </span><span class="NLM_article-title">Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">532</span><span class="NLM_x"> (</span><span class="NLM_issue">7597</span><span class="NLM_x">) </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1038/nature16979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature16979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=26909574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFOis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=532&publication_year=2016&pages=127-130&issue=7597&author=G.+Petzoldauthor=E.+S.+Fischerauthor=N.+H.+Thoma&title=Structural+basis+of+lenalidomide-induced+CK1alpha+degradation+by+the+CRL4%28CRBN%29+ubiquitin+ligase&doi=10.1038%2Fnature16979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase</span></div><div class="casAuthors">Petzold, Georg; Fischer, Eric S.; Thoma, Nicolas H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">532</span>
        (<span class="NLM_cas:issue">7597</span>),
    <span class="NLM_cas:pages">127-130</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thalidomide and its derivs., lenalidomide and pomalidomide, are immune modulatory drugs (IMiDs) used in the treatment of hematol. malignancies.  IMiDs bind CRBN, the substrate receptor of the CUL4-RBX1-DDB1-CRBN (also known as CRL4CRBN) E3 ubiquitin ligase, and inhibit ubiquitination of endogenous CRL4CRBN substrates.  Unexpectedly, IMiDs also repurpose the ligase to target new proteins for degrdn.  Lenalidomide induces degrdn. of the lymphoid transcription factors Ikaros and Aiolos (also known as IKZF1 and IKZF3), and casein kinase 1α (CK1α), which contributes to its clin. efficacy in the treatment of multiple myeloma and 5q-deletion assocd. myelodysplastic syndrome (del(5q) MDS), resp.  How lenalidomide alters the specificity of the ligase to degrade these proteins remains elusive.  Here we present the 2.45 Å crystal structure of DDB1-CRBN bound to lenalidomide and CK1α.  CRBN and lenalidomide jointly provide the binding interface for a CK1α β-hairpin-loop located in the kinase N-lobe.  We show that CK1α binding to CRL4CRBN is strictly dependent on the presence of an IMiD.  Binding of IKZF1 to CRBN similarly requires the compd. and both, IKZF1 and CK1α, use a related binding mode.  Our study provides a mechanistic explanation for the selective efficacy of lenalidomide in del(5q) MDS therapy.  We anticipate that high-affinity protein-protein interactions induced by small mols. will provide opportunities for drug development, particularly for targeted protein degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4FxWriI1ObVg90H21EOLACvtfcHk0lgpZblt0lqtzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFOis78%253D&md5=320fc6ff811da335fa8e02feab2d702d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature16979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16979%26sid%3Dliteratum%253Aachs%26aulast%3DPetzold%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DThoma%26aufirst%3DN.%2BH.%26atitle%3DStructural%2520basis%2520of%2520lenalidomide-induced%2520CK1alpha%2520degradation%2520by%2520the%2520CRL4%2528CRBN%2529%2520ubiquitin%2520ligase%26jtitle%3DNature%26date%3D2016%26volume%3D532%26issue%3D7597%26spage%3D127%26epage%3D130%26doi%3D10.1038%2Fnature16979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sheard, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Nissan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span> </span><span class="NLM_article-title">Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x"> (</span><span class="NLM_issue">7322</span><span class="NLM_x">) </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">405</span><span class="refDoi"> DOI: 10.1038/nature09430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature09430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=20927106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Gju7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=400-405&issue=7322&author=L.+B.+Sheardauthor=X.+Tanauthor=H.+Maoauthor=J.+Withersauthor=G.+Ben-Nissanauthor=T.+R.+Hindsauthor=Y.+Kobayashiauthor=F.+F.+Hsuauthor=M.+Sharonauthor=J.+Browseauthor=S.+Y.+Heauthor=J.+Rizoauthor=G.+A.+Howeauthor=N.+Zheng&title=Jasmonate+perception+by+inositol-phosphate-potentiated+COI1-JAZ+co-receptor&doi=10.1038%2Fnature09430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor</span></div><div class="casAuthors">Sheard, Laura B.; Tan, Xu; Mao, Haibin; Withers, John; Ben-Nissan, Gili; Hinds, Thomas R.; Kobayashi, Yuichi; Hsu, Fong-Fu; Sharon, Michal; Browse, John; He, Sheng Yang; Rizo, Josep; Howe, Gregg A.; Zheng, Ning</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7322</span>),
    <span class="NLM_cas:pages">400-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Jasmonates are a family of plant hormones that regulate plant growth, development and responses to stress.  The F-box protein CORONATINE INSENSITIVE 1 (COI1) mediates jasmonate signaling by promoting hormone-dependent ubiquitylation and degrdn. of transcriptional repressor JAZ proteins.  Despite its importance, the mechanism of jasmonate perception remains unclear.  Here we present structural and pharmacol. data to show that the true Arabidopsis jasmonate receptor is a complex of both COI1 and JAZ.  COI1 contains an open pocket that recognizes the bioactive hormone (3R,7S)-jasmonoyl-L-isoleucine (JA-Ile) with high specificity.  High-affinity hormone binding requires a bipartite JAZ degron sequence consisting of a conserved α-helix for COI1 docking and a loop region to trap the hormone in its binding pocket.  In addn., we identify a third crit. component of the jasmonate co-receptor complex, inositol pentakisphosphate, which interacts with both COI1 and JAZ adjacent to the ligand.  Our results unravel the mechanism of jasmonate perception and highlight the ability of F-box proteins to evolve as multi-component signaling hubs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Hj6OLb0OoLVg90H21EOLACvtfcHk0lg6c13mMFUu2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Gju7rP&md5=cf4039c73f3a900f74b02bbaa9f5df34</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnature09430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09430%26sid%3Dliteratum%253Aachs%26aulast%3DSheard%26aufirst%3DL.%2BB.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DWithers%26aufirst%3DJ.%26aulast%3DBen-Nissan%26aufirst%3DG.%26aulast%3DHinds%26aufirst%3DT.%2BR.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DHsu%26aufirst%3DF.%2BF.%26aulast%3DSharon%26aufirst%3DM.%26aulast%3DBrowse%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DS.%2BY.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DHowe%26aufirst%3DG.%2BA.%26aulast%3DZheng%26aufirst%3DN.%26atitle%3DJasmonate%2520perception%2520by%2520inositol-phosphate-potentiated%2520COI1-JAZ%2520co-receptor%26jtitle%3DNature%26date%3D2010%26volume%3D468%26issue%3D7322%26spage%3D400%26epage%3D405%26doi%3D10.1038%2Fnature09430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon-Villalobos, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span> </span><span class="NLM_article-title">Mechanism of auxin perception by the TIR1 ubiquitin ligase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x"> (</span><span class="NLM_issue">7136</span><span class="NLM_x">) </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span><span class="refDoi"> DOI: 10.1038/nature05731</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnature05731" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=640-645&issue=7136&author=X.+Tanauthor=L.+I.+Calderon-Villalobosauthor=M.+Sharonauthor=C.+Zhengauthor=C.+V.+Robinsonauthor=M.+Estelleauthor=N.+Zheng&title=Mechanism+of+auxin+perception+by+the+TIR1+ubiquitin+ligase&doi=10.1038%2Fnature05731"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fnature05731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05731%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.%26aulast%3DCalderon-Villalobos%26aufirst%3DL.%2BI.%26aulast%3DSharon%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DRobinson%26aufirst%3DC.%2BV.%26aulast%3DEstelle%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DN.%26atitle%3DMechanism%2520of%2520auxin%2520perception%2520by%2520the%2520TIR1%2520ubiquitin%2520ligase%26jtitle%3DNature%26date%3D2007%26volume%3D446%26issue%3D7136%26spage%3D640%26epage%3D645%26doi%3D10.1038%2Fnature05731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Protein degradation: Prime time for PROTACs</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1038/nchembio.1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1038%2Fnchembio.1887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=26284668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKntrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=634-635&issue=9&author=R.+J.+Deshaies&title=Protein+degradation%3A+Prime+time+for+PROTACs&doi=10.1038%2Fnchembio.1887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Protein degradation. Prime time for PROTACs</span></div><div class="casAuthors">Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">634-635</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  PROTACs (proteolysis-targeting chimeric mols.) are heterobifunctional small mols. that simultaneously bind a target protein and a ubiquitin ligase, enabling ubiquitination and degrdn. of the target.  Major progress in developing potent and specific PROTACs has recently been reported, invigorating prospects for novel PROTAC-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcMM05VgBV07Vg90H21EOLACvtfcHk0ljI_xiQLmTNdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKntrvF&md5=cea6459c9e7a6911b8368c544af23a1f</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1887%26sid%3Dliteratum%253Aachs%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520degradation%253A%2520Prime%2520time%2520for%2520PROTACs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D9%26spage%3D634%26epage%3D635%26doi%3D10.1038%2Fnchembio.1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Toure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-molecule PROTACS: new approaches to protein degradation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1966</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span><span class="refDoi"> DOI: 10.1002/anie.201507978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1002%2Fanie.201507978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1966-1973&issue=6&author=M.+Toureauthor=C.+M.+Crews&title=Small-molecule+PROTACS%3A+new+approaches+to+protein+degradation&doi=10.1002%2Fanie.201507978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule PROTACS: New Approaches to Protein Degradation</span></div><div class="casAuthors">Toure, Momar; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1966-1973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The current inhibitor-based approach to therapeutics has inherent limitations owing to its occupancy-based model: there is a need to maintain high systemic exposure to ensure sufficient in vivo inhibition, high in vivo concns. bring potential for off-target side effects, and there is a need to bind to an active site, thus limiting the drug target space.  As an alternative, induced protein degrdn. lacks these limitations.  Based on an event-driven model, this approach offers a novel catalytic mechanism to irreversibly inhibit protein function by targeting protein destruction through recruitment to the cellular quality control machinery.  Prior protein degrading strategies have lacked therapeutic potential.  However, recent reports of small-mol.-based proteolysis-targeting chimeras (PROTACs) have demonstrated that this technol. can effectively decrease the cellular levels of several protein classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdaqlIjCSsgrVg90H21EOLACvtfcHk0ljqyHlVAMP07w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2ltA%253D%253D&md5=47838cd15719757317cb8282c26cc59e</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507978%26sid%3Dliteratum%253Aachs%26aulast%3DToure%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520PROTACS%253A%2520new%2520approaches%2520to%2520protein%2520degradation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D6%26spage%3D1966%26epage%3D1973%26doi%3D10.1002%2Fanie.201507978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Man, H.; Muller, G. W.; Ruchelman, A. L.; Khalil, E. M.; Chen, R. S.; Zhang, W.</span>, <span> </span><span class="NLM_article-title">Arylmethoxy isoindolinone derivatives and compositions comprising and methods of using the same</span>. US Patent 8,518,972,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Man&author=G.+W.+Muller&author=A.+L.+Ruchelman&author=E.+M.+Khalil&author=R.+S.+Chen&author=W.+Zhang&title=Arylmethoxy+isoindolinone+derivatives+and+compositions+comprising+and+methods+of+using+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMan%26aufirst%3DH.%26atitle%3DArylmethoxy%2520isoindolinone%2520derivatives%2520and%2520compositions%2520comprising%2520and%2520methods%2520of%2520using%2520the%2520same%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Boichenko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deiss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez Alvarez, B.</span><span> </span><span class="NLM_article-title">A FRET-based assay for the identification and characterization of cereblon ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01735</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01735" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=770-774&issue=2&author=I.+Boichenkoauthor=S.+Deissauthor=K.+Barauthor=M.+D.+Hartmannauthor=B.+Hernandez+Alvarez&title=A+FRET-based+assay+for+the+identification+and+characterization+of+cereblon+ligands&doi=10.1021%2Facs.jmedchem.5b01735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A FRET-Based Assay for the Identification and Characterization of Cereblon Ligands</span></div><div class="casAuthors">Boichenko, Iuliia; Deiss, Silvia; Baer, Kerstin; Hartmann, Marcus D.; Hernandez Alvarez, Birte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">770-774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cereblon serves as an ubiquitin ligase substrate receptor that can be tuned toward different target proteins by various cereblon-binding agents.  This offers one of the most promising avenues for targeted protein degrdn. in cancer therapy, but cereblon binding can also mediate teratogenic effects.  We present an effective assay that is suited for high-throughput screening of compd. libraries for off-target cereblon interactions but also can guide lead optimization and rational design of novel cereblon effector mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzkRpBLlhlVbVg90H21EOLACvtfcHk0limA1C6izqm2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yktg%253D%253D&md5=f0400506428f439e81f579204e0bd39d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01735%26sid%3Dliteratum%253Aachs%26aulast%3DBoichenko%26aufirst%3DI.%26aulast%3DDeiss%26aufirst%3DS.%26aulast%3DBar%26aufirst%3DK.%26aulast%3DHartmann%26aufirst%3DM.%2BD.%26aulast%3DHernandez%2BAlvarez%26aufirst%3DB.%26atitle%3DA%2520FRET-based%2520assay%2520for%2520the%2520identification%2520and%2520characterization%2520of%2520cereblon%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D2%26spage%3D770%26epage%3D774%26doi%3D10.1021%2Facs.jmedchem.5b01735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Katagiri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonezawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, T.</span><span> </span><span class="NLM_article-title">Two distinct human myeloma cell lines originating from one patient with myeloma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1002/ijc.2910360217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1002%2Fijc.2910360217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=3926660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A280%3ADyaL2M3mtVWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1985&pages=241-246&issue=2&author=S.+Katagiriauthor=T.+Yonezawaauthor=J.+Kuyamaauthor=Y.+Kanayamaauthor=T.+Tamakiauthor=M.+Ohnishiauthor=S.+Taruiauthor=K.+Nishidaauthor=T.+Abe&title=Two+distinct+human+myeloma+cell+lines+originating+from+one+patient+with+myeloma&doi=10.1002%2Fijc.2910360217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Two distinct human myeloma cell lines originating from one patient with myeloma</span></div><div class="casAuthors">Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-6</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Two distinct cell lines (OPM-1 and OPM-2) were established from the peripheral blood of a 56-year-old female myeloma patient at the stage of terminal leukemic evolution associated with loss of cytoplasmic immunoglobulin heavy chain (G lambda----lambda).  The lines grew in suspension with a doubling time of 36-42 hr and 30-36 hr, respectively.  EBNA was absent from both lines.  The lines synthesized cytoplasmic lambda-chain, but had no detectable surface immunoglobulins.  Fc receptors and complement receptors could not be detected in either line.  The lines had very complex chromosomal abnormalities, but the patterns of chromosomes differed greatly between the two lines.  The two lines, together with the RPMI 8226 line established by Matsuoka et al. (1967), were analyzed for phenotypic expression as defined by a panel of monoclonal antibodies to B cells (B1, BA-1, BA-2, BA-3, OKIa-1 and OKT10/BMA0100).  Neither OPM-1 nor OPM-2 reacted with any of the antibodies tested except OKT10.  OPM-1 cells reacted weakly (less than 30%) with OKT10/BMA0100, while OPM-2 cells showed a fluctuating reactivity, ranging from 40 to 80%, with OKT10/BMA0100.  In contrast, RPMI 8226 reacted strongly with OKT10 and BA-2.  These results demonstrate the presence of phenotypic heterogeneity in all 3 myeloma cell lines, suggesting that the lines might represent different stages of terminal B-cell development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_-dVNKy-ESisZ1x6zOs0vfW6udTcc2eajyLpjkaw8x7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3mtVWnsw%253D%253D&md5=bf38cf9b35f120a08ab881db395c8f30</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910360217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910360217%26sid%3Dliteratum%253Aachs%26aulast%3DKatagiri%26aufirst%3DS.%26aulast%3DYonezawa%26aufirst%3DT.%26aulast%3DKuyama%26aufirst%3DJ.%26aulast%3DKanayama%26aufirst%3DY.%26aulast%3DTamaki%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DM.%26aulast%3DTarui%26aufirst%3DS.%26aulast%3DNishida%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DT.%26atitle%3DTwo%2520distinct%2520human%2520myeloma%2520cell%2520lines%2520originating%2520from%2520one%2520patient%2520with%2520myeloma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1985%26volume%3D36%26issue%3D2%26spage%3D241%26epage%3D246%26doi%3D10.1002%2Fijc.2910360217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liPwlXTc2g4lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&issue=4&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lj3yEVIGSv1Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3D4%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZ4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZ4','PDB','4TZ4'); return false;">PDB: 4TZ4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V3O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V3O','PDB','5V3O'); return false;">PDB: 5V3O</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01921">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_10647"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01921">10.1021/acs.jmedchem.6b01921</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Quantitation of GSPT1 degradation with chemiluminescent cell-based assay; comparison of lenalidomide and compound <b>6</b> binding modes; sample electron density from the CRBN-DDB1-compound <b>6</b> crystal structure; X-ray data and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_001.pdf">jm6b01921_si_001.pdf (580.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01921/suppl_file/jm6b01921_si_002.csv">jm6b01921_si_002.csv (0.22 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates for the structure of CRBN-DDB1- <b>6</b> have been deposited in the Protein Data Bank with the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V3O">5V3O</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01921&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-2%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01921%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01921" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a43b8490c221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
